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\
'Men ought to know that from the brain, and from the brain only, arise our pleasures joys, laughter, and jests, aswell as our sorrows, pains, griefs, and tears. Through it, in particular, we think, see, hear, and distinguish the ugly from the beautiful, the bad from the good, the pleasant from the unpleasant...'
-Hippocrates.
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Abstract
The aim of this project was to determine the neurotrophic factor survival 
requirements of PNS neurons during development and to clarify the role of 
certain receptors in mediating responsiveness. Members of the neurotrophin 
family of neurotrophic factors (NGF, BDNF, NT3 and NT4/5) and neurotrophic 
cytokines (CNTF, LIF, GSM, IL-6 and CT-1) were studied.
The activity of a recently identified neurotrophin, NT4/5, was 
investigated in vitro. In cultures of mouse neurons, mammalian NT4/5 
promoted the survival of the same kinds of neurons as BDNF and was as potent 
as BDNF, which is consistent with the action of both neurotrophins on the same 
receptor, TrkB. However, both mammalian NT-4/5 and the Xenopus homologue 
were less potent than mammalian BDNF on chicken embiyo neurons, which is 
consistent with the lower evolutionary conservation of NT4/5. Interestingly, 
mammalian NT4/5 exhibited differences in potency on certain populations of 
chicken neurons that responded equally well to BDNF, and this may reflect 
differences in TrkB receptors in these different populations of neurons.
To clarify the role of the common neurotrophin receptor in modulating 
the response of neurons to NGF, I then compared the actions of NGF with a 
mutated NGF protein that binds to TrkA, but does not bind to p75. At 
subsaturating concentrations, the NGF mutant was less effective than NGF in 
promoting the survival of embryonic sensory neurons and postnatal sympathetic 
neurons but was equally effective as NGF in promoting the survival of 
embryonic sympathetic neurons, indicating that binding of NGF to p75 enhances 
the sensitivity of NGF-dependent neurons to NGF at certain stages of 
development.
To investigate if neurotrophic cytokines act on developing sensory 
neurons, I studied their effects in vitro. Whereas trigeminal neurons were
responded to cytokines in the late fetal period, nodose neurons were supported 
by these factors throughout embryonic development. These findings indicate 
that different populations of PNS neurons display different patterns of 
responsiveness to neurotrophic cytokines during development.
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CHAPTER 1
GENERAL INTRODUCTION
1.1 Early Development in the Vertebrate Nervous System,
Eaiiy development of the vertebrate nervous system commences with a 
process called neurulation. With the exception of the neurons of certain cranial 
sensory ganglia, all elements of the central and peripheral nervous systems are 
derived from a specialised region of ectoderm that lies along the dorsal midline 
of the developing embryo. This ectoderm thickens and under the influence of 
underlying structures, rolls up to form a hollow groove. The lateral edges of this 
groove then begin to fuse rostrally and caudally. When the process of fusion is 
complete, the original neural groove is converted into a structure called the 
neural tube. This neural tube then separates from the overlying ectoderm and 
foims the main elements of the central nervous system. At the point where the 
neural tube and ectoderm separate, certain cells detach from these structures to 
form a continous column called the neural crest. Cells of the neural crest give 
rise to most of the peripheral nervous system (PNS) incorporating most sensory 
and autonomic neurons, various support cells within the PNS and Schwann cells. 
A subset of cranial sensory neurons are not derived from the neural crest but 
from regions of epithelial thickening that appeal* in the cephalic ectoderm of the 
eaily vertebrate embryo (Von Kuppfer, 1894).
l.Z Development of Sensory Neurons.
The differentiation of sensory neurons proceeds after migration of their 
progenitor cells from the neural crest and neurogenic placodes to the site of the 
sensory ganglia, and is chaiacterised by the appearance of axonal processes and 
the expression of certain neuron specific proteins, such as neurofilament protein 
(Le Douaiin, 1986).
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The neural crest gives rise to most of the neurons of the cranial and 
spinal sensory ganglia, and postganglionic neurons of the sympathetic and to the 
neurons of the autonomic and enteric nervous systems. The neurons of certain 
cranial ganglia, however, aie derived either entirely from neurogenic placodes or 
from combinations of placodal and neural crest cells. In cranial sensoiy ganglia, 
the placode-derived neurons aie always located distally with respect to neurons 
from the neural crest (Le Douaiin, 1982). The origin of neurons in avian cranial 
sensory ganglia has been determined by a series of mapping experiments 
involving the transplantation of neural crest and placode derived cells (Weston, 
1962; Le Douaiin, 1973). The result of these experiments are summarised in 
table 1.1. The cranial sensoiy ganglia, with the exception of a sub-population of 
neural-crest derived sensory neurons in the embryonic mid-brain (trigeminal 
mesencephalic nucleus or TMN), aie situated on five of the twelve pairs of 
cranial nerves. The cell bodies of peripheral sensory neurons aie located in the 
dorsal root ganglia, situated at the dorsal root of the spinal nerves, and in the 
cranial sensory ganglia.
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Ganglion Nerve Embryonic origin
Trigeminal
dorsomedial Neural crest
ventrolateral Placode
TMN Neural Crest
Geniculate VII Placode
Vestibular vm Otic placode
Acoustic vm Otic placode
Jugular-superior JX/X Neural Crest
Petrosal IX Placode
Nodose Placode
Table 1.1 Origins of the avian cranial sensory ganglia
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1.3 Programmed Cell Death During Nervous System Development.
A striking feature in the development of the vertebrate nervous system is 
the occurrence of extensive neuronal death. After sensory neurons have 
differentiated within sensory ganglia axonal outgrowth to peripheral and central 
targets commences. The peripheral targets comprise tissues that are innervated 
by the sensoiy axons, whereas the central taigets comprise second order neurons 
with which the sensory neurons synapse. During the period when neurons are 
innervating these targets, appropriate connections are established by means of 
selection. This selection is achieved by the production of limiting quantities of 
neurotrophic factors that are synthesised by the target tissues shortly after 
innervation commences. Inappropriately connected neurons do not receive an 
adequate supply of trophic factor and undergo a series of molecular events that 
ultimately results in their degeneration and death (for review see Oppenheim, 
1991 ).
Two types of morphological change that accompany cell death have been 
distinguished. One is termed necrosis, and is chaiacterised by cellular oedema 
that results in rupture of the plasma membrane and leakage of the cellular 
contents (Kerr etal., 1972). The other degenerative process, termed apoptosis, 
involves a progressive contraction of cell volume accompanied by nuclear 
condensation and degradation of DNA into oligonulceosomal fragments (Wyllie 
et aL, 1980). During development, neurons die by apoptosis, whereas necrosis 
generally occurs in pathological situations. Four main features are now thought 
to typify the apoptotic cell death observed in animal cells. These are: 
constitutive expression of cell death proteins, degeneration involving a 
proteolytic cascade, control by intracellular regulatory proteins, and activation of 
the death program by gene transcription (Jacobson et a l, 1997).
Genetic studies of two invertebrates, the nematode Caenorhabditis 
elegans and Drosophila melanogaster, have provided most of the insight into
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the genes regulating apoptosis. There is now a growing body of evidence to 
suggest that many of these proteins have been conserved throughout animal 
evolution (Hengartner et al., 1996). The constitutive expression of cell death 
proteins was initially discovered in genetic studies of C. elegans that identified 
two genes, called ced-3, and ced-4, that aie critical for the somatic cell death that 
occurs during nematode development (Chinnaiyan and Dixit, 1996; Jacobson et 
ah, 1996 for reviews). Mutation of either ced-3 or ced-4, abolishes the apoptotic 
capability of the cells that are required to die during C. elegans development 
(Chinnaiyan and Dixit, 1996). Several mammalian homologues of the CED-3 
protein have recently been identified. The first of these, interleukin-ip 
converting enzyme (ICE), is a cysteine protease necessaiy for the processing of 
pro-BL-lp into its active form (Yuan et a i, 1993). To date, around six 
homologues of CED-3 and ICE have been characterised and several more have 
been identified as expressed sequence tags (ESTs) of human genes comprising a 
new cysteine protease family termed 'caspases' (for cysteine aspase) (Chinnaiyan 
and Dixit, 1996; Jacobson et al., 1996). All caspases are known to cleave their 
substrates after specific aspartic acids. In addition, they can activate themselves 
or other caspases in vitro, leading to the suggestion that they act in a proteolytic 
cascade (Nagata et al., 1996). A further intracellular mechanism for the 
regulation of cell death has been conserved during evolution. The ced-9 gene 
acts to inhibit cell death in C. elegans, and is homologous to the bcl-2 gene 
which acts to inhibit cell death in mammals (Jacobson et al., 1996). A number 
of proteins that have homology to Bcl-2 have now been identified in mammals. 
Some homologous proteins, such as Bc1-Xl inhibit apoptosis, whereas others, 
such as Bax and Bad, promote apoptosis (Chinnaiyan and Dixit, 1996; Jacobson 
et al., 1996). Studies of Drosophila melanogaster have been useful in 
determining how cell death effectors may be activated (Chinnaiyan et al., 1996). 
The reaper gene encodes a 65 amino acid residue polypeptide that is 
upregulated during cell death in Drosophila and is capable of integrating signals 
from several pathways to activate the apoptotic death program (White et ah,
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1994; White et al.  ^ 1996). The means by which I'eaper effects cell death is 
uncleai', however, it is known to be transcriptionally upregulated to signal death 
and it possesses weak homology with the so-called 'death domain' of certain 
mammalian proteins, including Fas/APO-1, and TNFR-1 (Golstein et al, 1995).
1,4,1 Control of Neuronal Survival by Neurotrophic Factors
Classic work, showing that sympathetic and certain sensory neurons 
require a supply of an exogenously derived agent during a critical stage of their 
development, led to the discovery of nerve growth factor (NGF) (reviewed by 
Levi-Montalcini, 1987). In addition to this work, studies demonstrating that 
NGF is synthesised in the tai'get fields of NGF-dependent neurons in proportion 
to their innervation density during development (Korsching and Thoenen, 
1983a; Heumann et al., 1984; Shelton and Reichardt, 1984; Harper and Davies, 
1990), and that NGF is delivered from these tissues to the cell bodies of the 
innervating axons by rapid axonal transport (Hendry et ah, 1974; Korsching and 
Thoenen, 1983b), provided a basis for the "neurotrophic theory".
The neurotrophic theory proposes that tai'get fields directly influence the 
size of populations of neurons innervating them (reviewed by Purves et at., 
1988). Since a substantial number of neurons that innervate a pai'ticular target 
are lost by cell death shortly after target encounter (Oppenheim, 1991), limited 
availability of a trophic factor or factors in the target fields permits the survival 
of the required number of neurons (Thoenen and Barde, 1980). The striking 
changes in sensory and sympathetic innervation induced by addition of anti- 
NGF antibodies to neonatal mice (Levi-Montalcini, 1987), and more recently 
targeted mutation of the gene encoding NGF (Crowley et al., 1994), has 
provided confiimation of the neurotrophic theoiy.
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The neurotrophic theory is further reinforced by studies of the site and 
timing of NGF synthesis and NGF receptor expression during development. It 
has been demonstrated that the commencement of NGF synthesis in the target 
fields of NGF-dependent sensory and sympathetic neurons is concomitant with 
the onset of target field innervation (Davies et aL, 1987a;Korsching and 
Thoenen, 1988).
Additionally, it has also been shown that NGF receptors are not expressed until 
sensory neurons innervate their targets (Davies et al., 1987a) suggesting that 
NGF cannot affect the development of these neurons at earlier developmental 
stages.
The discovery of a second neurotrophin, BDNF (Barde et al., 1982), 
extended the neurotrophic theory still further. BDNF has been shown to 
promote the survival of subsets of embryonic neurons in vitro and can rescue 
these neurons if presented in vivo during the period of naturally occurring cell 
death (Hofer and Barde, 1988). Since the cloning of BDNF and several 
structurally related proteins, it has become apparent that NGF is part of a 
homologous family of proteins termed the "neurotrophins". To date, a total of 
six members of the neurotrophin family have been identified. Other known 
members of this family include, NT-3 (Ernfors et al., 1990a; Hohn et al., 1990; 
Jones and Reichardt, 1990 Maisonpierre et al., 1990a; Rosenthal et al., 1990), 
Xenopus NT-4 (Hallbook et al., 1991), mammalian NT-4/5 (Berkemeier et al., 
1991; Ip eta l, 1992a) and NT-6 (Gotz etal., 1994).
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Nerve Growth Factor
The initial discovei*y that a fraction of snake venom had nerve growth 
promoting activity (Cohen et al., 1956) led to the isolation and purification of a 
non-dialyzable, heat-labile protein (Cohen, 1959). Subsequent findings 
demonstrated that the mouse submandibular salivary gland was an extremely 
rich source of this protein, termed nerve growth factor (Cohen, 1960).
NGF derived from the mouse submandibular gland is an acidic protein 
consisting of a , p, and y subunits, with a molecular weight of 1301cD (Varon et 
ah, 1968). Further work established that biological activity is conferred by the 
NGF P subunit, a 26kD dimer consisting of two identical peptides, each 
containing 118 amino acids (Angelletti and Bradshaw, 1971; Angelletti et al., 
1973; Green and Shooter, 1980). Recently, a detailed analysis of the tertiary 
structure of NGF using X-ray diffraction, has revealed an arrangement of three 
anti-paiallel pairs of p strands that together form a flat surface where the two 
subunits associate (McDonald et al., 1991). The NGF molecule possess four 
loop regions that contain many of the residues that vary between the 
neurotrophins, suggesting that these regions confer binding specificity to the 
neurotophin receptors (reviewed by Ebendal, 1992). Further functional analyses 
of modified and truncated NGF have demonstrated that certain amino acid 
residues contribute to the specificity of binding of NGF to its receptors, and to 
the structural stability of the molecule (Ibanez et at, 1990; Kahle et al., 1992). 
Proteolytic cleavage of the first 9 amino acids at the amino terminus of 
recombinant human NGF, results in a 300-fold decrease in the affinity of NGF 
for TrkA (the NGF receptor tyrosine kinase), suggesting that these 9 residues are 
important for TrkA activation (Kahle et al. 1992). In addition, amino acid 
substitution of valine to alanine at position 21 considerably reduces the 
biological activity and receptor binding capacity of NGF (Ibanez et al, 1990).
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Analysis of a mouse cDNA clone has shown that NGF is generated from 
a 305 amino acid precursor, termed pre-proNGF (Scott et al., 1983). The NGF 
gene has also been isolated from several other species, and nucleotide sequence 
analysis has shown that the mature NGF protein has been highly conserved 
during evolution (Ullrich et al., 1983; Meier et a/.,1986; Ebendal et al., 1986; 
Selby et al., 1987; Whittemore et al., 1988; Schwarz et al., 1989). The mouse 
NGF gene spans 45 kb and consists of five exons separated by four introns. The 
mature NGF protein is encoded by a single 3' exon. Four transcripts encoding 
precursor proteins that differ in their amino termini are produced by alternative 
splicing of the 3' exon and the remaining 5' exons (Selby et al., 1987). The two 
largest transcripts encode precursor proteins with molecular weights of 27kD 
and 34kD (Edwards et al., 1988). The mRNA encoding the 271<D protein, 
possesses a hydrophobic signal peptide at the NH2 terminus and is more 
abundant in most tissues. The 34kD precursor predominates in the mouse 
salivary gland and has a hydrophobic signal peptide 70 residues downstream 
from the initiation codon. Both proteins are further processed by glycosylation 
and proteolytic cleavage to give the biologically active mature form of NGF 
(Edwards et al., 1988). The functional significance of the different transcripts is 
at present unknown.
The expression of NGF mRNA has been detected by sensitive 
hybridization techniques that have identified extremely low levels of NGF 
mRNA in RNA extracted from different tissues (Heumann et al., 1984; Shelton 
and Riechardt, 1984), and in tissue sections (Bandtlow et al., 1987). Careful 
examination of these NGF synthesising tissues has ascertained that many of 
them are innervated by NGF responsive neurons (Korsching and Thoenen, 
1983a; Heumann et al., 1984; Shelton and Reichardt, 1984; Korsching et al., 
1985). The exact identity of target cells that secrete NGF during normal 
development was first elucidated in a detailed study of the developing whisker 
pad in mouse embryos (Davies et al., 1987a). Enzymatic dissociation of the
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developing whisker pad into its main components, the epithelium (presumptive 
epidermis) and mesenchyme (presumptive dermis), and subsequent analysis of 
NGF expression demonstrated that the highest levels of NGF were expressed in 
the epithelium (Davies et al., 1987a). Furthermore, subsequent work has 
demonstrated that the concentration of NGF mRNA in the epithelia of the 
opthalmic, maxillaiy and mandibular territories each of the trigeminal ganglion, 
is related to the innervation density of the territory (Haiper and Davies, 1990). 
In conjunction with the spatial distribution of NGF mRNA, it has also been 
shown that NGF production in the target tissues coincides with the onset of 
target innervation, suggesting that NGF regulates the number of innervating 
neurons after the target cells have been contacted (Davies et al., 1987a; 
Korsching and Thoenen, 1988; Harper and Davies, 1990). In addition to cells 
that normally receive innervation from NGF dependent neurons, several other 
cell types have been observed to express NGF both in vivo and in vitro. For 
example, NGF has been shown to be expressed in vitro by Schwann cells 
(Bandtlow etal., 1987), astrocytes (Lindsay, 1979), and glial cell lines (Longo et 
al., 1978). However, studies of the distribution of NGF mRNA by in situ 
hybridization in the adult rat brain, have demonstrated that regions where these 
types of cells occur in vivo are not clearly labelled, in contrast to the cleai* 
labelling of hippocampal pyramidal neurons (Ayer-LeLievre et al., 1988).
The principal populations that aie supported by NGF aie nociceptive and 
thermoceptive neurons of both the spinal dorsal root ganglia and cranial sensory 
ganglia (reviewed by Davies 1994a). Mice that have undergone targeted 
disruption of the NGF gene display deficits in their responses to noxious 
mechanical stimuli. Furthermore, histological analysis of these mice has 
revealed exceptional cell loss in trigeminal and dorsal root sensory ganglia, and 
sympathetic ganglia (Crowley et a l, 1994). Significantly, the cell loss within 
dorsal root ganglia was restricted to subsets of neurons that were found to 
convey nociceptive and thermoceptive information (Crowley et al., 1994). In
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accordance with this study, overexpression of NGF in the epidermis of 
transgenic mice results in hypertrophy of sensory and sympathetic ganglia 
(Albers et a l, 1994). In contrast to previous studies suggesting an involvement 
of NGF in the development of basal forebrain cholinergic neurons, these neurons 
develop normally in mice with the NGF null mutation (Crowley et al, 1994). 
Taken together, these findings confirm that sensory and sympathetic neurons are 
critically dependent on NGF.
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Brain Derived Neurotrophic Factor
Brain derived neurotrophic factor isolated from pig brain was the second 
member of the neurotrophin family to be characterised. BDNF is a basic protein 
(pi > 10.1), with a molecular weight of 12.3 kD (Barde et al., 1982). The mature 
BDNF protein is 119 amino acids in length and, like NGF, exists as a stable 
homodimer linked by 3 disulphide bridges (Radziejewski et al., 1992) BDNF 
displays approximately 50% sequence identity to NGF, including conservation 
of all six of the structurally important cysteine residues (Leibrock et al., 1989). 
Further characterisation of BDNF has revealed that the BDNF gene spans 4.0 
kb, encodes four 5' exons and possesses one 3' exon which encodes the mature 
protein (Timmusk et al., 1993a; Metsis et al., 1993). In mammals, BDNF is 
predominantly expressed in the CNS, where it is present at moderate levels in 
several different regions including the cingulate and piriform cortices, certain 
thalamic and hypothalamic nuclei, and in the postnatal hippocampus (Liebrock 
et al., 1989; Ernfors et al., 1990a; Ernfors et al., 1990b; Maisonpierre et al., 
1990b; Phillips et al., 1990; Friedman et al., 1991; Huntley et al., 1992; Metsis 
et al., 1993). The expression of BDNF mRNA has also been demonstrated in 
the developing spinal cord and limb bud of the rat during the period when motor 
neurons are known to undergo programmed cell death (Henderson et al., 1993). 
Similarly, BDNF expression has been observed at early developmental stages in 
the chick, within the developing otic vesicle, dorsal mesenchyme (adjacent to 
the developing wing bud), and in the optic tectum prior to the arrival of retinal 
ganglion cell axons (Hallbook et al., 1993; Herzog et al., 1994). Certain 
subpopulations of sensory and motor neurons express BDNF mRNA at early 
developmental stages, consistent with a proposed role in the maturation of these 
cells (Ernfors et al., 1990b; Wetmore et al., 1990; Schecterson and Bothwell 
1992; Wright et al., 1992). Interestingly, BDNF mRNA has been detected in the 
whisker pad and the mandible of the developing mouse, structures which are 
innervated by the mandibular branch of the trigeminal ganglion (Schecterson
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and Bothwell, 1992). During development, the highest BDNF mRNA 
expressing regions are regions that are sensitive to touch, such as the digits, lips, 
tongue and mandible that contain specialised mechanoreceptors, called Merkel 
disks (Schecterson and Bothwell, 1992). While the expression of BDNF mRNA 
has generally been observed in the taiget tissues of innervating populations of 
BDNF responsive neurons, surprisingly, BDNF is also expressed in three types 
of sensory ganglia that originate from different embryonic sources in E8.5 
mouse embryos (Schecterson and Bothwell, 1992). Neural crest derived dorsal 
root sensory ganglia, placode derived geniculate ganglia, and neurons of the 
trigeminal ganglia, that are derived from both sources, have all been observed to 
express BDNF mRNA, suggesting that an autocrine mechanism may operate 
within these ganglia, allowing early developing neurons to provide their own 
trophic support (Schecterson and Bothwell, 1992).
In agreement with its observed patterns of expression, BDNF has been 
shown to support different populations of peripheral and central neurons. 
Certain populations of placode and neural crest-derived sensory neurons that do 
not respond to NGF survive in the presence of BDNF in vitro (Lindsay et a l, 
1985; Davies et al., 1986a; Davies et al., 1987b). Specific populations of central 
neurons have similarly been shown to respond to BDNF including embryonic 
motor neurons (Oppenheim et al., 1992; Yan etal., 1992; Sendtner et al., 1992a; 
Koliatsos et al., 1993), dopaminergic neurons from the substantia nigra (Hyman 
et al., 1991; Knüsel et al., 1991), cultured cerebellar granule neurons (Lindholm 
et al., 1993a) and cells of the developing and adult retinal ganglion (Johnson et 
al., 1986a; Thanos et al., 1989). In addition to its survival promoting effects, 
BDNF is also Icnown to influence the differentiation (Kalcheim and Gendreau 
1988) and maturation of developing sensory neurons (Wright et al., 1992) and 
certain central neurons (Marty et al., 1996). Furthermore, it has been suggested 
that BDNF may act via an autocrine mechanism in sensory neurons (Wright et 
al., 1992; Acheson et al., 1995). In support of this proposal, the early
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maturational change that is observed in E4.5 chick DRG neurons in response to 
BDNF, is retarded by antisense BDNF oligonucleotides (Wright et a l, 1992). 
Similarly, adult dorsal root sensory neurons which express BDNF mRNA, 
undergo a dose dependent decrease in survival, when treated with BDNF 
antisense oligonucleotides in vitro (Acheson et al, 1995).
Homozygous mutant mice lacking the BDNF gene display substantially 
reduced numbers of cranial and spinal sensory neurons. In particular, significant 
numbers of sensory neurons are lost in the trigeminal, geniculate and vestibular 
ganglia and in the nodose-petrosal complex (Ernfors et al, 1994a; Jones et a l,
1994). Surprisingly, in contrast to previous studies showing that motor neurons 
aie supported by BDNF in vivo (Yan et al., 1992; Oppenheim et a l, 1992; 
Sendtner et al., 1992) and in vitro (Vejsada et a l, 1995), motor neuron 
development was largely unperturbed by targeted disruption of the BDNF gene 
(Ernfors et a l, 1994a; Jones et a l, 1994). Although the CNS of BDNF deficient 
mice shows no gross structural abnormalities, the expression of neuropeptide Y 
and calcium binding proteins is altered in many neurons, suggesting that these 
neurons may not function normally (Ernfors et al, 1994a; Jones et a l, 1994).
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în-3
Neurotrophin-3 was isolated and cloned as a result of a search for 
proteins homologous to NGF and BDNF. This protein, like NGF and BDNF, 
has been shown to have survival promoting effects on both central and 
peripheral neurons.
Polymerase chain reaction (PCR) using oligonucleotide primers based on 
amino acid sequence similai'ities in the NGF and BDNF coding sequences has 
been used to clone mouse (Hohn et al, 1990), rat (Maisonpierre et a l, 1990a), 
and human (Jones and Reichardt, 1990; Rosenthal et a l, 1990) NT-3. The 
mature NT-3 polypeptide consists of 119 amino acid residues, has a pi of 9.3, 
and a relative molecular mass of 13.6kD (Hohn et al,l990; Maisonpierre et al, 
1990a). Several regions of similaiity aie conserved between NGF, BDNF and 
NT-3, including all six of the cysteine residues (Hohn et a l, 1990). Sequence 
alignment of human NT-3 and BDNF predicts that NT-3 is synthesised in 
precursor form as a 257 amino acid protein (Rosenthal et a l, 1990; Jones and 
Reichardt, 1990). In comparison with BDNF and NGF, NT-3 is known to 
possess several regions of variability which lie in consensus with other 
neurotrophins (Hohn et a l, 1990; Ibanez et al, 1991). Whereas the variable 
regions of NGF and BDNF are thought to convey specificity of binding to their 
respective Trk tyrosine kinase receptors, the specificity of NT-3 binding to TrkC 
(the NT-3 high-affinity receptor) is conveyed by a central P strand and not by 
the vai'iable loop regions of the molecule (Urfer et al, 1994).
The NT-3 gene has been structurally analysed using genomic cloning, 
and rapid amplification of cDNA ends (RACE). These studies have shown that 
the gene consists of two small upstream exons and a larger downstream exon 
(Leingartner and Lindholm, 1994). Two classes of NT-3 transcript are generated 
by alternative splicing of the small exons to the large exon (Leingartner and 
Lindholm, 1994). Multiple mRNA transcripts of differing lengths can be
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produced by combining the several transcription start sites in the small exons 
with three polyadenylation sites that are present in the large exon (Leingartner 
and Lindholm, 1994). Regulation of NT-3 gene transcription by two promoters 
was demonstrated by transfection of cerebellar granule neurons with a DNA 
construct comprising the small exons and a reporter gene (Leingartner and 
Lindholm, 1994). Additionally, it has been established that the NT-3 promoters 
contain silencer elements that control the differential expression of NT-3 
transcripts in neurons and non-neuronal cells (Shintani etal., 1993; Leingartner 
and Lindholm, 1994).
During development, the expression of NT-3 mRNA is seen in several 
tissues that receive inneiwation from the PNS, and in several regions of the CNS. 
Northern blot analysis has demonstrated the expression of NT-3 mRNAs in the 
heart, kidney, liver, spleen, intestine and lung, and in several brain regions 
including the cerebellum, medulla oblongata and hippocampus in rodents. This 
expression pattern suggests that NT-3 could serve as a target derived factor for 
sensoiy and sympathetic neurons (Maisonpierre et a l, 1990a; Rosenthal et al., 
1990). In developing tissues, the expression of NT-3 appears to coincide with 
the onset of neuritogenesis, and a dramatic increase in overall expression is seen 
between E ll  and E12 (Maisonpierre et al., 1990b). The general expression of 
NT-3 (measured by Northern blotting) in the chicken embryo is strongest at E4.5 
and subsequently decreases throughout development (Hallbook et al., 1993). 
This is in broad agreement with other studies that have demonstrated a gradual 
developmental decrease in NT-3 expression in mammalian tissues, however, in 
mammalian tissues maximal expression usually occurs at slightly later ages 
(Rosenthal et al., 1990; Maisonpierre et al., 1990b; Buchman and Davies, 1993). 
The spatial distribution of NT-3 mRNA expression has been demonstrated by in 
situ hybridization in the developing chicken and rat, and is seen in the E4 chick 
epidermis, in the region of the branchial arches, and in the rat it is detectable in 
tissues of the inner ear, the iris and, significantly, in target fields of the
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trigeminal ganglion, especially the epithelium of the whisker follicles (Hallbôôk 
et al., 1993; Pirvola et al., 1992; Ernfors et a l, 1992). Confirmation of the 
expression of NT-3 in the developing tiigeminal tai'get territory has been shown 
using quantitative Northern blotting. NT-3 mRNA is expressed at the highest 
levels in the epithelium of the most densely innervated target field, the maxillary 
tai'get field, at E l3, the age at which naturally occumng cell death commences in 
the trigeminal ganglion (Buchman and Davies, 1993). The widespread 
expression of NT-3 mRNA has also been demonstrated in muscle that is 
innervated by proprioceptive sensory neurons of the dorsal root ganglia (Ernfros 
et a l, 1990b; Hohn et a l, 1990; Maisonpierre et a l, 1990a; Rosenthal et a l, 
1990; Schecterson and Bothwell 1992; Henderson et al, 1993).
In the PNS, several studies have shown that NT-3 plays a role in the 
development of different populations of sensory and sympathetic neurons. 
Principally, NT-3 has been shown to promote the survival of developing muscle 
sensory neurons of the lumbar and cervical dorsal root ganglia, both in vitro 
(Wright et a l, 1992; Hory-Lee et a l, 1993; Gaese et a l, 1994) and in vivo 
(Ericksson et a l, 1994; Oakley et a l,  1995). Additionally, several other 
populations of sensory neurons aie known to respond to NT-3, these include 
proprioceptive neurons isolated from the trigeminal mesencephalic nucleus of 
the E8 chick (Hohn et a l, 1990) and neurons of the spiral (Gao et al., 1995; 
Ernfors et a l, 1995), nodose (Gaese et a l, 1994; Ockel et a l, 1996), and 
trigeminal ganglia (Buchman and Davies, 1993 Wilkinson et a l, 1996). 
Interestingly, trigeminal neurons only respond transiently to NT-3, undergoing a 
switch in trophic dependence from NT-3 to NGF, concomitant with observed 
changes in the level of NT-3 mRNA in the peripheral trigeminal target field 
(Buchman and Davies, 1993).
Other populations of PNS neurons respond to NT-3 in addition to 
sensory neurons. One study has shown that sympathetic neurons of the superior 
cervical ganglion undergo a switch in trophic dependence from NT-3 to NGF
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shortly after formation of the ganglion (Birren et al., 1993). Furthermore, the 
early development of sympathetic and sensory neurons may be more subtly 
influenced by NT-3. For example, sympathetic neuroblasts proliferate in 
response to NT-3 in vitro (DiCicco-Bloom et al., 1993) and cultured DRG 
neurons undergo an enhanced maturational change in the presence of NT-3 
(Wright e? a/., 1992).
Certain populations of central neurons also respond to NT-3 during 
development. Dissociated hippocampal neurons show a moderate survival 
response in the presence of NT-3 in vitro (Ohsawa et al., 1993) and sub­
populations of hippocampal neurons express the immediate early gene cFos in 
response to NT-3 (Collazo et al., 1992). Developing cerebellai* granule neurons 
have also been shown respond to NT-3 by the induction of cFos in vitro (Segal 
et al., 1992). In addition, these neurons synthesise NT-3 after addition of tri- 
iodo-thyronine, which in turn promotes hypertrophy and neuronal sprouting of 
Purkinje cells (Lindholm et al., 1993).
In the adult CNS, NT-3 may play a role in regulating the response of 
different classes of neurons to injuiy. In noradrenergic neurons of the locus 
coeruleus, sustained application of different neurotrophins in vivo has shown 
that NT-3, but not NGF or NT-4/5, can prevent degeneration after excitotoxic 
lesion by 6-hydroxydopamine (Arenas and Persson, 1994). Additionally, NT-3 
can enhance the collateral sprouting of corticospinal tract neurons after lesion 
(Schnell et a i, 1994), and has been shown to promote the survival of embryonic 
motor neurons in vitro (Henderson et al., 1993). In contrast, experimental work 
conducted in vivo has provided some conflicting evidence as to the efficacy of 
NT-3 on motor neuron survival. For example, injection of NT-3 into neonatal 
rats does not effectively rescue axotomized motor neurons (Sendtner et al., 
1992a, Koliatsos et al., 1993). Additionally, oligodendrocyte precursor cells 
from the optic nerve have been shown to survive and differentiate in response to
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NT-3, suggesting that NT-3 may influence the development of different classes 
of non-neuronal cells within the CNS (Baires etal., 1994),.
Recently, the function of NT-3 has been further clarified by several 
studies employing gene targeting in embryonic stem cells, to ablate the NT-3 
coding sequence in mice (Ernfors et al., 1994b; Farinas et al., 1994; Tessarollo 
et al., 1994). Lack of NT-3 leads to severe deficits in the complement of 
sensory and sympathetic neurons. Neuronal loss in the PNS is principally 
observed in dorsal root, nodose, and trigeminal sensory ganglia, the trigeminal 
mesencephalic nucleus, spiral ganglion of the cochlea and the sympathetic 
superior cervical ganglion (Ernfors et al., 1994b; Faiinas et al., 1994; Tessaiollo 
et al., 1994). The most severely affected neuronal population are proprioceptive 
sensory neurons of the dorsal root ganglia and their peripheral sense organs, the 
muscle spindles and Golgi tendon organs (Ernfors et al., 1994b). The loss of 
this particular neuronal population was subsequently established by 
immunostaining for carbonic anhydrase (CA) and parvalbumin (PV), which are 
both markers for proprioceptive neurons. Both markers are absent in the dorsal 
root ganglia of NT-3"/- mutant animals (Ernfors etal., 1994b)
In contrast with the severe effects that NT-3 gene deletion has on PNS 
neurons, neurons within the CNS do not appear to be seriously perturbed by the 
mutation (Ernfors et al., 1994b). Although these findings may not agree with 
many previous in vitro studies on the effects of NT-3, they are consistent with in 
vivo work showing that NT-3 does not effectively promote the survival of motor 
neurons after transection (Sendtner etal., 1992a; Koliatsos etal., 1993).
More detailed analyses of mice lacking the NT-3 gene have identified 
deficiencies in specific subtypes of cutaneous mechanoreceptors, using 
electrophysiological techniques (Airaksinen et al., 1996). In this study, 
heterozygous (-K/-) animals were used, since the homozygous animals die shortly 
after birth. The data obtained demonstrate that two functionally specific subsets
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of cutaneous afférents: low threshold slowly adapting mechanoreceptors (SAl 
neurons) that respond tonic ally to skin indentation, and low threshold D-hair 
afferents that respond dynamically to sldn stimulation, both require NT-3 during 
postnatal development (Airalcsinen et aL, 1996). The number of receptor organs 
(Merkel cells) of the low threshold mechanoreceptors are decreased in NT-3"^/" 
animals (Airaksinen et al., 1996). Furthermore, the regulation of Merkel cell 
number by NT-3 has been verified by a study showing that elevated levels of 
NT-3 in the epidermis, substantially increase the total number of these cells 
(Albers et al., 1996). Subsequent reseai'ch has also shown that NT-3 is required 
for the early development of sensory precursor cells. In two separate studies 
sections of El 1 DRGs from NT-3“/“ mice were analysed by the TUNEL method 
which visualises apoptotic cells containing fragmented DNA. These studies 
show that some DRG neurons from NT-3"/" mice undergo excessive cell death 
prior to the developmental period of programmed cell death (ElShamy and 
Ernfors, 1996; Farinas et al., 1996). In addition, in contrast to earlier published 
work suggesting that sympathetic neuroblasts of the developing superior cervical 
ganglion (SCG) are transiently dependent on NT-3 for survival (Birren et al.,
1993), a recent detailed study of NT-3"/" animals has revealed that these ganglia 
develop normally, and that deficiencies in the SCG of these mice, occur late in 
development (Wyatt et al., 1997).
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Neurotrophin-4/5
A fourth neurotrophin with survival promoting activity was recently 
discovered in Xenopus and mammalian embryos, and has been designated 
neurotrophin-4/5.
The gene for neurotrophin-4/5 was first isolated in a phylogenetic 
analysis of DNA sequences from known members of the neurotrophin family 
(Hallbôôk et al., 1991). An examination of NGF, BDNF and NT-3 genes from 
human, rat, chicken, viper, Xenopus, salmon and ray was carried out by PCR. 
This study showed that a fourth neurotrophin - designated; NT-4 - exists in both 
Xenopus and viper (Hallbôôk et al., 1991). The Xenopus NT-4 gene encodes a 
precursor protein of 236 amino acids that is processed into a 123 amino acid 
mature form. Xenopus NT-4 has 50-60% amino acid identity with NGF, BDNF 
and NT-3, including several of the structurally important cysteine residues 
(Hallbôôk et al., 199\). A mammalian NT-4 homologue was later identified and 
cloned, using sequences of the Xenopus and viper NT-4 (Ip et al, 1992a). 
Analysis of human placental DNA by the polymerase chain reaction also 
revealed the existence of a neurotrophin, termed NT-5 (Berkemeier e ta l, 1991). 
Since the sequences of mammalian NT-4 and NT-5 aie identical, the mammalian 
NT-4 homologue is now referred to as NT-4/5.
Northern blot analysis and RNase protection assays have shown that 
mRNA for NT4/5 is present in several peripheral tissues, and brain regions 
during development (Berkemeier e ta l,  1991; Ip et a l, 1992a; Timmusk et a l, 
1993b). The levels of NT-4/5 are differentially regulated in the heart, liver and 
muscle, with a gradual decrease in expression from E l3 to PI (Timmusk et a l, 
1993b). In adult rats, tissues which synthesise NT-4/5 include the thymus, 
muscle, lung, ovary, prostate, brain, heart, stomach and kidney (Berkemeier et 
a l,  1991; Ip et a l, 1992a). The expression of NT-4/5 mRNA has additionally 
been detected in several developing brain regions, including the cerebrum,
39
cerebellum, hippocampus, parts of the limbic system (Timmusk et al., 1993b) 
and in the developing rat limb bud (Henderson et al., 1993). Developmental 
vaiiation of NT-4/5 expression has been demonstrated in structures that are 
innervated by neurons of the trigeminal ganglion, with the maximum levels of 
NT-4/5 expressed between ElO - E13 in the developing trigeminal target 
territory (Ibanez e ta l, 1993; Arumae e ta l, 1993).
Several studies have recently demonstrated that different populations of 
neurons from the peripheral and central nervous system respond to NT-4/5 
during development and in adulthood. In the peripheral nervous system, the 
survival promoting effects of NT-4/5 have been demonstrated on several 
populations of sensory neurons, including neurons of the early trigeminal, 
jugular and nodose ganglia (Ibanez et a l, 1993; Davies et al, 1993a), and 
neurons of the dorsal root and paiavertebral sympathetic ganglia (Hallbook et 
a l, 1991; Berkemeier et a l, 1991). Additionally, neurons of the vestibular and 
spiral ganglia in the inner ear can be rescued from the detrimental effects of 
different neurotoxins, by administration of NT-4/5 both in vitro and in vivo 
(Zheng e ta l, 1995a; Zheng eta l, 1995b).
In the central nervous system, it has been elucidated that NT-4/5 is an 
effective agent for preventing the death of developing and adult spinal motor 
neurons (Henderson et a l, 1993; Friedman et a l, 1995; Funalcoshi et a l, 1995) 
and facial motor neurons (Koliatsos et a l, 1994). Furthermore, NT-4/5 can 
effect changes in the neurotiansmitter phenotype of developing motor neurons 
(Wong et a l, 1993). In addition to its effects upon motor neurons, certain other 
populations of neurons within the CNS also show responses to NT-4/5. For 
example, rat retinal ganglion cells within the developing and adult visual system 
respond to NT-4/5 both in vivo and in vitro (Cui et al, 1994; Cohen et a l, 1994; 
Sawai et a l, 1996). The survival promoting effects of NT-4/5 have been 
demonstrated in other areas of the visual system, for example, in the lateral 
geniculate nucleus of the ferret after monocular deprivation (Riddle et a l, 1995).
40
NT-4/5 has been shown to effect changes in the dendritic aiborization of neurons 
in layers 4, 5 and 6 of the visual cortex (Cabelli et a l, 1995; McAllister et ah, 
1995). Other populations of CNS neurons such as dopaminergic neurons of the 
rat substantia nigra (Studer et al., 1995) and cerebellai' granule cells (Gao et al.,
1995), aie also known to undergo morphological changes in the presence of NT- 
4/5.
Ablation of the NT-4/5 gene results in phenotypic defects that typically 
affect sensory but not motor neurons (Conover et al., 1995; Liu et al., 1995; 
Erickson et al., 1996). In NT-4/5 homozygous null mutant animals, the 
populations of neurons most severely affected are those of the nodose, petrosal, 
and geniculate ganglia (Conover et al., 1995; Liu et al., 1995). Since both NT- 
4/5 and BDNF aie known to undergo signal transduction via the same receptor 
tyrosine kinase, BDNF"/" and NT-4/5"/" double homozygous knockout mice 
have been generated. In these mice, drastic reductions in the numbers of 
nodose-petrosal and geniculate neurons, more severe than those seen with either 
gene deletion alone, are evident (Conover et al., 1995; Liu et al., 1995). 
Evidence from these studies strongly suggests that motor neurons require 
additional factors for their survival during development since populations of 
facial motor neurons and lumbar spinal motor neurons are not significantly 
affected by either mutation alone, or a combination of the two (Conover et al., 
1995; Liu et al., 1995). Furthermore, no obvious defects are observed in 
sympathetic neurons or dopaminergic neurons in the substantia nigra.
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Neurotrophin-6
To date, neurotrophin-6 has only been identified in the teleost fish, 
Xiphophorus maculatus (Gotz et al., 1994). NT-6 was cloned from a genomic 
library of Xiphophorus DNA by low stringency hybridization to overlapping 
sequences of NGF (Gotz et al., 1994). Alignment of the NT-6 sequence with 
Xiphophorus NGF, BDNF or with salmon NT-3 revealed that it did not 
represent an homologue of the Icnown neurotrophins (Gotz et al., 1994).
The predicted structure of NT-6 suggests that in precursor form, it is a 
protein of 286 amino acids, with a moleculai* weight of 31.4 kD (Gotz et al., 
1994). In addition, six structurally important cysteine residues are conserved 
(Gotz et al., 1994). Other features of the molecule include; a putative signal 
sequence at the N terminus, a pro-region containing basic motifs necessary for 
the proteolytic cleavage of the mature protein, a 143 amino acid sequence 
encoding the mature foim of the molecule (Gotz et al., 1994).
Northern blot analysis of the expression of NT-6 during teleost 
development has revealed a 1.4 kb transcript expressed from the onset of 
organogenesis (day 8) in several tissues. NT-6 mRNA is expressed in the 
developing and mature brain, and in the heart, skeletal muscle and other tissues 
of adult fish (Gotz et al., 1994). The highest expression of NT-6 according to in 
situ hybridization analysis, is in the valvula cerebelli, a rostral protrusion of the 
teleostean cerebellum under the midbrain tectum (Gotz et al., 1994).
Like NGF, NT-6 supports the survival of embryonic chick DRG and 
sympathetic neurons. However, lower levels of survival are seen with saturating 
concentrations of NT-6 compared to those observed with NGF (Gotz et al., 
1994). Cultured nodose and ciliary neurons do not survive with NT-6, 
suggesting that the spectrum of NT-6 activity is similar to that of NGF (Gotz et 
al., 1994).
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1.4.2 Neurotrophin Receptors
BDNF = N T 3=
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Adapted From Davies, 1994b
Figure 1.1 Schematic diagram summarising the interaction of neurotrophins with members of 
the Trk family of tyrosine kinase receptors.
NGF, BDNF, NT-3, and NT-4/5 recognise two types of transmembrane 
receptors: Trk receptors (TrkA, Trk B, or TrkC) and p75. The Trk family of 
receptor tyrosine kinases show a specificity in their preference for neurotrophin 
binding, whereas the p75 receptor interacts with each neurotrophin, albeit with 
slightly different binding properties. Although much has been learned about the 
signalling mechanism of the Trk receptors, the functions of p75 are complex. 
One of the major difficulties encountered in the study of p75 is that unlike the 
Trk receptor tyrosine kinases, it lacks an inherent enzymatic activity. However, 
accumulating evidence with regard to its structural homology to a family of 
receptors including TNF, CD 40 and Fas, suggests that the p75 receptor may be 
capable of fulfilling a number of different functions.
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The Low AMnity NGF Receptor (p75)
The gene encoding the human low affinity NGF receptor was first 
identified by gene transfer assays, followed by immunological detection of the 
transfected receptor-expressing cells (Johnson et a l, 1986b). Genomic 
sequences containing the human NGF receptor locus were subsequently cloned 
from these cells (Chao et a l, 1986), whilst the rat low affinity NGF receptor 
gene was independently cloned from another NGF receptor-expressing cell line 
(Radeke et a l, 1987). The human gene encodes a 75 kD cell surface 
glycoprotein, designated gp75, or simply p75, consisting of a single 
transmembrane polypeptide of 427 amino acid residues, 399 of which 
correspond to the mature protein (Johnson et a l, 1986b; Radeke et a l, 1987; 
Large et a l, 1989). The extracellular domain consists of 222 amino acid 
residues, containing four cysteine repeats, that has approximately 30% sequence 
homology with a family of cell surface receptors which include the lymphocyte 
surface antigens; CD 27, CD 30, CD 40, OX 40, the Fas cell surface antigen, 
that mediates apoptosis, and the p55 tumour necrosis factor receptor (see Chao, 
1994).
Experiments in which mutations were made in the extracellular domain 
of p75, have demonstrated that perturbation of the cysteine rich regions confers 
detrimental effects on the binding capacity of p75 for NGF, whereas mutating 
other regions of the molecule, including the cytoplasmic domain has, no such 
effects (Welcher et a l, 1991; Yan and Chao, 1991). This region has not been 
highly conserved during evolution, there being only 55% homology between the 
central domains of the human and chicken receptors (Johnson et a l, 1986b; 
Large et a l, 1989). However, comparison of the cytoplasmic domain of p75 
with that of the tumour necrosis factor receptor (TNFR-1) and Fas (also known 
as CD95/APO-1), has revealed these proteins share homology within an 80 
amino acid region Icnown as the 'death domain' (Chapman, 1995). In addition, a
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predicted structural similarity occurs between a region of the p75 cytoplasmic 
domain, the 14 residue wasp toxin mastoparan, and the hamster p2-adrenergic 
receptor, all of which are presumed to form amphipathic a-helices that possibly 
interact with G-proteins (Feinstein and Lai'hammar, 1990).
The p75 receptor is widely expressed in both the central and peripheral 
nervous system (Ernfors et aL, 1988; Yan and Johnson, 1989). Since avian 
embiyos are readily accessible for study during development, some of the early 
expression studies focused on the developing chicken embryo. In the chick 
CNS, p75 mRNA has been identified in a wide variety of cell populations at 
various stages of development, with expression seen in most CNS regions, from 
E4 onwai'ds (Heuer et ah, 1990). In the PNS, in situ hybridization analysis has 
demonstrated that autonomic and primaiy sensory neurons express p75 from the 
earliest developmental stages, with levels of p75 mRNA increasing substantially 
from E5 in both sensory and sympathetic ganglia (Heuer et ah, 1990). 
Developmental studies of p75 expression by Northern blotting and in situ 
hybridization have shown that p75 mRNA is present in developing NGF 
dependent sensory neurons before they begin to innervate their targets, and the 
levels of mRNA substantially increase after target contact is made (Hallbook et 
ah, 1990; Wyatt et ah, 1990). Furthermore, in developing trigeminal ganglion 
neurons, the level of p75 mRNA is upregulated in vitro by BDNF and NGF 
during successive phases of development, when these neurons aie responsive to 
BDNF and NGF (Wyatt and Davies 1993). Correspondingly, several other 
studies using postnatal and adult sensory, sympathetic, and CNS derived 
neurons, and the neuron-like PC 12 phaeochromocytoma cell line, have 
suggested that NGF upregulates the level of p75 mRNA (Doherty et a/., 1988; 
Miller e ta l,  1991; Cavicchioli e ta l,  1989; Higgins e ta l,  1989; Lindsay e ta l,  
1990; Verge et a l, 1990; Miller et a l, 1994). However, the developmental 
expression of p75 mRNA in the trigeminal ganglia of NGF"/" mice does not 
differ from that seen in wild type animals (Davies et al, 1995a).
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Several populations of non-neuronal cells also express p75 receptors, and 
these including neuroepithelial cells such as melanocytes, meningeal cells, glial 
cells, and Schwann cells (DiStefano and Johnson, 1989). Schwann cells also 
secrete a proteolytically cleaved form of p75 with an unknown function 
(DiStefano and Johnson, 1989). Additionally, other non-neural populations of 
p75 expressing cells include, basal kératinocytes, epithelial cells lining the ducts 
of mammary and prostatic glands, and spleen cells (Thompson et al., 1988; 
Chesa et al, 1988).
The functional role of p75 in signal transduction is still controversial (see 
review by Chao 1994). Initial studies suggested that p75 alone is insufficient for 
the high-affinity binding of NGF and subsequent cellulai' responses (Chao et a l, 
1986; Radeke et a l, 1987; Hempstead et al., 1989). Further investigations 
which revealed that the TrkA, TrkB and TrkC tyrosine kinases are signal 
transducing receptors for NGF, BDNF, and NT-3 respectively, called into 
question whether p75 played any role in neurotrophin signalling (reviewed by 
Bothwell, 1991; Chao, 1992; Meakin and Shooter, 1992). Since p75 binds to all 
members of the neurotrophin family (reviewed by Chao, 1994), it has been 
suggested that it serves as a common subunit for different neurotrophins, with 
specificity conferred by the Trk tyrosine Idnase subunit of the receptor complex 
(Bothwell et a l, 1991; Thoenen, 1991). In contrast, the dissociation rates of 
neurotrophin binding to p75 vary, with NGF having the fastest rate and NT-3 the 
slowest, suggesting that p75 may take pait in ligand discrimination (Rodriguez- 
Tebar, 1992).
A number of studies have produced results suggesting that Trk receptors 
alone are sufficient to bind NGF with high-affinity (Klein et a l,  1991a; 
Lamballe et a l, 1991a; Jing et a l, 1992), Recently, however, contrasting 
studies have shown that the effects of neurotrophins can vaiy depending on the 
ratio between the p75 and Trk tyrosine Idnase receptors (Hempstead et a l, 1992; 
Benedetti et a l, 1993). Additionally, tyrosine phosphorylation of TrkA
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receptors is known to be influenced by the co-expression of p75 (Berg et a l, 
1991; Verdi et al., 1994; Barker and Shooter, 1994). The proposal that p75 does 
play a role in neurotrophin signalling comes from experiments showing that 
deletion of the cytoplasmic sequences of p75 leads to the loss of high-affinity 
binding in cultured PC12 cells (Hempstead et al., 1990), and detailed in vitro 
survival experiments using NGF responsive neurons from p75 deficient mice 
(Davies et al., 1993b; Lee et al., 1994). In PC 12 cells, that normally express 
both p75 and TrkA, high-affinity NGF binding sites form, whereas very few 
high-affinity sites are detected when truncated p75 receptors (lacking the 
extracellular region) are overexpressed in these cells (Benedetti et al., 1993). 
Transfection of p75 expression constructs into TrkA expressing fibroblast cell 
lines produces high-affinity binding sites, whereas tiansfection of p75 constructs 
containing deletion mutations in the p75 cytoplasmic or extracellular domains 
cannot reproduce this effect (Battleman et al., 1993). In addition, 
overexpression of p75 enhances NGF induced autophosphoiylation of TrkA in a 
neuronal progenitor cell line (Verdi et al., 1994). Evidence of a p75-TrkA 
complex has been provided by observations that physical interaction with TrkA 
immobilises p75 in PC12 cells (Wolf et al., 1995). Furthermore, copatching 
experiments that utilise anti-p75 antibodies, have shown that both the 
extracellular and cytoplasmic domains of p75 are required for the p75-TrkA 
interaction (Ross et al., 1996). More recently, p75 has been implicated in the 
internalisation of neurotrophins, since retrograde transport of BDNF and NT-3 
in the chick isthmo-optic nucleus can be inhibited by anti-p75 antibodies (von 
Bartheld et al., 1996).
Several studies have suggested that p75 may be involved in programmed 
cell death. For example, immortalised cerebellar neuronal cell lines expressing 
p75 display distinctly faster rates of apoptosis in the absence of NGF (Rabizadeh 
et al., 1993). Lowering the levels of p75 expression in cultured NGF-dependent 
sensory neurons increases the survival of these neurons in the absence of NGF,
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but only at late stages of development (Baiiett and Baitlett, 1994). In contrast to 
its apparent cytotoxic action in the absence of bound NGF, recent work has 
suggested that p75 cytotoxicity is triggered by NGF binding (Frade et a l, 1996; 
Casaccia-Bonnefil etal., 1996). Addition of anti-NGF antibodies or antibodies 
that inhibit NGF binding to p75 causes a significant reduction in the number of 
retinal neurons that undergo apoptosis in the chick embryo retina, prior to 
innervation of the tectum by retinal axons (Frade et al., 1996). Furthermore, 
addition of NGF rapidly induces the death of mature oligodendrocytes in vitro 
(Casaccia-Bonnefil et a l, 1996). Interestingly, in both studies, the cells in 
question express p75 in the absence of TrkA, raising the possibility that NGF- 
bound p75, in the absence of TrlcA conveys a death signal (Frade et a l, 1996; 
Casaccia-Bonnefil et a l, 1996).
Recent evidence suggests that the cytoplasmic domain of p75 takes part 
in intracellular signalling. Neurotrophin binding to p75 activates the 
sphingomyelinase pathway both in a glioma cell line and in transfected NIH 3T3 
cells, producing the lipid second messenger ceramide (Dobrowsky et a l, 1994). 
The production of ceramide initiated by NGF via p75 is specific, and is 
dependent on the intracellular domain of the receptor (Dobrowsky et a l, 1994). 
This pathway is utilised by a number of cytokine receptors including the tumour 
necrosis factor receptor. Among the downstream targets activated by the TNF 
receptor is the transcription factor NF-kB, which, when activated by external 
stimuli, translocates to the nucleus where it binds to DNA and activates 
transcription (Baeuerle and Henkel, 1994). The p75 mediated activation of this 
transcription factor has been directly demonstrated in cultured Schwann cells 
(Carter et a l, 1996). Further studies have described interactions of p75 with the 
extracellular signal regulated Idnases ERKl and ERK2 (Volonté et a l, 1993), 
and have shown that peptide analogues of the raastoparan-like region within the 
cytoplasmic domain have biological function (Dostaler et a l, 1996). 
Furthermore, the activation of NF-kB following exposure to ceramide mimics
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the effect of p75 mediated NGF signalling in cultured Schwann cells (Carter et 
al., 1996). Sphingomyelin generated ceramide is a possible candidate for 
mediating the apoptotic effects of p75, since it has been previously established 
as a potent inducer of apoptosis via TNFR-1, which has homology to p75 
(Rabizadeh et al., 1993; Kolesnick and Golde, 1994; Hannun and Obeid, 1995). 
In support of this hypothesis, several recent studies have demonstrated that 
ceramide mediates apoptosis in cultured rat mesencephalic neurons (Brugg et 
al., 1996), embryonic chick neurons (Weisner and Dawson, 1996), and PC12 
cells (Hartfield et al., 1996). In contrast, ceramide has been implicated in the 
prevention of cell death after NGF withdrawal in cultured sympathetic neurons, 
raising questions as to whether the actions of this second messenger depend on 
the cellular' context or possibly on the maturity of the neuronal population 
studied (Ito and Horigome, 1995). Furthermore, the signal transduction 
mechanism which leads to apoptosis could be conveyed by a different signalling 
pathway. Since a region of the p75 cytoplasmic domain has homology with the 
Fas/TNFR-1 'death domain', it is feasible that the same apoptotic pathway is 
triggered by p75 (reviewed by Davies, 1997).
To date, the most definitive functional studies of p75 have resulted from 
the generation of mice that have null mutations in the coding region of the p75 
gene (Lee et al., 1992). These studies have shown that p75 deficient animals 
display deficits in populations of sensory and sympathetic neurons, with no 
major effects on neurons within the CNS (Lee et al., 1992). Embryonic and 
post-natal neurons from trigeminal, dorsal root, and superior cervical ganglia of 
p75 deficient mice, have a decreased sensitivity to NGF, during certain stages of 
their development when compaied with the equivalent populations of 'wild-type' 
neurons in vitro (Davies et al., 1993b; Lee et al, 1994). Mutant animals are 
particularly deficient in cutaneous nerve fibres immunoreactive for substance P 
and calcitonin gene-related peptide (CGRP), combined with a profound 
deficiency in thermoception (Lee et a l, 1992).
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The Trk Family of Receptor Tyrosine Kinases.
T rkA
The trk (tropomysosin kinase) proto-oncogene was initially discovered 
by molecular analysis of a human colon carcinoma (Martin-Zanca et al, 1986; 
Martin-Zanca et al., 1989). Two receptor tyrosine Idnase isofoitns of 790 and 
796 amino acid residues are encoded by this proto-oncogene (Martin-Zanca et 
al., 1989; Mealdn et al., 1992; Barker et al., 1993; Shelton et al., 1995). The 
protein encoded by the trk proto-onocogene (alternatively referred to as Trk, 
TrkA, or gpl40%&) is a 140kD membrane spanning protein that possesses 
several characteristic features of cell surface receptors, including a 32 amino 
acid long putative signal peptide, an amino terminal moiety rich in potential 
consensus sites for AT-glycosylation, a transmembrane domain, a kinase catalytic 
region highly homologous to that of other tyrosine Idnases and a short 15 residue 
carboxy tail (Martin-Zanca et al., 1989). The extracellular domain of TrkA 
exhibits two different cell-adhesion related motifs. The amino terminal moiety 
consists of an array of three leucine-rich motifs in tandem, flanked by two 
distinct cysteine-rich regions. Two immunoglobulin domains lie adjacent to the 
second cysteine cluster (Schneider and Schweiger, 1991). Affinity cross-linking 
experiments using i^sj-iabelled NGF have demonstrated that NGF binds to this 
receptor with a dissociation constant of lO'^M and binding stimulates receptor 
autophosphorylation (Klein et al., 1991, Hempstead et a l, 1991;Kaplan et a l, 
1991a). Furthermore, in vitro experiments have demonstrated that NGF and 
NT-3 confer a mitogenic response on fibroblast cells tiansfected with expression 
vectors encoding the TrkA receptor, although NT-3 elicits a more moderate 
response and is less efficient than NGF in competing for TrlcA (Cordon-Caido et 
al., 1991). In addition, studies of Trk receptor Idnases expressed in fibroblasts 
have shown that NT-3 can signal via TrkA (Klein et al., 1991; Soppet et al., 
1991; Squinto et al., 1991) and that NT-4/5 is also able to signal via TrkA
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(Berkemeier et al., 1991). Additionally there is some evidence that NT-3 can 
signal via TrkA in developing sensory and sympathetic neurons, since NT-3 
promotes the in vitro survival of these neurons in mice that have homozygous 
null mutations in the trkC gene (Davies et al., 1995a),
During development, the expression of trJcA mRNA is confined to 
defined structures of the nervous system, and the onset of expression occurs 
during the eaiiy stages of neurogenesis (Martin-Zanca et al., 1990; Schropel et 
al., 1995). Northern blot, and in situ hybridization analyses have revealed trIiA 
mRNA expression in discrete regions of the peripheral nervous system, 
including the DRG and several cranial sensory and symapthetic ganglia (Martin- 
Zanca et al., 1990; Tessarollo et al., 1993; Schropel et al., 1995). Additionally, 
expression of the TrkA protein has been demonstrated using 
immunocytochemical localisation, by cells of the rat DRG and trigeminal 
ganglia, and by subpopulations of cells in the dorsal horn of the spinal cord 
(Averill et al., 1995). In the CNS, TrkA mRNA expression has been observed in 
cholinergic neurons of the basal forebrain and striatum (Vazquez and Ebendal., 
1991; Holtzman et al., 1992; Merlio et al., 1992; Steininger et al., 1993), in non- 
cholinergic neurons of the thalamus (Venero and Hefti 1993), and in 
magnocellular neurons of several brainstem nuclei (Merlio et al., 1992). 
Additionally it has been demonstrated that the expression of trkA mRNA in the 
cholinergic neurons of the adult rat forebrain is up-regulated by NGF (Holtzman 
et al., 1992). Taken together, the results of these studies demonstrate that 
expression of the TrlcA receptor is coincident with some of the Icnown targets of 
NGF.
Outside of the nervous system, trJcA mRNA expression has been 
observed in certain cells of the immune system, including activated CD4+ T- 
lymphocytes and monocytes (Ehrhard et al., 1993; Ehrhaid et al., 1994), and in 
cells of the spleen and thymus (Lomen-Hoerth et al., 1995).
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Signal transduction by TrkA occurs through ligand induced 
homodimerization of the two receptor subunits, resulting in autocatalytic 
tyrosine phosphorylation and, ultimately, a cascade of signalling events 
culminating with altered gene expression within the nucleus (Kaplan et al,, 
1991b; Klein et at., 1991a; Jing et al, 1992). In all TrkA receptors, nine 
homologous tyrosine residues have been characterised, seven within and two 
flanking the Idnase domain (Middlemas et at., 1994; Loeb et a l, 1994; Stephens 
et a l,  1994). Experiments using cultured PC 12 cells have identified 
phosphotyrosine binding sites for three intracellular arc-homology region 2 
(SH2) proteins in the cytoplasmic region of all Trk receptors (Stephens et a l, 
1994). The adapter protein She, and PLCy-l, both bind to tyrosine residues 
flanking the kinase domain. These are the juxtamembrane tyrosine residue 
Y490 and the carboxy terminal tyrosine residue Y785, respectively (Stephens et 
a l,  1994). The non-catalytic sub-unit of PI-3 Idnase (p85) also binds to a 
tyrosine residue within the kinase domain namely, Y751 (Stephens et a l, 1994). 
Beyond these receptor binding proteins, a different adapter protein, known as 
GRB2, which possesses a phosphotyrosine binding SH2 domain and a proline 
binding SH3 domain, form a complex with the mammalian protein SOS (son-of- 
sevenless) (Suen et a l, 1993). Following TrlcA receptor autophosphorylation, 
the SH2 binding region of the GRB2 protein is recruited to the membrane and 
associates with She (Ohmichi et a l, 1994; Obermeier et a l, 1994). The SOS 
protein is an exchange factor, that activates a small G-protein, p21Ras, by 
facilitating the exchange of GDP for GTP on the p21Ras protein (reviewed by 
McCormick 1994). A second She binding protein, called GAP, has also been 
established as an activator of p21Ras following binding of neurotrophins to the 
Trk receptors (D'Arcangelo et a l, 1993; Stephens et a l, 1994). The chain of 
signalling events downstream of p21Ras involves the serine/threonine kinase 
proto-oncogene ra/which activates the mitogen-activated protein kinase Idnase 
(MAPKK) by phosphorylation of two serine residues (Alessi et a l, 1994). The 
MAPKK protein is a dual specificity kinase, activating mitogen-activated
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protein kinase (MAPK) by phosphorylation of tyrosine and threonine residues 
(Jaiswal et al, 1993; Saito et a l, 1994). In PC12 cells, the MAPK consists of 
two related kinases, the extracellulai* signal-regulated Idnases ERKl and ERK2, 
that have a diverse array of cellular targets (reviewed by Davis, 1993). In non­
neuronal cells, the MAP kinases have been demonstrated to activate 
transcription factors; ERK2 phosphorylates Myc and ERKl phosphorylates Elk, 
which is involved in the induction of the immediate eaiiy gene c-fos (reviewed 
by Davis, 1993). The signal transduction pathway that occurs in primary 
sensory neurons may require additional elements to those that are common for 
other cell types, however, at this juncture this remains to be elucidated.
Mice that have taigeted mutations in the trk gene develop severe sensoiy 
and sympathetic neuropathies, and most die within one month of birth (Smeyne 
et a l, 1994). These mice typically display extensive cell loss within trigeminal, 
dorsal root and sympathetic ganglia, and also have decreased cholinergic basal 
forebrain projections to the hippocampus and cortex (Smeyne et a l, 1994). The 
effects of trk gene deletion on these PNS ganglia are highly reminiscent of 
earlier studies that used immunological methods to inhibit the activity of NGF, 
and NGF gene deletion confirming that TrkA is the receptor for NGF in vivo 
(Levi-Montalcini, 1987; Crowley et a l, 1994). When compaiing the effects of 
NGF and trk gene deletions, the striking difference between the two studies is 
the effect on basal forebrain cholinergic neurons. Whereas the CNS appears 
normal in NGF"/" mice (Crowley et a l, 1994), TrkA animals display 
substantial loss of cholinergic fibres projecting from the medial septum to the 
hippocampus, and from the nucleus basalis to the cerebral cortex (Smeyne et a l,
1994). This may reflect a role for TrkA in fibre outgrowth as opposed to neuron 
loss possibly with NT-3 as the TrkA activating ligand (Smeyne et a l, 1994). 
Further detailed analyses of TrkA deficient mice has revealed that small 
myelinated and unmyelinated axons projecting from the dorsal root ganglia aie 
massively depleted and is coupled with a loss of peptides associated with
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nociceptive function (Silos-Santiago et a l, 1995). More recent analysis of TrkA 
deficient mice has revealed that the onset of neuronal depletion within the 
trigeminal ganglion is coincident with the switch to NGF dependence observed 
in vitro (Pinon et al., 1996).
TrkB
The TrkB tyrosine kinase receptor was cloned as a result of an analysis 
of trk gene expression in the developing mouse (Klein et al., 1989). The trkB 
gene locus demonstrates a complex pattern of transcription, describing at least 
eight different transcripts ranging in size from 0.7 to 9.0 kb, encoding at least 
two different classes of receptors (Klein et a l, 1989; Klein et a l,  1990; 
Middlemas et a l, 1991). The signal transducing isoform of TrkB designated 
gpl4 5 '^^ B or TrkB'TK+ , is an 821 amino acid molecule that is heavily 
glycosylated and contains several motifs that are common to tyrosine kinase 
receptors (Klein et a l, 1989; Klein et a l, 1990; Middlemas et a l, 1991). The 
overall homology between the extracellular domains of rat TrkA and TrlcBTK+ 
receptors is 57%, with the kinase catalytic domains displaying the highest degree 
of homology at around 88% (Klein et a l, 1989). Two non-signal transducing 
isoforms of TrkB, designated TrlcB'^ '^ -^, have thus far been identified. They 
possess the same extracellulai* domain as TrkB'TK+, however, they differ in their 
cytoplasmic domains, since they lack the kinase catalytic region (Klein et al., 
1990; Middlemas et a l, 1991; Allen et a l, 1994). The extracellular region of 
the TrkB receptor has been shown to possess thiee N-terminal tandemly linked 
leucine rich motifs, two cysteine clusters, and two immunoglobulin like domains 
(Schneider and Schweiger, 1991). Recently these leucine rich regions have been 
demonstrated to be capable of binding to BDNF, NT3 and NT-4 /5 (Windisch et 
a l, 1995a, Windisch et a l, 1995b; Ninkina et a l, 1997).
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Expression of trkB mRNA has been detected in discrete regions of the 
developing nervous system of the mouse, both by Northern blot analysis, and in 
situ hybridization (Klein et al., 1989). Northern blotting has revealed that trkB 
mRNA expression is highest in the developing brain, but it is also detected in a 
number of non-neural tissues, including the lung and muscle (Klein et al., 1989). 
Non-neural tissues such as the lung and muscle display predominant expression 
of small RNA transcripts, encoding the non-catalytic TiicB^K- isoform of the 
receptor (Klein et al., 1989). Within the developing nervous system, in situ 
hybridization analysis has revealed that expression is prominent in the brain, 
spinal cord, spinal sensory ganglia and paiavertebral sympathetic chain ganglia 
(Klein et a l, 1989). The expression of trkB mRNA is also seen in structures 
resembling certain cranial ganglia, including the trigeminal ganglion (Klein et 
al., 1989). In situ hybridization analysis of trkB in the chicken embryo has 
revealed a pattern of expression in developing peripheral ganglia that correlates 
well with the localisation of neurons known to respond to BDNF (Dechant et al, 
1993). Additionally, the onset of trkB mRNA expression commences early 
during embryogenesis, consistent with the view that BDNF plays a role in the 
early development of certain peripheral ganglia (Dechant et a l, 1993; Wright et 
a l,  1992). Developmental variations in the expression of the different TrlcB 
isoforms have also been observed in certain cranial sensoiy ganglia (Ninkina et 
a l, 1996). High levels of mRNA encoding the TiicBTK+ isoform are detected in 
trigeminal neurons during the period when these neurons respond to BDNF in 
vitro, whereas an increase in the non-catalytic TrkB^K- isoform is observed at 
later stages of development when these neurons aie known to have undergone a 
switch in trophic dependence from BDNF to NGF (Buchman and Davies, 1993; 
Ninkina et a l,  1996). This study suggests that the loss of BDNF response 
shown by trigeminal neurons during development is imparted by increased 
levels of the non-catalytic receptor (Ninkina et a l, 1996). The TrkB'^K* isoform 
has been proposed to play a role in limiting the spatial distribution of BDNF by 
sequestering the ligand, and subsequently creating distinct borders that sepai ate
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different BDNF responsive systems, such as the optic tectum, and the 
developing trigeminal system (Biffo et al., 1995). The expression of full length 
and truncated TrlcB has additionally been demonstrated in the developing visual 
system (Takahashi et al., 1993; Biffo et al., 1995; Gamer et al., 1996), where the 
tmncated isoforms are found to be upregulated with increasing age (Allendorfer 
et al., 1994). The TrkB^K- isoform is also highly expressed within adult sensory 
neurons (McMahon et al., 1994), and its expression is increased in adult facial 
motor neurons in response to injury (Kobayshi et al., 1996).
In addition to its role as the primary receptor for BDNF, TrlcB has been 
demonstrated to bind NT-3 when ectopically expressed in non-neuronal cells, 
but with a lower affinity than BDNF (Klein et al., 1991; Glass et al., 1991; 
Squinto et al., 1991; Soppet et al., 1991). Recent studies have revealed that 
TrkB is not only the primary receptor for BDNF, but is also the cognate receptor 
for NT-4/5 (Klein et al., 1992). Introduction of a point mutation in the 
extracellular domain of the TrkB receptor abolishes the binding of NT-4/5 
whereas the binding of BDNF is unaffected (Klein et al,, 1992). Analysis of the 
extracellular region of the various Trk receptors has implicated the 
immunoglobulin domains in ligand discrimination between the neurotrophins 
(Urfer et al., 1995), whereas the adjacent juxtamembrane region has also been 
suggested to participate in binding NT-3 and NT-4/5 (Clary et al., 1994; 
Strohmaier et al., 1996). In contrast, recent studies have demonstrated that the 
leucine rich motifs of Trk receptors are the essential ligand binding regions 
(Windisch et al., 1995a; Windisch et al., 1995b). Recently, novel isoforms of 
TrkB have been identified in developing sensory neurons that have variations in 
the extracellular binding region, lacking two or all three of the leucine-rich 
motifs (Ninkina et al., 1997). When expressed in fibroblast cell lines, these 
isoforms do not bind either BDNF, NT-3 or NT-4/5, and the transfected 
fibroblasts do not survive or show responses to neurotrophins (Ninkina et al., 
1997). This study suggests that the leucine-rich motifs in TrlcB are essential for
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ligand binding and signalling and that the immunoglobulin-like domains alone 
are insufficient to confer neurotrophin binding via TrkB
Targeted dismption of the trkB gene results in severe nervous system 
lesions and premature death of the affected animals (Klein et al., 1993). The 
specific structures affected by this mutation include trigeminal and dorsal root 
ganglia within the peripheral nervous system, and the facial motor nucleus 
within the central nervous system (Klein et al., 1993). Stractures known to have 
a function in feeding, including the trigeminal ganglion, facial motor nucleus 
and vagal nucleus are particularly affected by the TrkB mutation, resulting in 
aberrant feeding behaviour in the neonatal animals (Klein et al., 1993). All of 
these structures have previously been shown to express trkB transcripts during 
development (Klein et al., 1993). Other neuronal deficiencies were observed in 
the CNS, in the spinal cord at lumbar levels L2-L5 (Klein et a l, 1993). Further 
detailed analysis of TrkB"/" mice has shown that the loss of neurons within the 
trigeminal ganglion occurs at an early developmental stage, consistent with the 
dependence of early trigeminal neurons on BDNF in vitro (Pinon et al., 1996).
TrkC
The third member of the neurotrophin receptor tyrosine kinase family to 
be identified was TrkC (Lamballe et ah, 1991b). TrkC was initially identified as 
the product of a cDNA clone isolated from a porcine brain cDNA libraiy, and 
displays the same structural features as the related TrkA and TrlcB tyrosine 
kinase receptors (Lamballe et al., 1991b). The mature TrkC protein has a 
molecular weight of 145kD, and the overall homology of porcine TrkC with the 
human Trk and mouse TrkB receptors is 67% and 68%, respectively. The 
extracellulai' domains exhibit 54% (TrkC and TrlcA) and 53% (TrkC and TrlcB) 
homology including conservation of several cysteine residues (Lamballe et al., 
1991b). The kinase domains of the Trk receptors exhibit a high degree of
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homology, TrkC being 87% homologous to TrkA and 88% homologous to TrkB 
(Lamballe et al., 1991b). The three receptors also share several characteristic 
features including a threonine residue at position 682, a tryptophan residue at 
position 757 and possesses a short, 15 residue, carboxy tail containing 8 
identical amino acids (Lamballe et al., 1991b). Several variants of the TrkC 
receptor are produced by differential RNA splicing. To date, four TK+ and three 
TK- receptor isoforms have been identified (Lamballe et al., 1993; Tsoulfas et 
a l,  1993; Valenzuela et al., 1993; Garner and Large, 1994). The TK+ TrkC 
isoforms have the same overall stiucture, but differ in that the splice variants 
possess 14 (TrkC K14), 25 (TrkC K25), or 39 (TrkC K39) additional amino acid 
residues in the tyrosine kinase domain of the receptor (Lamballe et al., 1993; 
Tsoulfas et a l, 1993; Valenzuela et al., 1993). The 14 and 25 amino acid 
residue sequences aie unique and are unrelated to any other known sequences, 
whereas the 39 amino acid-long insert consists of a combination of the 14 and 25 
amino acid sequences (Tsoulfas e ta l,  1993).
Most of the available information regarding the expression of trkC  
mRNA has been generated using probes that do not discriminate between the 
different isoforms of the receptor. Weak expression of trkC transcripts can first 
be detected at E7.5, in the early neuroectoderm of the mouse, by ribonuclease 
protection assay (Tessaiollo et al., 1993). By E9.5, in situ hybridization analysis 
reveals that the developing DRG, telencephalon, and spinal cord are all 
expressing trkC mRNA (Tessarollo et al., 1993; Lamballe et al., 1994). At 
El 1.5, trkC expression can be seen in discrete regions of the developing PNS 
such as the dorsal root and trigeminal ganglia, and the ganglia of the VII, VIII, 
IX, and X cranial nerves (Tessarollo et ah, 1993; Lamballe et al., 1994). At this 
stage of development, expression is also prevalent in many regions of the CNS, 
including the telencephalon, diencephalon, mesencephalon, rhombencephalon 
and neural tube (Tessarollo et al., 1993; Lamballe et a l, 1994). In mid-gestation 
E l3.5 embryos, trkC transcripts are present primarily in two structures within
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the PNS, the trigeminal and the otic ganglion. In the CNS, trkC expression is 
seen at relatively high levels in the cerebellar Purkinje, and Golgi cells, the 
telencephalon, septal nuclei, spinal cord, and, at lower levels in the 
hypothalamus, mesencephalon, and brain stem (Tessarollo et al., 1993; 
Lamballe et a l, 1994). At E l5.5, the highest level of trkC transcripts in the PNS 
are in the otic and trigeminal ganglia, and the spinal nerves. At this age the 
DRG also display punctate labelling of peripheral cells (Tessarollo et al., 1993; 
Lamballe et al., 1994). Within the CNS, E15.5 embryos express trkC mRNA in 
the tectum, telencephalon, septal region, mesencephalon, brainstem, cerebellum. 
At this age trkC mRNA is expressed for the fust time in the pontine nuclei and 
developing hippocampus (Tessarollo et al., 1993; Lamballe et a l, 1994). In late 
stage embryos, at E17.5, the majority of trkC hybridization observed in the PNS 
is seen in the periphery of individual dorsal root ganglia. Within the CNS, trkC 
mRNA is observed in the caudatoputamen and associated fibres, located 
between the caudate and forebrain subventricular zone, in the medial septal 
nucleus and the hypothalamus, the cerebellum, tectum, medulla and spinal cord 
(Lamballe et al., 1994).
During development, the expression of trkC transcripts has additionally 
been observed in various areas outside of the nervous system (Tessaiollo et al., 
1993; Lamballe et al., 1994). These areas include several facial structures such 
as the vibrissae of the snout, the dental papillae, the posterior tongue, sublingual 
glands and olfactory epithelium in the head (Tessarollo et al., 1993; Lamballe et 
al., 1994). In the body cavity, trkC mRNA is expressed in the submandibular 
gland, the subendothelial mesenchyme of arteries, the mesenchyme surrounding 
the urogenital ducts, the diaphragm, adrenal glands and within adipose tissue 
(Tessaiollo etal., 1993; Lamballe etal., 1994).
In adult animals trkC mRNA expression continues to be seen in several 
regions within the CNS, including regions of the forebrain such as the cerebral 
cortex, hippocampus, thalamus, and hypothalamus and in laige motor neurons
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within the spinal cord (Merlio et a l, 1992; Tessaiollo et al., 1993; Lamballe et 
al, 1994).
Neurotrophin-3 binds to the different isoforms of TrkC with similar 
affinity and Idnetics, and induces the rapid phosphoiylation of tyrosine residues 
within the cytoplasmic domain of the receptor (Lamballe et a l, 1993; Tsoulfas 
et a l, 1993; Valenzuela et a l, 1993). However, at this juncture, only the TK+ 
isoform TrkC K1 is Icnown to activate PLCy and phosphatidyl inositol-3 kinase
(PI-3 kinase), although both the insert containing K14 and K25 isofoims possess 
recognition sites for PLCy and PI-3 kinase (Lamballe et a l,  1993). When
ectopically expressed in cells of the NIH 3T3 fibroblast cell line, the TrkC Kl, 
K14, and K25 isoforms have all been observed to induce DNA synthesis on 
exposure to NT-3 (Lamballe et a l, 1993). However, neither the K14 nor K25 
isoform could induce the efficient transformation of these cells (compared with 
those expressing TrkC K l) upon exposure to NT-3 (Lamballe et a l, 1993). 
Further experiments have demonstrated that only TrkC Kl can induce the 
proliferation of transfected NIH 3T3 cells and the neuronal differentiation of 
PC 12 cells, suggesting that the different isoforms of TrkC may act via different 
signalling pathways (Lamballe et a l, 1993; Tsoulfas et al., 1993; Valenzuela et 
al, 1993).
Inactivation of the gene encoding full length TrkC produces striking 
deficits within the PNS (Klein et a l, 1994). The homozygous mutant mice are 
reduced in size by postnatal day 4 (P4) and most die by P21 (Klein et a l, 1994). 
The behavioural phenotype of the mutant mice suggests a deficit in 
proprioception, and subsequent analysis of the DRG of these animals has 
demonstrated that the group la primary afferent sensory neurons subserving 
proprioception are substantially reduced in number (Klein et a l,  1994; 
Minichiello et a l, 1995). No gross defects are observed in CNS structures that 
express trkC transcripts, although TrkC"/" mice generally do not survive until 
adulthood (Klein et a l, 1994). Studies using antibodies that inactivate the TrkC
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receptor during chick embryogenesis produce a phenotype that is remarkably 
similai" to that resulting from trkC gene deletion. In particulai* there are severe 
reductions in the total complement of neurons within the DRG (Lefcort et al„ 
1996). Detailed neuroanatomical analyses of the TrkC"/" mutant mice has 
recently revealed specific defects in the cochlear ganglion and in the innervation 
of hair cells within the inner ear (Schimmang et a l, 1995). In addition, the 
vestibulai' ganglia of TrkC"/" mice also have significantly reduced numbers of 
neurons (Schimmang et a l, 1995). These detailed studies have also revealed 
differences between the phenotypes of TrkC and NT-3 deficient mice. For 
example, there is an approximately 66% reduction in the complement of neurons 
within the lumbar DRG of neonatal NT-3"/" animals (Ernfors et a l, 1994a; 
Faiinas et a l, 1994) In contrast, in the lumbar DRG of trkC'f' animals, there is 
only an 18% reduction (Klein e ta l,  1994 ; Minichiello e ta l, 1995). Similaily, 
the number of neurons in the spiral ganglia of NT-3"/" mice is reduced by -86%, 
whereas the decrease seen in TrkC"/" neonates is 51% (Schimmang et a l, 1996). 
These differences may be due to the ability of NT-3 to signal via the TrlcA or 
TrkB receptors, since NT-3 has been demonstrated to promote the in vitro 
survival of mid-gestation trigeminal and nodose sensory neurons from TrkC"/" 
embryos, but not from embryos that also lack functional TrkA or TrlcB receptors 
(Davies et al, 1995a).
1.5 Other Neurotrophic Factors And Their Receptors.
Neurotrophic Cytokines.
Neurotrophic or 'neuropoietic' cytolcines are a group of distantly related 
proteins that effect similar biological responses in a variety of different cell 
types. Members of this cytokine subfamily include; ciliary neurotrophic factor 
(CNTF), growth promoting activity (GPA), leukaemia inhibitory factor (LIF), 
oncostatin-M (OSM), interleukin-6 (IL-6), interleukin-11 (IL-11), granulocyte
61
macrophage colony stimulating factor (GM-CSF) and the newly isolated 
cardioti’ophin-1 (CT-1). Although these proteins shaie less than 30% amino acid 
homology, they possess high a degree of structural homology, based on their 
predicted tertiaiy structures (Bazan et al., 1991). Additionally, these cytokines 
are thought to be evolved from a common ancestral gene (Bruce et al., 1992), 
and are known to transduce signals via shared multi-subunit receptors (Fig 1.2; 
Stahl and Yancopoulos 1994).
Ciliary Neurotrophic Factor
CNTF was initially identified as a result of its ability to promote the 
survival of embryonic chick ciliary neurons in vitro (Adler et al,, 1979). Ciliaiy 
neurons had been observed to survive in the presence of chick skeletal muscle 
cells, rat oculai' tissues, and fragments of sciatic nerve (reviewed by Sendtner et 
al., 1994). After a systematic analysis of different ocular tissues, Adler and 
colleagues demonstrated that the iris, ciliaiy body, and choroid layer were the 
richest sources of the putative survival factor that they termed 'ciliary 
neuronotrophic factor' (Adler et al., 1979). Subsequent studies, utilising ion- 
exchange chromatography, revealed that the survival factor was an acidic protein 
with a molecular weight of 20-24kD (Barbin et al., 1984; Manthorpe et al., 
1986). Based on paitial amino acid sequence data, the cDNAs for rat and rabbit 
CNTF were cloned (Stockli et al., 1989; Lin et al., 1989). Additionally, the 
mouse and human genomic clones have been identified and investigated 
(Kaupmann et al., 1991; Lam et al., 1991). Biochemical analysis of CNTF has 
revealed that it is a 200 amino acid long protein with a molecular weight of 
22.7kD (pi > 5.78) (Stockli et al., 1989; Lin et al., 1989). One unusual feature 
of CNTF is that it lacks a consensus sequence for glycosylation and a secretory 
signal peptide, suggesting that it is a cytosolic protein (Stocldi et al., 1989; Lin 
et al., 1989). The human CNTF homologue has subsequently been cloned and
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was found to be 80% homologous to rat CNTF (Masiakowski et al., 1991; Lam 
et al., 1991; Negro et al., 1991). Although no high degree of sequence 
homology exists between CNTF and other known proteins, structural similarities 
have been identified between CNTF, LIF, OSM, IL-6, and GM-CSF based on 
the tertiary sequences of these proteins, which distinguished four a-helices 
(Bazan, 1991). Experiments using site dhected mutagenesis have determined 
that up to 14 N-terminal and 27 C-terminal amino acid residues can be removed 
from the CNTF molecule without drastically reducing its biological activity 
(Negro et al., 1994). Longer deletions, or the elimination of internal stretches of 
amino acids, have been shown to abolish the biological activity of CNTF (Negro 
etal., 1994).
Early experiments carried out in vitro, demonstrated that a partially 
purified form of CNTF had a broad spectrum of survival activity on PNS 
neurons (Manthoipe et al., 1983). These results were later confirmed with 
purified recombinant CNTF, using several populations of chicken embryo 
neurons including E8 trigeminal, nodose, and dorsal root ganglion sensory 
neurons, parasympathetic ciliary neurons, and neurons of the paravertebral 
sympathetic chain ganglia (Manthorpe et al., 1982; Manthorpe et al., 1986). 
Similarly, neurons of developing rat nodose ganglion show increased survival in 
the presence of CNTF in vitro (Thaler et al., 1994). Furthermore, within the 
PNS, CNTF has additionally been shown to exert its survival promoting effects 
upon postnatal neurons of the rat acoustic ganglion (Hartnick et al., 1995). 
Interestingly, dorsal root ganglion sensory neurons have been observed to 
exhibit changes in their survival requirements. At E8, DRG neurons are 
unresponsive to CNTF, whereas around 40% of these neurons can be rescued by 
ElO (Manthorpe et al., 1982). Likewise, E21 rat sympathetic neurons that are 
normally unresponsive to CNTF in vitro survive in the presence of CNTF after 
an initial period in culture with NGF (Kotzbauer et al., 1994). The equivalent
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age postnatal neurons demonstiate an immediate response to CNTF (Kotzbauer 
etal., 1994).
Within different populations of CNS neurons, CNTF displays similar 
age-related effects to those seen with PNS neurons. For example, it does not 
promote the survival of chick spinal motor neurons at E4 (Longo et al., 1982; 
Bloch-Gallego et al., 1991), but does promote the survival of purified motor 
neurons at E6 (Arakawa et al., 1990). In keeping with these findings, the 
administration of CNTF in ovo to E5-E9 chicks induces an increase in the 
number of spinal motor neurons (Oppenheim etal., 1991). Likewise, a number 
of studies have concluded that CNTF has a trophic effects upon spinal cord 
motor neurons in developing and postnatal rodents, both in vitro and in vivo 
(Sendtner et al.., 1990; Sendtner et al., 1992a; Henderson et al., 1993; Forger et 
al., 1993; Mitsumoto et al., 1994; Li et al., 1994; Vejsada et al., 1995). Other 
populations of CNS neurons that respond to CNTF include hippocampal neurons 
and cerebellar Purkinje neurons (Ip et al., 1991; Larkfors etal., 1994).
In addition to the survival promoting effects of CNTF, several studies 
have revealed that CNTF has an effect on other properties of developing 
neurons. In the precursor neurons of the E7 sympathetic chain ganglia, CNTF 
can arrest cell division and concomitantly induces the expression of vasoactive 
intestinal peptide (VIP) immunoreactivity (Ernsberger et al., 1989). 
Depolai'ization of cultured sympathetic neurons with elevated levels of K+, has a 
similar effect to that of CNTF on the expression of VIP and neuropeptide Y 
(NPY), however, this effect cannot be repeated on sensory (DRG) neurons (Rao 
et a l, 1992). Similarly, CNTF has been demonstrated to influence the levels of 
choline acetyltransferase (ChAT) and tyrosine hydroxylase (TH) activity in 
neonatal rat sympathetic neurons (Saadat et al., 1989). Additionally, CNTF has 
been shown to enhance the expression of TH immunoreactivity by cultured rat 
neurons from the locus coeruleus, and substantia nigra as well as upregulating
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the expression of the endogenous neurotransmitters for these populations of 
neurons (Louis et al, 1993; Magal et a l, 1993)
The expression of CNTF mRNA has chiefly been studied using Northern 
blot analysis. The highest level of expression detected by this method is in the 
PNS, within the sciatic nerve of adult rats (Williams et al, 1984). CNTF mRNA 
cannot be detected in the new-born rat (Stockli et a l, 1989), and the CNTF 
mRNA expression in the peripheral nerve does not occur until one month 
postnatally, suggesting that CNTF is not a physiological survival factor for 
embryonic neurons (Dobrea et a l, 1992). The expression of CNTF mRNA and 
protein has been suggested to coincide with the differentiation of Schwann cells 
of the peripheral nerve (lessen and Mirsky, 1992). Northern blot analysis of 
total RNA from the skeletal muscle, liver, spleen and lung, has demonstrated the 
presence of very low levels of CNTF mRNA in the skeletal muscle of adult rats 
(Stocldi et a l, 1989; Ip et a l, 1993c, Giovannini et al, 1993a). Taken together, 
the results of these experiments suggest that skeletal muscle is not a source of 
CNTF, rather it is more likely to originate in Schwann cells ensheathing the 
innervating nerve fibres within the muscle (Sendtner et a l, 1994). In contrast, 
cultured Schwann cells express only low levels of CNTF mRNA, however, 
CNTF-like biological activity can be detected in the conditioned medium of 
these cells (Carroll et a l, 1993; Meyer eta l, 1992).
CNTF is not expressed in the hindlimbs or brain in the critical period 
during the development of spinal cord motor neurons, nor is it expressed in 
significant levels within the cortex or hippocampus (Ip et a l, 1993c). This 
suggests that CNTF is not a target derived factor for CNS neurons. 
Interestingly, several studies have reported that CNTF mRNA is drastically 
reduced following peripheral nerve lesion, with the levels recovering slowly, 
until a significant increase was observed 4 weeks after lesion (Sendtner et a l, 
1992b; Freidman et al, 1992; Seniuk et a l, 1992). However, in marked contrast 
to the studies on PNS neurons, it has been shown that CNTF mRNA is rapidly
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up-regulated in the CNS after lesion of the hippocampus and cortex, with the 
levels remaining elevated for up to 3 weeks after lesion, suggesting that CNTF 
may be released in response to the trauma (Ip et al., 1993b). The cells 
responsible for the production of CNTF mRNA and protein are thought to be 
reactive astrocytes which invade the site of the lesion (Ip et al., 1993b).
Dismption of the CNTF gene produces effects within the nervous system 
that are consistent with a role for CNTF in the maintenance of motor neurons in 
adult animals, but not during development (Masu et al., 1993). Abolition of the 
gene by homologous recombination results in a progressive atrophy of adult 
mouse motor neurons, leading to a gradual decrease in muscle strength (Masu et 
al., 1993). No evidence of perinatal disturbance in motor neuron development is 
appaient, since morphometric analysis of lumbai* spinal cord, and facial motor 
neurons revealed no significant differences between postnatal CNTF"/" and wild- 
type mice (Masu et al., 1993). However, 8-14 weeks after birth, morphological 
changes are evident in lumbar and facial motor neurons, and at 28 weeks the 
number of facial motor neurons are reduced by 22% (Masu et al., 1993). No 
change in the number of ChAT, VIP or TH positive nerve fibres innervating the 
footpad and a second cholinergic target, the periosteum are apparent in the 
CNTF"/“ animals (Masu et al., 1993; Francis et ai, 1997).
Growth Promoting Activity
Growth promoting activity (GPA) was initially identified as a trophic 
factor for ciliary ganglion neurons after its extraction and partial purification 
from chick eye extracts (Nishi and Berg 1981). Following this, GPA was 
purified and chaiacterised from a sciatic nerve preparation, revealing a 21.5 kD 
protein lacking a consensus signal sequence that had 57% amino acid identity 
with mammalian CNTF, suggesting that GPA may be the avian homologue of 
CNTF (Eckenstein et al., 1990). Following its initial purification, the cloning of
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a cDNA for GPA was cairied out using an embryonic chick eye cDNA library, 
allowing the tissue specific expression of the molecule to be deduced (Leung et 
a/., 1992).
Northern blot analysis of GPA expression during development has 
demonstrated that the uvea of the eye, containing tissues innervated by the 
ciliary ganglion, contains the highest levels of mRNA for GPA. Expression was 
also seen in the E l8 sciatic nerve (Leung et al., 1992). The analysis of GPA 
expression in the chick eye at closely staged intervals from E7 to E l9, has 
revealed that expression increases between E ll and E l9, the period when ciliaiy 
ganglion neurons are undergoing programmed cell death (Leung et al., 1992).
In experiments conducted in vitro, GPA was shown to promote the 
survival of several populations of neurons within the PNS (Eckenstein et al., 
1990; Heller et al., 1993) GPA supports developing pai'asympathetic ciliaiy 
ganglion neurons and lumbar sympathetic chain neurons, and in contrast to 
previous studies carried out using CNTF, GPA promotes the survival of E8 
DRG neurons (Eckenstein et al., 1990; Manthorpe et ai, 1982). The effects of 
GPA have been also been compared with CNTF on the proliferation and 
functional differentiation of sympathetic neurons, revealing that these two 
factors produce stiikingly similar effects but with different efficacy (Heller et 
al, 1993).
Leukaemia Inhibitory Factor
Leukaemia inhibitoiy factor (LIF) was initially purified and characterised 
as a protein secreted from cultured heart cells that possessed the ability to induce 
sympathetic noradrenergic neurons to synthesise acetylcholine and form 
cholinergic synapses (Fukada, 1985). Purified conditioned medium from 
primary cultures of neonatal heart cells, revealed a protein with a molecular
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weight of 45kD, which reduced to ~22kD after treatment with a deglycosylating 
enzyme (Fukada, 1985). Amino acid sequence data demonstrated that this 
cholinergic differentiation factor was identical to amino acid sequences of 
several known proteins, one of which, termed 'leukaemia inhibitory factor' 
induced the leukaemic myeloid Ml cell line to undergo differentiation into a 
macrophage-like phenotype (Gearing et al., 1987). The amino acid sequence 
data was then used to obtain cDNA clones of murine and human LIF that display 
75% homology, and give rise to a mRNA transcript of approximately 4.1 kb 
(Gearing et al., 1987; Stahl et al., 1990). The mature murine LIF protein 
comprises 179 residues, possesses 7 potential N-linked glycosylation sites, and 
has a pi of -9.0 (Gearing et al., 1987).
During development and embryogenesis, the expression of LIF mRNA 
has been observed at low levels in several tissues, by Northern blot, RNAse 
protection and in situ hybridization analyses (Bhatt et al., 1991). Whereas LIF 
mRNA can be detected in most developing tissues throughout development, the 
highest levels of this cytokine are expressed in the uterine endometrial glands, 4 
days post coitum, suggesting that LIF may play a role in the implantation of the 
developing blastocyst (Bhatt et al., 1991). Within adult tissues. Northern blot 
analysis has revealed the expression of LIF transcripts in the brain, heart, 
thymus, liver and intestine, where the highest level of LIF signal are detected 
(Bhatt et al., 1991). The developing sldn of neonatal mice is also a site of high 
expression, where it is thought that embryonic stem cell populations may be 
responsible for LIF production (Bhatt et al., 1991). RT-PCR analysis has 
specifically identified sites of LIF expression within peripheral tissues and in the 
CNS of postnatal rats (Yamamori, 1991), and in the spinal column, limbs, and 
DRG of the developing mouse (Muiphy et al., 1993). The expression of LIF 
mRNA within peripheral tissues is localised in the targets of cholinergic 
sympathetic neurons such as the developing sweat glands and within the skin of 
the rat footpad, presenting the possibility that LIF is a target derived neuronal
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differentiation factor for these neurons in vivo (Rao and Landis, 1990; 
Yamamori, 1991). In the postnatal brain, RT-PCR technique has demonstrated 
expression of LIF transcripts within the superior colliculi and visual cortex, 
suggesting a possible role for LIF in the developmental plasticity of the visual 
system (Yamamori, 1991). Changes in the expression of LIF mRNA in response 
to injury of the adult peripheral nerve have also been detected, using RNAse 
protection assay and in situ hybridization (Banner and Patterson, 1994). In adult 
rats the expression of LIF mRNA was dramatically upregulated 24 hours after 
sciatic nerve transection, immediately proximal and distal to the lesion site, 
providing strong evidence that this cytoldne may act in response to nervous 
system damage (Banner and Patterson 1994).
Within the nervous system, LIF has a wide range of effects on both 
central and peripheral neurons. In many cases the studies carried out thus far 
have indicated that the actions of LIF are similar, if not identical, to those of 
CNTF. Cultures of non-dividing mouse neural crest cells from E9 embryos, 
were observed to undergo differentiation into a sensory neuron-like phenotype 
and express the neuropeptide CGRP, in the presence of LIF (Murphy et al.,
1991). Furthermore, LIF supports the survival of cultured sensory neurons 
derived from E 12 - E l5 DRG, in a manner reminiscent of the actions of CNTF 
(Murphy et al., 1991). Consistent with the role of LIF in development of the 
DRG, is the observation that mRNA for LIF is expressed in the central and 
peripheral targets of the ganglia, and also within the ganglia themselves, during 
the critical period when these neurons are innervating their targets and 
undergoing naturally occurring cell death, (Murphy et al., 1993). Following 
application of ^^^I-labelled LIF or CNTF to the lesioned sciatic nerve, both 
factors are retrogradely transported within the nerve in vivo , providing evidence 
that these factors may be involved in a response to injury (Hendry et al., 1992; 
Curtis et al., 1993; Curtis et al., 1994). Similarly, ^^^I-LIF binds to dissociated 
DRG neurons in vitro , and in vivo it is retrogradely tiansported by these neurons
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after subcutaneous injection into the footpad (Hendry et a l, 1992). In addition 
to DRG neurons, other populations of developing sensory neurons survive in 
response to LIF and CNTF. In nodose ganglion cultures from E l6.5 rats LIF 
and CNTF support the survival of 50% of the neurons (Thaler et ah, 1994). By 
birth less than 10% of these neurons survive with LIF or CNTF, suggesting a 
loss of responsiveness with age (Thaler et a i, 1994). Embiyonic mouse neurons 
of the nodose and trigeminal ganglia have also been reported to survive in 
culture with both LIF and CNTF (Horton et a l, 1996). Furthermore, LIF and 
CNTF elicited the same survival response in dissociated postnatal sympathetic 
neurons in vitro (Kotzbauer et a l, 1994).
Evidence has accumulated that in addition to its survival and 
differentiation promoting effects, LIF effects a change in neurotransmitter and 
neuropeptide expression in cultured sympathetic and sensory neurons. In 
sympathetic neurons, for example, a switch from noradrenergic to cholinergic 
phenotype has been observed after addition of exogenous LIF in vitro. A 
similar switch has been observed in vivo in transgenic mice overexpressing LIF 
(Ure et a l, 1992; Bamber et a l, 1994). Similarly, LIF has been observed to 
induce mRNA for several neuropeptides in cultured sympathetic neurons (Fann 
and Patterson, 1994). There is also evidence that LIF may affect the expression 
of neurotransmitters and neuropeptides in developing sensory neurons, since 
non-neuronal cells from the DRG have been observed to secrete LIF, which has 
been demonstrated to inhibit catecholamine expression in cultured rat trigeminal 
neurons (Fan and Katz, 1993). Furthermore, neurons generated in neural crest 
cultures in the presence of LIF express both CGRP and substance P, suggesting 
that LIF may inhibit the synthesis of neurotransmitters not used by sensory 
neurons and promote the synthesis of neuropeptides (Murphy et a l, 1991; 
Muiphy e ta l, 1994).
In addition to the effects of LIF and CNTF within the PNS, both factors 
elicit similar responses upon CNS neurons. Both LIF and CNTF have been
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observed to promote the survival of spinal motor neurons after deafferentation or 
axotomy in vivo (Qin-Wei et a l, 1994; Vejsada et a l, 1995), and in purified 
spinal cord motor neurons in vitro (Martinou et a l, 1992; Henderson et a l, 
1993). Furthermore, LIF has been demonstrated to promote the differentiation 
of isolated spinal cord precursor cells into a neuronal phenotype (Richards et a l, 
1996). In addition, both CNTF and LIF effect similai* changes in ChAT activity 
in motor neuron cultures (Martinou et a l,  1992), and in cultures of neurons 
isolated from the ventral mesencephalon, which contains neurons of the cranial 
motor nuclei (Zurn and Werren, 1994).
Inactivation of the gene encoding LIF has no obvious deleterious effects 
on nervous system development, however, it has been observed to affect the 
implantation of blastocysts in the uteri of homozygous mutant mice, which is 
consistent with previous observations of LIF expression during embryonic 
development (Stewait et a l, 1992; Bhatt et a l, 1991), Further analysis of these 
mice has revealed that the noradrenergic to cholinergic switch that occurs in vivo 
in sympathetic neurons innervating the developing sweat gland occurs normally 
(Rao et a l, 1993). However, in the absence of LIF, neuropeptide induction in 
response to injury is suppressed both in vivo and in vitro in peripheral neurons 
(Rao et a l, 1993). Taken together, these results suggest that some functional 
redundancy may occur between cytokines. More recently, double gene targeting 
experiments have been performed by crossing LIF"/" and CNTF"/" mice in order 
to examine the extent of co-operative action of both factors in vivo (Sendtner et 
a l,  1996). Whereas CNTF"/" animals suffer relatively mild motor neuron 
degeneration the degenerative changes in the double mutant animals were more 
extensive, appeared earlier, and were functionally reflected by a marked 
reduction in grip strength (Sendtner et al, 1996).
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Oncostatin M
Oncostatin M (OSM) is a cytokine that acts as a growth regulator for a 
vaiiety of mammalian cells in vitro. OSM was initially isolated and cloned from 
mRNA extracted from cells of the U937 cell line, after these cells had been 
induced to differentiate into macrophage-like cells by treatment with a phorbol 
ester (Malik et al., 1989). Subsequently, a clone was also obtained from a 
human brain cDNA library (Malik et al., 1989). Sequence analysis of these 
clones demonstiated that OSM is synthesised from a 2 kb mRNA encoding a 
252 amino acid long precursor polypeptide, that undergoes further cleavage to 
yield a 196 residue mature protein with a moleculai* weight of -28 kD (Malik et 
al., 1989). The predicted OSM sequence has no homology with other Icnown 
proteins, but the sequence of the 3' non-coding region contains an A+T-rich 
stretch with sequence motifs found in the 3' untranslated regions of many 
cytokine cDNAs (Malik etal., 1989). Recently, OSM has been recognised as a 
member of the family of neurotrophic cytokines since they share an overall 
structural homology (Bazan, 1991). One further interesting finding is that the 
genes encoding OSM and LIF are tandemly linked on chromosome 22 in the 
human genome, suggesting they have a common evolutionary origin 
(Giovannini etal., 1993b).
The expression of OSM is largely restricted to haematopoietic cells, 
including activated peripheral blood T-lymphocytes, and lipopolysaccharide 
induced human monocytes (Bruce et al., 1992). The only known non- 
haematopoietic source of OSM mRNA has been detected in cells derived from 
the AIDS related Kaposi's sarcoma (Bruce et al., 1992).
The effects of OSM in vitro have been determined largely using var ious 
cell lines, and overlap with those of other haematopoietic cytolcines such as LIF 
(Bruce et al., 1992). OSM induces the differentiation of murine Ml myeloid 
leukaemia cells into a macrophage-like phenotype in a similar way to LIF and
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IL-6 (Rose and Bmce, 1991). Similarly, OSM has been demonstrated to inhibit 
the differentiation of cultured embryonic stem cells into a variety of phenotypes, 
an attribute shared by LIF (Piquet-Pellorce et ah, 1994). Additionally, both LIF 
and OSM stimulate the expression of acute-phase response proteins in a human 
hepatoma cell line (Piquet-Pellorce et al., 1994). Within the developing nervous 
system, the only documented evidence of the action of OSM has been carried 
out using late stage murine DRG neurons. OSM displays a slightly lower 
survival promoting effect on these neurons than that elicited by CNTF or LIF 
{WâTQetal., 1995).
Transgenic mice have recently been generated that over-express the 
bovine form of OSM, which bears 58% sequence identity to the human OSM 
(Malik et al., 1995). The OSM over-expressing fusion genes were injected into 
mouse embryos under the direction of various tissue specific promoters, 
resulting in gross abnormalities in vaiious tissues (Malik et al., 1995). In order 
to test the potential effects of bovine OSM on neurons in vivo, a neuron-specific 
promoter was used, which directs gene expression within the brain, spinal cord 
and peripheral ganglia (Malik et al., 1995). Of the resulting transgenic mice, 
50% died at birth and the remainder displayed restricted growth, accompanied 
by tremors, ataxia, and a progressive wealcening of strength in the hindlimbs. 
However, no histological analyses of these transgenic animals has been carried 
out (Malik e ta l, 1995).
lnterleukin-6
The convergence of several lines of investigation on factors regulating B- 
lymphocyte growth and differentiation ultimately lead to the identification of a 
single growth regulatory protein termed 'interleukin-6' (reviewed by Lee, 1992). 
Molecular cloning of human and murine cDNAs encoding IL-6 revealed a 184 
amino acid protein with two potential N-linked glycosylation sites , and a
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relative molecular mass of -26 IcD (Hirano et a l, 1986; Chui et al., 1988; 
Northemann et al., 1989)
Northern blot analysis has identified IL-6 mRNA transcripts in several 
tissues of the adult rat, including several structures within the CNS (Schdbitz et 
al., 1993; ICiefer et al., 1993). The aieas of IL-6 expression have been more 
specifically identified using in situ hybridization, and include; the large 
pyramidal neurons of the pyriform cortex, medial habenular nuclei, 
ventromedial and dorsomedial hypothalamus, hippocampal formation, optic 
tract, fimbria, coipus callosum, the internal and external capsule and the granular 
cell layer of the cerebellum (Schobitz et al., 1993; Gadient et a l, 1994). No 
expression is observed in brainstem stractures or in the spinal cord, and none has 
been reported in either cranial or peripheral sensory or autonomic ganglia 
(Schobitz et a l, 1993). IL-6 expression has also been demonstrated in cultured 
microglia and astrocytes (Cadman et al., 1994) and is up-regulated in the 
peripheral nerve and facial motor nucleus after nerve injury (Reichert et al., 
1996; Kiefer gfaA, 1993).
The pleiotropic functions of IL-6 are numerous and have been well 
documented, with the principal role of this cytokine related to immune 
functions, such as the production of antibodies by B-cells (Hirano et al., 1986), 
induction of acute phase response proteins by hepatocytes (Gauldie et a l, 1987) 
and the proliferation of B-lymphoma cells (Piquet-Pellorce et a l, 1994). An 
increasing body of evidence now suggests that IL-6 also plays a role in the 
physiological and pathological events that take place in the developing and 
mature nervous system. Within the CNS, IL-6 is a survival factor for cultured 
embiyonic and postnatal midbrain catecholaminergic neurons (Kushima et al.,
1992), developing cholinergic neurons of the spinal cord (Kushima and 
Hatanaka et a l, 1992), and basal forebrain cholinergic neurons (Hama et a l,
1989). IL-6 also promotes the differentiation of PC12 cells into a neuron like 
phenotype (Satoh et a l, 1988) and induces ChAT synthesis and substance P
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expression in sympathetic neurons (Fann and Patterson, 1994). Furthermore, IL- 
6 in conjunction with the soluble IL-6 receptor (see below) were demonstrated to 
promote neurite outgrowth when added to explant cultures of embryonic DRG 
(Hirota et al,, 1996).
IL-6 deficient mice generated by gene targeting suffer defects in their 
capacity for liver regeneration and are protected against bone loss induced by 
ovariectomy (Kopf et a l, 1994; Poli et al, 1994; Cressman et a l, 1996). IL-6“/" 
animais do not suffer any obvious phenotypic defects within the central or 
peripheral nervous system either during development or in adulthood (Kopf et 
al, 1994; Poli et a i, 1994; Cressman et a l, 1996).
Cardiotrophin=l
Cardiotrophin-1 (CT-1) was initially cloned as a result of a seaich for 
factors that induce cardiac myocyte hypertrophy in vitro (Pennica et al, 1995a). 
Sequencing of a 1.7kb cDNA encoding CT-1 revealed that this cytokine has a 
relative molecular mass of 21.5 IcD, and possesses a potential N-linked 
glycosylation site, and, like CNTF, does not possess a hydrophobic signal 
sequence (Pennica et a l, 1995a; Pennica et a l, 1996a). Furthermore, the amino 
acid sequence of CT-1 displays some similarity with that of LIF and CNTF, with 
24% and 19% identity, respectively (Pennica et a l, 1995a). The predicted 
tertiary structure of CT-1 additionally beais some similarity to CNTF and LIF, 
indicating that this cytokine is also a member of the neurotrophic cytokine 
family (Pennica eta l, 1995a).
CT-1 protein has been detected in the murine heait tube between E8.5- 
E10.5 and in myocardial cells later in development (Sheng et a l, 1996). After 
E12.5, CT-1 protein expression is present in a number of tissues, including 
skeletal muscle, bone, liver, kidney, and epithelia (Sheng et a l, 1996). In the
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PNS, CT-1 is weakly expressed in the DRG of El 1.5 embryos, with expression 
increasing at later developmental stages (Sheng et al, 1996). Similarly, of CT-1 
is also expressed in the spinal cord and brain at later stages of development, 
however the levels are not as high as in those observed in the PNS (Sheng et aL, 
1996). More detailed analysis of CT-1 mRNA expression using in situ 
hybridization, and RT-PCR, has revealed that CT-1 is also present in the 
developing limb-bud at E13.5-E14.5, the stage at which motor neurons 
innervating this structure commence programmed cell death (Pennica et al., 
1996).
The effects of CT-1 that have been thus far documented aie similar to 
those of CNTF and LIF. For example, CT-1 induces; acute phase proteins in 
cultured hepatocytes (Peters et ah, 1995), inhibits the proliferation of the Ml 
myeloid leukaemic cell line, and inhibits the differentiation of embryonic stem 
cells (Pennica et ah, 1995b). CT-1 has also been demonstrated to have effects 
on cells of the central and peripheral nervous system. Within the CNS, unlike 
CNTF, CT-1 can promote the survival of cultured midbrain dopaminergic 
neurons, however, it is not as potent as glial cell line-derived neurotrophic factor 
(Pennica et ah, 1995b). CT-1 can also induce a neurotransmitter switch in 
cultured rat sympathetic neurons, increasing ChAT activity whilst inhibiting 
tyrosine hydroxylase activity (Pennica etal., 1995b). CT-1 promotes the 
survival of embryonic ciliary neurons in vitro, however, at low concentrations, 
CT-1 is not as potent as CNTF (Pennica et al., 1995b). In addition, CT-1 
promotes the long term survival of purified E14 spinal cord motor neurons in 
culture , and is more potent over time than either CNTF or LIF (Pennica et a l, 
1996b).
At this juncture, targeted gene disruption experiments have not been 
conducted, and it will be of interest to see whether CT-1 gene inactivation has an 
effect on the in vivo survival of central or peripheral neurons.
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1.5.2 Cytokine Receptors.
CT-1 GSM LIF CNTF IL-6
p 1J 1f }p Itf1 11) 11 1 1 1
gpl30 LIFRP gpI30 ? gpl30 LIFRP gpl30 LIFRP gpl30 gpl30
Adapted from Stahl and Yancopoulos, 1994
Figure 1.2 Schematic diagram showing the interaction of neurotrophic cytokines their receptors.
The neurotrophic cytokines; CNTF, LIF, OSM, IL-6, and CT-1 are now 
known to utilise subunits of a multicomponent receptor signalling system (see 
Fig. 1.2 above). This receptor sharing between cytokines largely accounts for 
the degree of pleiotropy and functional redundancy displayed by these proteins, 
and may have evolved to allow signalling by many members of the cytokine 
family, such that each member can elicit actions upon distinct targets (reviewed 
by Stahl and Yancopoulos, 1994). The distribution of the receptor components 
also helps to explain the known target cell specificity of the individual 
cytokines. The receptor subunits have been designated the suffix a  or P, 
correspondent with their capacity to transduce a signal across the cell membrane. 
Thus, the a  components are non-signalling receptors capable of binding to their 
cognate ligands, that play a role in recruitment of the p receptor subunits, 
whereas the p components themselves are the signal transducing elements. So 
far, a  subunits have been described for CNTF (CNTFRa) and IL-6 (IL-6Ra), 
however, there remains the possibility that CT-1 also requires an additional a  
subunit, whereas LIF or OSM do not. However in the case of OSM an 
additional OSM specific signalling component may replace LIFRp.
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The p receptor subunits form homo or hetero-dimers upon binding of the 
appropriate ligand. The LIF receptor constitutes a hetero-dimer comprised of 
LIFRp and glycoprotein-130 (gplSO) subunits. The other cytokines, with the 
exception of IL-6, similarly form these heterodimers, but in addition may also 
require an a  component (Bruce et a l, 1992). The IL-6 receptor is comprised of 
a homodimer of two gplBO subunits and the accessoiy IL-6Ra component 
(Bruce et aL, 1992). The receptor components are brought together at the cell 
surface in a stepwise manner, upon binding of the appropriate ligand (reviewed 
by Stahl and Yancopoulos, 1994). Thus, in the case of CNTF, the ligand first 
binds to the CNTFRa component, which recruits gplSO, and finally, forms a 
complex with LIFRp. Constitutively associated with the P subunits are non­
receptor tyrosine kinase proteins of the Jalc/Tyk family, that become activated 
upon p-subunit dimerization. These proteins in turn activate a variety of 
intracellular signalling molecules, such as the STAT family of DNA binding 
ti'anscriptional activators (Stahl and Yancopoulos, 1994).
CNTFRa
The CNTF alpha receptor (CNTFRa) was initially cloned using a 
strategy that employed an 'epitope tagged' form of CNTF, which when bound to 
neuronal cell lines, served as the basis for extraction of the receptor (Squinto et 
aL, 1990; Davis et aL, 1991). CNTFRa has a structure unrelated to the 
receptors for the neurotrophins, but is similar to the receptor for IL-6, having an 
approximate 30% sequence homology (Davis et al, 1991). Sequence analysis of 
cDNAs encoding the isolated receptor have revealed a protein of approximately 
411cD, containing four potential N-linked glycosylation sites. A high degree of 
sequence homology is apparent between the human and rat forms of CNTFRa, 
with approximately 94% of the nucleotides conserved between species (Ip et al., 
1993c). One interesting feature of the CNTFRa receptor is the absence of a
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cytoplasmic domain (Davis et al., 1991). The receptor is anchored to the cell 
membrane via a glycosyl-phosphatidylinositol (GPI) linkage that can be cleaved 
on treatment with phosphatidylinositol-specific phospholipase C (PIPLC), an 
enzyme that cleaves the anchors of GPI linked proteins (Davis et a l, 1991). 
Furthermore, a soluble form of CNTFRa has been identified that can form 
functional receptor complexes upon cells expressing gpl30 and LIFRp. This 
soluble form of CNTFRa has been detected in cerebrospinal fluid and in skeletal 
muscle after nerve injury, suggesting a physiological role for the released form 
of the receptor after injury (Davis et a l, 1993a).
Northern blot analysis, and in situ hybridization have detected the 
expression of CNTFRa transcripts in many tissues of the adult rat, especially 
within tissues of neuronal origin (Davis et a l, 1991; Ip et al., 1993c). 
Widespread expression is seen within the CNS in several brain regions including 
cortical layer V, and motor neurons of the ventral spinal cord. Prominent 
expression is observed in the facial and trigeminal motor nuclei, consistent with 
the view that CNTF acts on different motor neuron populations (Davis et al., 
1991; Ip et al., 1993c). During development, CNTFRa mRNA is also detected 
within the PNS in the sciatic nerve, and the dorsal root, ciliary and superior 
cervical ganglia, consistent with previous in vitro work demonstrating different 
effects of CNTF on neurons from these ganglia (Davis et al., 1991; Ip et al., 
1993c). Additionally, prominent expression of CNTFRa mRNA occurs during 
development within the neuroepithelial linings of brain vesicles, within 
developing DRGs and in the spinal cord of E ll-E l 5 rats, which contains many 
dividing neuronal precursor cells (Fredriksen and McKay, 1988; Murphy et al., 
1991; Ip et al., 1993c). The expression of CNTFRa mRNA has also been 
demonstrated in non-neural cells within the developing embryo, and the adult 
rat, with maiiced expression in adult skeletal muscle and in developing structures 
associated with the heart and intestinal tract (Ip et al., 1993c).
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Reconstitution experiments using cell lines transfected with 
combinations of the various receptor components have revealed that the 
CNTFRa is not sufficient for signalling, and forms a functional receptor only 
when it is co-expressed with LIFRp and gpl30 subunits (Baumann et al., 1993; 
Davis et al., 1993b; Gearing et at., 1994). Similarly, introduction of the LIFRp 
and gpl30 subunits, which are alone sufficient for LIF signalling, does not 
constitute a fully functional receptor for CNTF (Baumann et al., 1993; Davis et 
al., 1993b; Gearing et al., 1994). CNTF binds to the CNTFRa-LIFRp complex 
or CNTFRa-LIFRp-gpl30 with high affinity (KD -10-12 m) whereas CNTF 
binds to CNTFRa alone or CNTFRa-gpl30 with low affinity (KD ~1Q-^M). 
However, whether the high affinity CNTFRa-LIFRP complex has a 
physiological role is not cleai" (Gearing et a i, 1994; Wong et al, 1995).
Targeted mutation of the gene encoding CNTFRa has a profound effect 
on motor neuron development and results in perinatal lethality (DeChiara et al., 
1995). The phenotype of mice with this mutation is strikingly different to that of 
mice that have undergone CNTF gene inactivation, which display much milder 
changes within the CNS (DeChiara et al., 1995; Masu et al., 1993). Typically, 
CNTFRa"/" mice have a reduction in the total complement of motor neurons in 
the brainstem trigeminal, facial and hypoglossal motor nuclei (27%, 41% and 
51% respectively), and a 33% reduction was noted in the lumbar' motor neuron 
pool (DeChiara et al., 1995). Since comparison of CNTF"/" and CNTFRa"/" 
mice has demonstrated that inactivation of the CNTF gene leads to a less severe 
phenotype than inactivation of the CNTFRa gene, it has been proposed that 
CNTFRa may be a receptor for an as yet unidentified ligand, as none of the 
other identified cytoldnes forms a receptor complex with CNTFRa (DeChiara et 
al., 1995).
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ÏL“6Roc
The interleukin-6 receptor (IL-6Ra) was initially isolated and cloned 
from a human natural Idller-like cell line (Yamasald et al., 1988). Subsequently, 
a homologous IL-6Ra cDNA has been isolated from rat liver that has 71% 
identity with the human leukocyte IL-6Ra in the coding region (Baumann et al.,
1990). These studies have demonstrated that IL-6Ra is an 801cD protein, with 
-468 amino acid residues, 6 potential N-linked glycosylation sites, and a short 
hydrophobic sequence that is a putative intracytoplasmic domain (Yamasaki et 
al., 1988;Baumann etal., 1990).
Northern blot and in situ hybridization analysis have shown that the 
expression of IL-6Ra within the nervous system is co-localised with its ligand, 
IL-6 (Schobitz et al., 1992; Schobitz et al., 1993). The mRNAs for both IL-6 
and IL-6Ra are expressed in the dentate gyrus and regions CAl and CA4 of the 
hippocampus, the habenulae, the dorsomedial and ventromedial hypothalamic 
nuclei, the optic tract and the pyriform cortex of the adult rat (Schobitz et al., 
1992; Schobitz et al., 1993). This widespread tissue distribution has been 
suggested to correlate with a role for IL-6 in the co-ordination of metabolic, 
behavioural and neuroendocrine changes in the brain, and since the cytokine and 
receptor are co-localised, may imply an autocrine or paracrine mode of action 
(Schobitz et al., 1992; Schdbitz et al., 1993). Further experiments have 
demonstrated an increased immunoreactivity to IL-6Ra and IL-6 in Schwann 
cells after lesion of the hypoglossal nerve, suggesting a role for IL-6 and its 
receptor in injury responses (Hirota et al., 1996). Within the PNS, IL-6Ra 
mRNA is expressed by cultured primary sympathetic neurons, and its expression 
is upregulated after treatment with IL-6 (Marz et al., 1996). The expression of 
IL-6Ra by sympathetic neurons suggests a potential role for IL-6 in modulating 
sympathetic function.
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The mode of signalling that IL-6 employs is similar to that of CNTF. 
Initially, EL-6 binds to IL-6Ra and subsequently recruits the gpl30 signalling 
subunit (Taga et al., 1989). Deletion of the intracytoplasmic region of IL-6Ra 
does not reduce the capacity of EL-6 to induce growth inhibition on a murine cell 
line, suggesting that the intracytoplasmic domain is not necessary for effective 
signalling (Taga et al., 1989). Similarly, a soluble form of the receptor (sIL- 
6Ra) lacking the transmembrane and cytoplasmic domains fomis complexes 
with gpl30 and has functional capabilities (Taga et al., 1989; Lust et a l, 1995).
Transgenic mice that constitutively express IL-6Ra in conjunction with 
EL-6 have been reported to display accelerated regeneration of the axotomized 
hypoglossal nerve, further suggesting a role for IL-6 and IL-6Ra in nerve 
regeneration after trauma in vivo (Hirota et al., 1996).
LIFRp
The LIF receptor-p was isolated and cloned by expression screening of a 
human placental cDNA library using iodinated LIF (Gearing et a l, 1991). The 
LIF receptor is homologous to the IL-6 P receptor, gpl30 (discussed below), 
which suggests that the two receptors might shaie a common signal transduction 
pathway (Geaiing et al., 1991). A murine cDNA encoding the LIF receptor has 
subsequently been isolated by cross hybridization, and shares -70% amino acid 
identity to the human sequence (Gearing et al., 1991). The cDNA for human 
LIF encodes a 190kD protein, with 1097 residues comprising a pre-pro LIFRp, 
which consists of a signal sequence, a lai*ge 789 residue extracellular* domain, a 
transmembrane domain and a 238 residue cytoplasmic domain (Gearing et al.,
1991). The receptor possesses 20 potential N-linked glycosylation sites, 19 of 
which reside in the extracellular domain, and sequence comparison between the 
LIFRP and gpl30 receptors revealed -65% amino acid identity in the 
tiansmembrane region (Gearing eta l, 1991).
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Expression of LIFRp mRNA during development has been demonstrated 
by in situ hybridization, and a novel technique using heterozygous embryos 
raised for the purpose of gene deletion experiments (see below), where the lacZ 
reporter gene was incorporated into the targeting vector and used to examine the 
developmental distribution of the receptor (Li et al., 1995). Expression in the 
developing nervous system is apparent in the hindbrain and neural crest at E9.5, 
and from E14.5 through to adulthood, expression is prominent in the brainstem 
motor nuclei, including the hypoglossal and facial nuclei, and also the nucleus 
ambiguus (Li et al., 1995). LIFRP is also expressed in spinal motor neurons, 
and within the PNS, in dorsal root ganglia (Li et al., 1995).
Reconstitution and affinity cross-linking experiments have revealed that 
coexpression of LIFRP and gpl30 are required for the formation of functional 
receptors for LIF, OSM, CNTF, and CT-1 (Baumann et a l, 1993; Davis et a l, 
1993b; Gearing et a l, 1994; Pennica et a l, 1995b). Further experiments have 
demonstrated that the signalling mechanism of LIFRP involves activation of the 
MAP kinases ERKl and ERK2 (Boulton et a l, 1994; Thoma et a l, 1994), in 
addition to recruitment of adapter proteins known such as SHC, GRB2, and 
activation of PLCy, PI-3 kinase, and members of the STAT family of
transcription activating factors (Boulton et a l,  1994; Stahl et a l,  1994). 
Activation of STAT signalling proteins by tyrosine phosphorylation has been 
shown to be conferred by members of the Jak/Tyk family of non-receptor 
protein tyrosine Idnases that are pre-associated with LIFRp and gpl30 (Boulton 
e ta l, 1995).
Targeted mutation of the gene encoding LIFRp causes perinatal death, 
and results in a reduction in the total number of spinal cord and brainstem 
astrocytes, concomitant with a reduction in MAP kinase activation, and loss of 
the in vitro survival response of DRG neurons to LIF, OSM and CNTF (Ware et 
a l, 1995). Detailed histopathological analysis of LIFRp"/" mice has revealed
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losses of > 35% in the complement of facial motor neurons, in addition to the 
loss of 40% of motor neurons in the lumbar spinal cord and 50% of neurons 
within the nucleus ambiguus (Li et a i, 1995). The effect of gene deletion on 
motor neuron populations is more severe in LIFRp"/" mice than that seen in mice 
deficient for LIF or CNTF or both (Sendtner et al., 1996), and has striking 
parallels with the loss of many brainstem motor neuron populations observed in 
CNTFRa"/" mice (DeChiara et ai, 1995).
gp 130
Molecular cloning of a human gpl30 cDNA has revealed that it is a 
130kD glycoprotein, of 918 amino acid residues, with a single transmembrane 
domain, 14 potential N-linked glycosylation sites, and an extracellular domain 
that consists of six fibronectin type III modules (Hibi et al., 1990). Functional 
analysis of gpl30 using amino acid substitution, has demonstrated that the 
receptor possesses a region of -61 residues in the cytoplasmic domain that are 
critical for the generation of a signal (Murakami et al., 1991). A  murine 
homologue of the gpl30 receptor has been cloned, and revealed its nucleotide 
sequence is 76% homologous to the human cDNA (Saito et al., 1992). Both 
murine and human gpl30 display significant homology to the receptors for 
prolactin, growth hormone, erythropoietin, GCSF, LIFRp and several of the 
receptors for other interleukins (Hibi et al., 1990; Gearing et al., 1991; 
Murakami et al., 1991; Saito et al., 1992).
Ubiquitous expression of gpl30 has been observed by Northern blot 
analysis. Gpl30 mRNA is present in the brain, heart, thymus, spleen, kidney, 
lung, and liver of the adult mouse (Saito et al., 1992). The levels of gpl30 
mRNA aie significantly increased in several of these tissues, when examined 
after several hours in vivo treatment with IL-6 (Saito et al., 1992). During
development, the expression of gpl30 in whole embiyos is evident as early as 
E6, with levels reaching a pealc by E8, after which they gradually decline (Saito 
et al., 1992). Several haematopoietic cell lines have been demonstrated to 
express gpl30 mRNA (Hibi et al., 1990; Saito et al., 1992J. Additionally, 
gpl30 expression has been demonstrated in the neuron-like PC 12 
phaeochromocytoma cell line and also in cultured sympathetic neurons, using 
RT-PCR and in situ hybridization (Maiz et al., 1996). Both gpl30 and IL-6Ra 
mRNAs are up-regulated in sympathetic neurons after co-treatment with IL-6 
and TNFa (Marz et al., 1996). Furthermore, gpl30 protein is up-regulated in 
the axotomised peripheral nerve, supporting the view that IL-6 signalling plays a 
role in the response to injury (Yao et al., 1997).
The association of gpl30 and the IL-6Ra to form a functional receptor 
for IL-6 was initially demonstrated by co-precipitation experiments utilising IL- 
6 specific antibodies (Taga et al., 1989). These experiments suggested that the 
two polypeptide chains in the IL-6Ra extracellular domain interact with gpl30, 
since the intracytoplasmic domain could be abolished without any functional 
loss occurring (Taga et al., 1989). The IL-6 receptor complex was originally 
thought to consist of a heterodimer of IL-6Ra and gpl30 components 
(ICishimoto et al., 1992). Subsequently, it was observed that this model was 
dissimilar from the proposed receptors for LIF and CNTF which were 
demonstrated to consist of LIFRp - gpl30 heterodimers (Ip et al., 1992b). 
Therefore, the receptor for IL-6 was proposed to be a complex of IL-6-bound IL- 
6Ra, together with a homodimer of two gpl30 subunits (Ip et al., 1992b). This 
proposal has been verified by studies using transfected cells that overexpress 
LIFRp and gpl30 subunits. In these studies, disulphide linked homodimers of 
gpl30 were retrieved after stimulation with IL-6, and only these homodimers 
were associated with tyrosine kinase activity (Davis et al., 1993b; Murakami et 
al., 1993). The heterodimeric LIFRP - gpl30 complex has now been 
demonstrated as a signal transducing receptor for LIF, CNTF, OSM, IL-6 and
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CT-1 (Davis etal., 1993b; Murakami etal., 1993; Sporeno etal., 1994; Pennica 
et al., 1995b). Intracellular signal transduction has been demonstrated upon 
ligand binding, and is conveyed by pre-associated members of the Jalc/Tyk non­
receptor tyrosine kinases, as with LIFRp (Stahl et al., 1994)
Targeted inactivation of the gene encoding gpl30 results in a reduction 
in the total complement of haematopoietic cells and striking defects within the 
developing heart, leading to embryonic lethality (Yoshida et al., 1996). The 
specific developmental defects result in a loss of cai’diac myocytes, cells whose 
development is known to be regulated by the cytokine CT-1 (Pennica et al., 
1995b; Zheng et al., 1996). No obvious developmental defects are apparent 
within the nervous system of gpl30"/" mice, however, since the gpl30"/" 
mutation results in embryonic lethality, it is possible that any nervous system 
defects due to the mutation may not be evident until late stages of development 
or adulthood. A more detailed analysis of these embryos is currently being 
undertaken (Yoshida e ta l,  1996).
1.6 The TGFp Family of Neurotrophic Factors and Their Receptors.
The ti'ansforming growth factor p (TGFp) family of proteins comprises a 
number of structurally related growth factors that regulate cell growth, 
differentiation, motility, organisation and cell death, during development (for 
review, see Massagué 1994). To date, around 30 members of the TGFP 
superfamily have been identified, that have numerous functions in different 
tissues (Massagué et a l, 1994). The effects of members of the TGFp family on 
neuronal survival are limited, however, TGFp 1 and TGFP 2 have been 
demonstrated to promote the survival of midbrain dopaminergic neurons and 
protect against the neurotoxin MPTP (Poulsen et a l, 1994; Kreiglstein et a l, 
1995). Recently two proteins of the TGFp family, glial cell line-derived
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neurotrophic factor (GDNF) (Lin et al., 1993), and neurturin (NTN) (Kotzbauer 
et al., 1996), have been identified that have extensive survival promoting effects 
on developing PNS and CNS neurons (Lindsay and Yancopoulos, 1996; 
Kotzbauer etal., 1996; Buj- Bello etal., 1995).
Signalling by the majority of TGFp family members utilises a receptor 
complex consisting of two transmembrane serine/threonine kinases, whereas 
GDNF and NTN aie now known to signal via the Ret receptor tyrosine kinase, 
coupled with unique GPI-linked a  components similar to the CNTFRa 
(Massagué et al., 1996; Durbec et al., 1996) The receptors for GDNF and NTN 
have been designated GDNFRa (Jing et al., 1996; Treanor et al., 1996) and 
NTNRa (Baloh et al., 1997; Buj-Bello et al., 1997; Klein et al., 1997) 
respectively.
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Objectives of This Study.
Since the discovery of NGF, the survival of different populations of 
developing PNS neurons has been found to be regulated by an increasing 
number of neurotrophic factors. These neurotrophic factors regulate survival via 
cell surface receptors that transduce signals across the cell membrane and in 
some cases, the same cell surface receptors are utilised by different neurotrophic 
factors. In this study I attempt to clarify the role of certain neurotrophic factors 
and their signalling mechanisms during nervous system development.
In the first part of this study, I have focused on a newly identified 
member of the neurotrophin family, NT-4/5, that like BDNF, binds to the TrkB 
tyrosine kinase receptor. Initially, I compared the survival promoting activity of 
mammalian NT-4/5 with BDNF on different populations of neurons from 
mammalian and chicken embryos, at different stages of their development. I 
then extended this study to investigate the survival responses of different 
populations of chicken BDNF responsive neurons to a homologue of NT-4/5, 
Xenopus NT-4.
Since all of the neurotrophins bind to the low affinity p75 receptor, in the 
second part of this study I have examined the responses of different populations 
of mammalian and chicken neurons at different developmental stages, using a 
mutated NGF protein that does not bind to the p75 receptor. Thus I have used 
an alternative approach to the analysis of neurotrophin function in the p75 
'knockout' mouse, in order to further clarify the role of the p75 receptor in 
neurotrophin signalling during nervous system development.
In the final part of this study, I have studied the ability of developing 
cranial sensory neurons to survive in the presence of a group of neurotrophic 
factors that do not belong to the neurotrophin family. The structurally related 
neurotrophic cytokines, CNTF, LIF, OSM, IL-6 and the newly identified CT-1,
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are known to signal via different cell surface receptors and intracellular 
pathways to the neurotrophins. I have examined the survival promoting effects 
of this group of proteins in comparison with members of the neurotrophin family 
at closely staged intervals during the development of populations of sensory 
neurons that respond to different neurotrophins.
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CHAPTER 2
GENERAL METHODS
2.1 Introduction.
Cranial sensory neurons have many advantages for studying the different 
phases of neuronal development. These neurons and their progenitor cell 
populations aie well-defined, may be easily obtained for in vitro experimental 
studies, and are accessible to experimental manipulation in ovo, in the case of 
avian embryos, from the eaiiiest stages of their development (Davies, 1989; 
Vogel and Davies 1993). The peripheral target fields of several cranial sensoiy 
ganglia, such as the trigeminal ganglion, are clearly delineated, and this has 
facilitated detailed studies of the influence of the target field on various aspects 
of neuronal development (Lumsden and Davies, 1983; Lumsden and Davies, 
1986; Davies, 1987; Buchman and Davies, 1993). In contrast to the functional 
heterogeneity of dorsal root ganglia, cranial sensory neurons are for the most 
part segregated into functionally distinct populations. Perhaps as a consequence 
of their functional segregation, populations of cranial sensory neurons have quite 
distinct neurotrophic factor requirements. This has previously facilitated studies 
of the function of different neurotrophic factors in regulating neuronal survival 
(Davies et a l, 1986a; Allsopp et a i, 1993a; Allsopp et al, 1993b Paul and 
Davies, 1995).
In this chapter, techniques for culturing different populations of 
embryonic chicken cranial sensory and autonomic neurons, and selected 
populations of embryonic mouse cranial sensory and autonomic neurons will be 
described. The description will be restricted to the establishment of dissociated 
cultures. Because non-neuronal cells can be effectively removed from these 
cultures, analysis of the effects of a particular factor on neurons is not 
complicated by any indirect effects mediated by non-neuronal cells.
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2.2 Dissection Techniques.
Instruments and Equipment
All dissections and subsequent preparation of neuronal cultures were 
carried out in a laminai* flow hood using standaid sterile technique. For the final 
stages of dissection, a stereomicroscope with zoom lens was employed, using a 
fibre optic light source for illumination.
In the initial stages of most dissections, toothed forceps, straight and 
curved watchmaker's forceps, and a scalpel were required. Tungsten needles 
were required to complete dissections and to remove adherent connective tissue 
from the dissected neural tissue. These were made from 0.5 mm diameter 
tungsten wire as follows (Figure 2.1). The wire was cut into 3 to 5 cm lengths 
using wire cutters. The wire was then bent 1 cm from the end, to an angle of 
around 60°. This end was immersed with the bent portion near horizontal in 5M 
KOH. A current of 3 to 12 volt DC was passed through the wire and a second 
copper electrode was immersed in this solution. The tungsten was then etched 
away over several minutes so as to form a taper from the bend to the tip of the 
needle. To form a sharp point at the tip, the bent portion was placed vertically in 
the solution for several seconds. The needles were washed in water to remove 
the alkali. For dissection, the needles were held in chuck-grip platinum wire 
holders. Forceps and scalpels were sterilised by flaming in alcohol. Tungsten 
needles were sterilised in a Bunsen burner flame, which additionally tempered 
the wire thus increasing its rigidity.
Plastic ware: Sterile plastic dishes (60 and 100 mm diameter, supplied by
Corning).
Solutions: All dissections were carried out using Liebowitz’s L I5 medium 
without sodium bicarbonate (supplied by GIBCO, see appendix).
91
Electrod#
Figure 2.1 Diagram detailing the method for making electrolytically sharpened tungsten 
needles. (From Davies, 1988)
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2.2 Dissection of chicken embryo cranial sensory neurons.
Naturally occurring cell death occurs in cranial sensory ganglia during 
the mid-embryonic stages. Because each population of cranial sensory neurons 
is dependent on a particular neurotrophic factor or combination of factors, 
studying these neurons at this stage of development has previously been used for 
analysing the function and co-operation of neurotrophic factors (Davies, et al., 
1986a; Davies et al., 1986b; Davies and Lindsay 1985; Allsopp et al., 1993a). 
The location of the cranial sensory ganglia in the E10 chick embryo is shown in 
Figure 2.2. The precise embryonic stage was determined using the criteria of 
Hamburger and Hamilton (1951).
TMN
1mm
F igu re  2.2 Lateral aspect of the head and neck of an ElO chicken embryo showing the locations 
of the trigeminal mesencephalic nucleus (TMN) and the trigeminal (T), geniculate (G), 
vestibulo-acoustic (VA), petrosal (P), jugular (J) and nodose (N) ganglia. (From Davies and 
Lindsay, 1985)
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Dissection of mid-embryonic trigeminal sensory ganglia.
1. Fertile chicken eggs were incubated in a forced-draft, humidifed incubator at 
38°C for the required time. To remove embryos, the eggs were held with their 
blunt end uppermost (where the airspace is located) and each egg was swabbed 
with 70% alcohol and allowed to dry. The shells were cracked in a line around 
the airspace by tapping with forceps and this portion of the shell was removed. 
The membrane lining the airspace was then removed. The embryo, together 
with its adherent membranes, was then carefully removed with a pair of curved 
forceps.
2. Embryos were washed in a 60 mm dish containing L I5 medium and all 
membranes were removed with a pah* of watchmalcer's forceps.
3. Tungsten needles were used to isolate paits of the developing head containing 
the trigeminal ganglia (Figure 2.3a).
4. The part of the head containing the trigeminal ganglia was bisected along the 
saggital plane, in the following way. A tungsten needle was inserted into the 
cavity of the developing fourth ventricle and the tissue was turned so that its 
ventral aspect lay next to the bottom of the dish. The tungsten needle was then 
pressed against the bottom of the culture dish from where it was inserted. To cut 
through the roof of the fourth ventricle, the bisection was completed by pushing 
a tungsten needle down thr ough the tissue to the bottom of the dish.
5. The hindbrain was removed from the medial aspect of each half of the 
bisected tissue using tungsten needles
6. Ganglia were dissected from the surrounding tissues by bringing two 
tungsten needles down on either side of each ganglion and removing any 
adherent connective tissue with these needles. Ganglia were further sub 
dissected into their dorsomedial and ventr olateral aspects (Figure 2.3b)
7. The ganglia were collected and removed to a separate 35 mm dishes using a 
siliconised Pasteur pipette.
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Figure 2.3a Dorsal aspect of the cranial base after removal of the brain, showing the lines for 
sub dissecting this tissue into blocks that contain the trigeminal ganglion (block A), vestibulo- 
acoustic, and geniculate ganglia (block B) and the jugular and petrosal ganglia (block C). The 
trigeminal ganglion (T) and the roots of the vestibulo-acoustic (V) and jugular (J) ganglia are 
shown. (Modified from Davies, 1988).
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Figure 2.3b Sub dissection of the trigeminal ganglion into dorsomedial (DM) and ventrolateral 
(VL) poles. The ophthalmic lobe (OL) is separated from the maxillo mandibular lobe (MML) 
along the interrupted line shown in A. The MML is sub dissected along the lines shown in B to 
obtain the DM and VL poles. (Modified From Davies, 1988).
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Dissection of the mid-embryonic trigeminal mesencephalic nucleus (TMN).
This population of neural crest-derived, BDNF-dependent, primary 
sensory neurons was dissected from the midbrain (Davies, 1986).
1. The brains were collected in L15 medium (20 to 40 in most preparations).
2. These were transferred to a fresh plastic dish containing L I5, and the 
dissection was completed with tungsten needles as shown in Figure 2.4.
TV
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Figure 2.4 Successive stages in the dissection of the median part of the TMN from an E12 
chick embryo. A, Dorsal aspect of the brain showing the location of the two coronal incisions 
(interrupted lines) for isolating the midbrain. B, Caudal aspect of the isolated midbrain showing 
the location of the two parasagittal incisions for removing the roof of the cerebral aqueduct after 
carefully stripping off the overlying pia mater. C, Dorsal aspect of the cerebral aqueduct 
showing the location of the incisions for cutting out the median part of the TMN. D, Sub 
dissection of the median part of the TMN. Abbreviations; tectal vesicle (TV), tectal commissure 
(TC), posterior commissure (PC), cerebral aqueduct (CA) rostral (R), middle (M), caudal (C). 
(Adapted from Davies, 1986)
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Dissection of the mid-embryonic nodose ganglia.
The ganglia are located either side of the midline in tissues lying in front of the 
vertebral column at the base of the neck.
1. Embryos were extracted from eggs using a pair of curved forceps placed 
beneath the neck and the embryos were decapitated close to the base of the skull.
2. The skin was removed from the front of the neck and upper thorax using a 
pair of watchmakers forceps and the great vessels emerging from the heai't (the 
aorta, superior and inferior vena cava, and pulmonary arteiy) were exposed by 
separating the overlying muscular and skeletal tissues at the upper part of the 
thorax.
3. Using one blade of a pair of watchmakers forceps, which was inserted deep to 
the root of the great vessel (i.e., between these and the underlying vertebral 
column), the great vessels were held and their attachment to the heart severed 
using a second pair of watchmakers forceps. The great vessels and the attached 
tissues lying in front of the neck were gently pulled away from the underlying 
vertebral column, using the second pair of forceps to loosen the tissues so that 
they peeled away from the vertebral column without tearing it (Figure 2.5).
4. This tissue, which contains both nodose ganglia, was gathered in a fresh 65 
mm dish containing L I5 medium. The tissue was then sub-dissected using 
tungsten needles. The nodose ganglia are recognised by their opaque white 
exterior, spindle shape and attached vagus nerve. The vagus nerves were 
removed and the ganglia were cleaned of all adherent tissue using tungsten 
needles.
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Figure 2.S Vential aspect of the thoracic region of an ElO chicken embryo after removal of the 
skin and reflection of the ventral thoracic wall to either side of the midline, exposing the heart 
and great vessels. The great vessels are clasped with a pair of forceps prior to removing tlie 
attached tissues. The connective tissue lying either side of the great vessels contains the two 
nodose ganglia (N) attached to the vagus nerves (shown by the interrupted lines).
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Dissection of paravertebral sympathetic chain ganglia.
These ganglia aie located either side of the inidline, lying proximal to the 
vertebral column and ventral to the dorsal root ganglia.
1. Embiyos were removed from eggs using a pair of curved forceps placed 
beneath the neck and the embryos were decapitated close to the base of the skull.
2. Skin was removed from the front of the neck and upper thorax using a pair of 
watchmalcers forceps. A pair of curved forceps was used to remove the thoracic 
and abdominal viscera, exposing the spinal column and lumbosacral dorsal root 
ganglia.
3. The posterior thoracic and abdominal walls were gently washed with L I5 
from a Pasteur pipette.
4. Using the blade of a pair of watchmakers forceps, the ganglia were gently 
peeled away from the vertebral column (Fig. 2.6) Care was taken to ensure the 
ganglia were kept intact. Ganglia were then removed using a siliconised Pasteur 
pipette and pooled in a fresh 65mm dish containing LI5 medium.
2mm
Figure 2.6 Ventral aspect of the lumbosacral region of an ElO chick embiyo after evisceration 
showing the location of the paravertebral sympathetic chain ganglia (SC) (Adapted from Davies, 
1988)
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2.3 Dissection of cranial sensory ganglia from mouse embryos.
Mouse trigeminal and nodose ganglia, like those of the developing chick 
are readily accessible for study (see Fig. 2.7). The dissection technique for 
obtaining these ganglia differs with embryonic age. In all cases, the embryos 
were removed from pregnant females under sterile conditions .
1. The pregnant females were Idlled at the required stage of gestation (Theiler, 
1972) by cervical dislocation.
2. 70% alcohol (from a wash bottle) was then sprayed onto the abdomen,
3. A small incision in the skin on the front of the abdomen was made, and the 
skin just above and below the incision was taken between the index finger and 
thumb of each hand. The sldn was pulled away from the incision, immediately 
tearing it and exposing the abdominal muscles beneath.
4. Holding the anterior abdominal muscle with a pair of toothed forceps, a small 
incision was made with a pair of fine scissors, taldng caie not to cut into the 
intestines. Once air has entered the peritoneal cavity through this hole, an 
incision can be easily extended without cutting the intestines and contaminating 
the dissection with bacteria.
5. Each uterine horn was removed by holding with a pair of toothed forceps and 
cutting it free with a pair of scissors.
6. E9 to E l2 embryos were removed from the uterine horns by using a pair of 
fine toothed forceps to pinch a small part of the musculature on the anti- 
mesometrial border of the uterine horn next to each embryo. The uterine muscle 
was then cut open with a pair of fine scissors. After this procedure, the embryo, 
contained within the intact chorion and amnion, was extruded by contraction of 
the remaining uterine muscle. Cai*e was taken not to tear these membranes as 
nalced embiyos are forcibly extraded by muscular contraction of the uterine wall.
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Removing embryos from the uterus within their membranes can minimise this 
damage. Embryos from E13 onwards are more easily removed from the uterine 
horns within their membranes. This entailed making one continuous incision 
along the anti-mesometrial border of each uterine horn thus exposing the 
embiyos enclosed within their membranes.
7. The embryos were detached from the uterine horns whilst still within their 
membranes. This was done by detaching them from the placenta with a pair of 
watchmaker's forceps. The embryos were transferred to a fresh 65mm dish 
containing L I5 medium, and the chorion and amnion were removed using 
watchmaker's forceps.
8. For very young embryos this procedure was carried out by aspirating the 
embryos into the blunt end of a Pasteur pipette after the elongated, narrow part 
of the pipette had been carefully broken off allowing the wide part of the pipette 
to be inserted into a pipette bulb.
Dissection of trigeminal ganglia from ElO to E12 embryos,
1. Using tungsten needles, two coronal incisions through the head were made, 
one just above each eye, the other between the maxillary and mandibular 
processes of the first branchial arch (Figure 2.8 A). The trigeminal ganglia can 
be seen as two opaque structures in the tissue slice obtained (Figure 2.8 B).
2. The ganglia can be easily removed from the tissue slice and freed of any 
adherent mesenchymal tissue using tungsten needles. To free the ganglion of 
this tissue, one needle was used to steady the ganglion and the other to pinch off 
the adherent tissue against the bottom of the dish.
3. The dissected ganglia were then transferred to a 35 mm dish containing L15 
medium using a siliconised Pasteur pipette
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Figure 2.7 Drawing showing the medial aspect of the head of an El 1 mouse embryo. The 
location of the trigeminal (V) and nodose (X) ganglia are marked. Scale bar = 1 mm.
(Adapted from Davies and Lumsden, 1986)
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Figure 2.8 Drawings showing the dissection of the trigeminal ganglia from an El 1 mouse 
embryo. A, lateral aspect of the El 1 head showing the location of the transverse incision 
(interrupted lines) for obtaining a slice of tissue that contains both trigeminal ganglia. B, rostral 
aspect of this slice showing the location of the trigeminal ganglia. Trigeminal ganglion (TG), 
maxillary process (Mx), mandibular process (Mn), fourth ventricle (IV).
(Adapted from Davies and Lumsden, 1984 ).
102
Dissection of trigeminal ganglia from E13 and older embryos.
This dissection is similar to that of earlier ganglia except that a pair of 
fine scissors were used in the early stages of the dissection to cut through the 
caitilage (or bone in late foetal stages) of the developing head. The scissors used 
for this dissection have very fine serrations along the blades which help to grip 
the tissue to stop it from sliding out of the blades.
1. The top of the skull was removed, in a plane just above the eyes and whisker 
pads, using a pair of forceps to steady the embryo.
2. A second cut parallel to the first, passing thiough the mouth was then made.
3. Tissue slices were transferred to a fresh 65 mm dish containing L15 medium 
and two further cuts were made with the pair of scissors in front and behind the 
trigeminal ganglia.
4. These pieces of tissue were transferred to a fresh 65 mm dish containing L15 
medium and tungsten needles were used to free the ganglia from the surrounding 
tissues and remove adherent connective tissue.
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Dissection of nodose and superior cervical ganglia from mouse embryos.
In contrast to avian embryos, the nodose ganglion (otherwise known as 
the inferior vagal ganglion) remains situated close to the base of the skull in 
mouse embryos. The dissection is similar at all ages except that a pair of fine 
scissors is required during the initial stages of the dissection in E13 and older 
embryos.
1. The top of the skull and underlying forebrain were removed using the same 
plane of section described for the first incision of the trigeminal dissection.
2. The embryos were decapitated and the head cut in half along the saggital 
plane (using tungsten needles up to E 12 and a pair of scissors or a number 15 
scalpel in E l3 and older embryos).
3. Using tungsten needles, the hindbrain was removed from each bisected head.
4. The cleft-like jugulai' foramen was then opened to the midline (Figure 2.9). 
For E12 and E l3 embiyos this was done by inserting one tungsten needle into 
the jugulai' foramen so that it lay beneath the base of the skull, medial to the 
foramen, and bringing a second needle into apposition with the first, so as to cut 
through the intervening tissues. For older embryos a pair of iridectomy scissors 
was used to achieve this.
5. A pair of tungsten needles was used to open up the jugular foramen which 
revealed the nodose ganglion lying at the base of this foramen. The nodose 
ganglion is spherical in structure with a prominent vagus nerve attached to its 
distal aspect. The ganglion is clearly distinguished from the superior cervical 
sympathetic ganglion (first visible at E l3) which is an elongated structure that is 
attached caudally to the sympathetic chain, which is much thinner than the vagus 
nerve.
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Figure 2.9 Drawings of the medial aspect of the left half of an E14 mouse embryo head 
showing successive stages in the dissection of the nodose ganglion. The bisected midline 
structures lying along and in front of the cranial base are stippled. A. The incision passing 
from the jugular foramen (J) to the midline is shown by the interrupted line. The direction in 
which the large ossified part of the occipital bone (O) should be reflected to open up the jugular 
foramen after making the previous incision is shown by the large curved arrow. T, tongue; 
ACF, anterior cranial fossa; R, root of the trigeminal nerve; IE, inner ear. B. The nodose 
ganglion (N) and superior cervical sympathetic ganglion (S) are revealed after extending the 
jugular foramen to the midline and reflecting the large ossified part of the occipital bone 
backwards.
105
2.4 Tissue dissociation techniques.
Dissected neural tissue was incubated with tiypsin, washed and triturated 
to give a single cell suspension. The procedure is similar for mammalian and 
avian tissue of all embryonic stages, but the strength of the trypsin and 
incubation times were adjusted for the particular tissue.
1. Using a Pasteur pipette, the dissected tissue was transferred to a 10 ml 
conical tube containing 1 to 2 ml of calcium/magnesium-free, Hanks Balanced 
Salt Solution (CMF-HBSS). The tissue was washed, by agitation and the CMF- 
HBSS was then removed. For chicken ganglia, 0.9 ml of fresh CMF-HBSS was 
added, plus 0.1 ml of 1% trypsin (Worthington) in CMF-HBSS (stored as a 
stock solution in 0.1 ml aliquots at -20°C). For eaily mouse ganglia, 0.95 ml of 
fresh CMF-HBSS and 0.05 ml of 1% trypsin were added .
2. The lower end of the tube was immersed in a water bath, at 37°C, for 10 min 
for early sensory ganglia from chicken embryos, 15 to 20 min for mid- 
embryonic ganglia from chicken embryos, 5 min for early sensory ganglia from 
mouse embryos and up to 10 min for older embryonic mouse sensory ganglia. 
These times were adjusted for different batches of trypsin. The optimum time 
was discovered to be a compromise between neuronal damage due to over- 
trypsinization, and neuronal damage due to the vigorous trituration required to 
dissociate under-trypsinized tissue. If the tissue started to disaggregate before 
trituration, the time was too long. If the tissue dissociated with difficulty and 
incompletely with trituration, the time was not long enough.
3. After trypsinization, most of the trypsin solution was removed using a 
Pasteur pipette. The tissue was washed with 2 x 10 ml of Hams F12 or F14 
medium containing 10% heat-inactivated horse serum to remove and inactivate 
the residual trypsin. Removal of the medium was facilitated by pelleting the 
tissue between washings in a bench top centrifuge, at 2000 x g, for 1 to 2 min
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(this was essential for small ganglia). If the neurons were to be sepaiated from 
the non-neuronal cells by differential sedimentation, it was necessary to wash 
the tissue with about 5 ml of HBSS to remove traces of semm.
4, After washing, the tissue was dissociated into a single-cell suspension by 
trituration. This step was critical . Trituration was carried out using a 
siliconized Pasteur pipette with the tip whose tip had previously been heated in a 
Bunsen burner flame to form a fine bore. The tissue was triturated in 1.5 ml of 
culture medium or, if the neurons were to be sepaiated from non-neuronal cells 
by differential sedimentation (see below), HBSS without serum. The tissue and 
media were talcen up into the pipette and the contents were slowly expelled with 
firm pressure. If done correctly, the early ganglionic tissue were completely 
dissociated after three to five passages. When using older tissue, some 
connective tissue fragments were left after all of the neurons had dissociated. 
These larger tissue fragments were allowed to settle after the first two or three 
passages. The supernatant suspension was then taken into a fresh tube and 
gentle tiituration was continued (over-trituration causes substantial neuronal 
damage, especially in the case of large, older neurons). The trituration was 
monitored using an inverted phase contrast microscope, by examining a drop of 
the dissociated cell suspension on a glass slide. One characteristic of over­
trituration is the loss of neuronal processes. Neurons that have been triturated 
carefully should have long processes attached to their cell bodies.
Because of the increasing amounts of collagenous connective tissue in 
late embryonic and postanatal ganglia, this tissue sometimes requires treatment 
with collagenase prior to trypsinization. Therefore in instances where late stage 
embryonic or postnatal tissues were used, the tissue was incubated with 500 
Hg/ml collagenase (Worthington) in F12, for 10 to 15 min, at 37°C. The tissue 
was then washed in HBSS prior to tiypsinization.
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2.5 Separation of neurons from non»neuronai cells.
A variety of different non-neuronal cells synthesise and release 
neurotrophic factors in culture. Therefore, it is essential to remove these cells 
prior to culture when studying the effects of neurotrophic factors on any 
population of neurons. If they aie not removed, the percentage neuronal survival 
in control cultures may be unacceptably high. Furthermore, if non-neuronal 
cells aie present, it cannot be concluded whether the effect of a factor or reagent 
on neuronal survival is due to a direct action of the factor on the neurons, or 
whether it is mediated via the non-neuronal cells.
Several different methods may be used to remove satellite cells and 
Schwann cells from mid to late embryonic dissociated ganglionic tissue. The 
method of differential sedimentation described here was found to be the most 
effective, reliable and rapid for removing non-neuronal cells from cranial 
sensoiy ganglia.
Differential adhesion was found to be advantageous when the size 
difference between neurons and non-neuronal cells is very small (as in the case 
of the vestibular ganglion), and may be desirable in these instances. However, 
neither method works very well for very early ganglia which contain progenitor 
cells in addition to satellite and Schwann cells. In these cases the potential 
effects of factors produced by non-neuronal cells can be reduced by setting up 
very low density cultures in a relatively large volume of culture medium (which 
was also routinely done for older embiyonic cultures) or by setting up single cell 
cultures (Wright, et al, 1992).
A further complication encountered when setting up early ganglionic cell 
cultures is that progenitor cells may differentiate into neurons in culture. 
Therefore, when studying the effects of factors on the survival of eaidy nemons, 
it must be borne in mind that an increase in the number of neurons in eai'ly
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ganglionic cell cultures could result not only from the enhanced survival of 
differentiated neurons, but also from an enhanced rate of neuronal 
differentiation. An increase in the number of neurons in early ganglionic cell 
cultures due to growth factor treatment, may also reflect an increase in the 
number of progenitor cells. An increase in progenitor cells may occur as a result 
of proliferation or enhanced survival. Such an increase will create a larger pool 
of cells that can subsequently differentiate into neurons. To distinguish between 
these alternatives it is necessary to follow the fates of individual neurons in these 
cultures (Buchman and Davies, 1993; Paul and Davies, 1995).
Differential sedimentation of embryonic chicken neurons.
This technique depends on differences in sedimentation rates of cells in a 
liquid medium. Generally, the larger the cell, the faster its rate of sedimentation, 
therefore neurons sediment more quickly than non-neuronal cells because of 
their greater size. Several variations of the method described by Miller and 
Phillips (Miller and Phillips, 1969) have been applied to embryonic neural 
tissue (Lam, 1972; Barkley, et al., 1973; Cohen, et ah, 1973; Cohen et al; 1978; 
Berg and Fischbach, 1978). This method is applicable to all populations of 
neurons in the peripheral nervous system and is very efficient (at least 60% of 
the neurons in the starting tissue are recovered uncontaminated by other cells). 
Furthermore, since the cells sediment through culture medium, neuronal 
viability is veiy high.
1. Sedimentation was carried out in a 100 ml cylindrical, siliconised glass 
dropping funnel with a ground glass outlet tap (Figure 2.10). Funnels were 
sterilised before use by autoclaving. Each funnel was filled to a height of 8 to 
10 cm with F14 medium plus 10% heat-inactivated horse serum (thoroughly
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mixed and filtered through a 0.2 fim Millipore filter beforehand). Funnels were 
clamped vertically in a stand, and placed on a vibration-free surface at 2 ±
0 .5 0 c , overnight.
2. The dissociated cell suspension was usually made up to a volume of about 2 
ml in HBSS. The cell suspension was carefully layered on the medium, by 
running it down the inside of the funnel, and the foil on top of the dropping 
funnel was then replaced.
3. After an hour, the foil was removed from the spout, and 4 to 5 ml aliquots 
were mn off into sterile tubes.
4. Samples of 0.5 ml were talcen from each fraction, and placed in a 24 multi­
well plate (with 16 mm diameter wells). These were examined with a phase 
contrast microscope to determine which fractions contained only neurons. Mid- 
embryonic and older neurons were clearly distinguished from other cells by their 
chaiacteristic rounded phase bright cell bodies and elongated processes.
5. All of the neuronal fractions were pooled and were plated in Nunc tissue 
culture dishes, as described below.
110
Figure 2.10 Drawing of a dropping funnel showing a cell suspension (heavy stipple) layered on 
culture medium (light stipple).
(Adapted from Davies, 1988)
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2.6 Cell Culture Techniques.
Preparation of the culture substratum.
Neurons were grown on a laminin/polyornithine substratum. For most 
experiments, 35 mm diameter plastic tissue culture dishes were used (Nunc 
dishes available from provided the best results). The following substratum was 
used :
1. 1 ml of 0.5 mg/ml poly-DL-ornithine in 0.15M borate buffer (pH 8.6 and 
filter-sterilised using a 0.2 |im filter prior to use) was placed in each dish and left 
to stand overnight at room temperature.
2. The polyornithine solution was then aspirated, and the dishes were washed 
three times with sterile distilled water. Dishes were then left to air-dry in a 
laminai* flow hood.
3. A 150 \il aliquot of a 20 pg/ml solution of laminin in F14 medium was placed 
in the centre of each dish, and a pipette tip was used to spread this over about 
two-thirds of the dish surface. Dishes were then placed in a tissue culture 
incubator for at least 4 h.
4. Dishes were removed from the incubator and washed twice with F 14 culture 
medium (it is important not to allow the dishes to dry between washes as 
medium will form crystalline deposits on the base of the dish). 1 ml of medium 
was placed in each dish after washing.
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Preparation of the culture medium.
Powdered F 14 (a special formulation from Imperial labs see appendix) 
was made up with highly purified water that was sequentially passed through a 
chaicoal filter, reverse osmosis system and a Milli-Q system before being double 
distilled. The F14 medium was made up from a frozen XIO concentrate (stored 
in 50ml aliquots kept at -40°C ). The XI F14 was made up by adding Ig of 
sodium bicarbonate to 450ml of water, then a 50ml aliquot of XIO F14 was 
added and CO2 was bubbled through the medium until the pH reached between 
pH6.5 and pH7. 100 mg of streptomycin and 60 mg of penicillin were also 
added. The medium was then filter sterilised through a 0.2 pm filter, and stored 
at 4 0 c.
For culturing embryonic chicken neurons, the medium was supplemented 
with 10% heat-inactivated horse serum that was filtered through a 0.2 pm filter 
before use. Serum obtained from GIB CO generally gave the best results. For 
embryonic mouse neurons, the use of serum was avoided. Instead, a defined 
medium was used, containing the following supplements added to XI F 14 
medium: 2 mM glutamine, 0,35% bovine serum albumin (Pathocyte-4, ICN), 60 
ng/ml progesterone, 16 pg/ml putrescine, 400 ng/ml L-thyroxine, 38 ng/ml 
sodium selenite and 340 ng/ml tri-iodo-thyronine. The use of this medium was 
employed as it was not conducive for the growth of non-neuronal cells. 
Generally, mouse neurons were not separated from their non-neuronal 
counterparts using differential sedimentation, owing to their similaiity in size.
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Seeding the neurons.
To carry out a dose response to a neurotrophic factor, a suitable range of 
dilutions was first set up in culture medium at double the required final 
concentration.
The culture medium was removed from the washed dishes and 1 ml of each 
dilution was placed in triplicate dishes. Control dishes (usually at least four) 
each received 1 ml of medium. To avoid possible observer bias, dishes were 
often coded.
The most reliable results were obtained when the neurons were plated at 
a density of between 400 and 800 per dish. The suspension of neurons was 
placed in a suitable volume of medium in a large screw-top tube (e.g. 50 ml 
centrifuge tube) and the neurons were evenly distributed in the medium by 
gently rocking the tube end-over-end several times. The neurons were dispersed 
within each dish using a microlitre pipette, in two lots of 0,5 ml (to ensure even 
distiibution). It was important to avoid touching the medium in the dishes with 
the pipette tip, otherwise small quantities of neurotrophic factor could be 
transferred to other dishes. Dishes were returned to a humidified CO2 incubator 
at 370  C (4% CO2 was used for F I4 medium). Because of the veiy low neuron 
density required, the most reliable method of estimating the correct neuron 
density at the time of plating neurons was observation by eye. For this purpose, 
a 1ml aliquot of the cell suspension was placed in a test culture dish and the 
resulting neuronal suspension was examined with a phase contrast microscope.
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Quantification of neuronal survival.
To quantify neuronal survival, a standard graticule for examining the 
same ai*ea of each culture dish was used. These were made from the base of a 90 
mm plastic dish using a scalpel blade to inscribe a 12 xl2 mm squaie divided 
into 2 mm squares, using graph paper as a template.
1. The graticule was mounted on the stage of an inverted phase contrast 
microscope with the inscribed surface uppeimost.
2. To determine the number of neurons seeded per dish, several dishes were 
examined after 6 hours in culture. Each dish was centred over the graticule, and 
the number of neurons within the inscribed area was counted. A small 
percentage of neurons (usually less than 10%) are damaged during dissociation, 
and do not attach to the substratum. These neurons were ignored and only those 
that had attached were counted.
3. The number of surviving neurons in all dishes was counted after at least 48 
hours in culture. In almost all cases, long neurites had grown from these 
neurons. Viable neurons were those neurons with rounded, phase bright cell 
bodies with a neurite length > 5 times the diameter of the cell body (Fig 2.11)
4. The survival responses of neurons to a particular neurotrophic factor are 
expressed as percentage survival. This is, the quotient of the number of attached 
neurons in the graticule area at six hours and the number surviving in this same 
area at 48 hours.
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Figure 2.11 A. Phase contrast photomicrograph of an ElO DMTG neuron after 48 hrs in culture 
in the presence of NGF. B. Phase contrast micrograph of an ElO DMTG neuron after 48 hrs in 
culture in the absence of trophic factors. Scale bar = 25.0|im.
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Neurotrophic Factors,
The neurotrophins used in this study were obtained from the following 
som'ces.
Recombinant human NGF, was bacterially expressed in Eschericia coli, 
a gift of Dr. Arnon Rosenthal, Genentech Inc. Recombinant human NGF- 
mutant, was bacterially expressed in Eschericia coli, a gift of Dr. Arnon 
Rosenthal, Genentech Inc., USA. Recombinant human BDNF, was bacterially 
expressed in Eschericia coli, a gift of Dr. Arnon Rosenthal, Genentech Inc., 
USA. Recombinant human NT-4/5, was bacterially expressed in Eschericia 
coli, a gift of Dr. Arnon Rosenthal, Genentech Inc., USA. Recombinant 
Xenopus NT-4, was bacterially expressed in Eschericia coli, a kind gift of Prof. 
Yves Bai'de, Max-Planck Institute, Munich, Gerrmany
The neurotrophic cytokines used in this study were obtained from the 
following sources. Recombinant human CNTF, was bacterially expressed in 
Eschericia coli, a gift of Dr. Arnon Rosenthal, Genentech Inc., USA. 
Recombinant human LIF, was bacterially expressed in Eschericia coli, a kind 
gift of Dr. Perry Bartlett, Walter and Eliza Hall Institute, Melbourne, Western 
Australia. Recombinant human OSM, was bacterially expressed in Eschericia 
coli, a kind gift of Dr. Perry Bartlett, Walter and Eliza Hall Institute, Melbourne, 
Western Australia. Recombinant human IL-6, was bacterially expressed in 
Eschericia coli, a kind gift of Dr. Perry Baitlett, Walter and Eliza Hall Institute, 
Melbourne, Western Australia. Recombinant human CT-1, was bacterially 
expressed in Eschericia coli, a gift of Dr. Dianne Pennica, Genentech Inc., USA.
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CHAPTER 3
THE ROLE OF NEUROTROPHIN-4/5 DURING CRANIAL 
SENSORY NEURON DEVELOPMENT.
3.1 Introduction
The neurotrophins NGF, BDNF and NT-3 have been structurally and 
functionally conserved during evolution. NGF, BDNF, and NT-3 from frog and 
mammals share 90-95% of their primary structure (Hallbook et al., 1991) and 
neurons from aves, reptiles amphibians and rodents respond equally well to the 
mammalian factors (Thoenen and Baide, 1980; Levi-Montalcini and Aloe, 1985; 
Barde et al., 1987; Hohn et al, 1990; Maisonpierre et al., 1990b; Rosenthal et 
al., 1990; Buchman et al., 1993). NT-4/5 is a recently identified member of the 
neurotrophin family that has been isolated from both Xenopus and mammalian 
tissues (Hallbook et al., 1991; Berkemeier et al., 1991; Ip e? al., 1992a). The 
biological activity of NT-4/5 had been examined in several previous studies 
(Henderson et al., 1993; Ibanez et al., 1993; Zheng et a l, 1995a; Zheng et al., 
1995b), however, a detailed compaiison of the species specificity and biological 
activity of Xenopus NT-4 and mammalian NT-4/5 had not been undertaken.
Cranial sensory neurons have been useful in studying the specificity of 
neurotrophins (Davies, 1987). In contrast to the functional heterogeneity of 
neurons in dorsal root ganglia (DRG), cranial sensory neurons are segregated 
into populations that deal with different kinds of sensation. As a possible 
consequence of this functional segregation, discrete populations of cranial 
sensory neurons require different neurotrophins when cultured during the period 
of naturally occurring cell death. In the chick embryo, the small diameter 
cutaneous sensory neurons of the jugulai' ganglion and the dorsomedial pai t of 
the trigeminal ganglion (DMTG) are supported by NGF (Davies and Lindsay, 
1985), but show little response to BDNF (Davies et a l, 1986b) or NT-3 (Hohn
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et aL, 1990). The large diameter cutaneous sensoiy neurons of the ventrolateral 
part of the trigeminal ganglion (VLTG) aie supported by BDNF (Davies et a l, 
1986b), but show a negligible response to NGF (Davies and Lumsden, 1983) or 
NT-3 (Hohn et al., 1990). The proprioceptive neurons of the trigeminal 
mesencephalic nucleus (TMN) are supported by BDNF or NT-3 (Davies et al., 
1986a; Hohn et al., 1990), but are unresponsive to NGF (Davies et al., 1987). 
The enteroceptive neurons of the nodose ganglion contain subpopulations of 
neurons that are supported by either BDNF or NT-3 (Lindsay et al., 1985; 
Davies et al., 1986b; Hohn et al., 1990), but aie unresponsive to NGF (Lindsay 
and Rohrer, 1985). Cranial sympathetic and parasympathetic neurons also have 
distinct neurotrophin requirements. Superior cervical sympathetic ganglion 
(SCG) neurons aie supported by NGF and NT-3 (Chun and Patterson, 1977; 
Greene, 1977; Rosenthal et al., 1990), and the parasympathetic neurons of the 
ciliary ganglion are supported by ciliaiy neurotrophic factor (CNTF), but not by 
NGF, BDNF, NT-3 or NT-4/5 (Baibin et a l, 1984; Davies et a l, 1986b; Hohn 
et a l, 1990). Additionally, recent studies have shown that the survival of NGF- 
dependent cranial sensory neurons is transiently supported by BDNF and NT-3 
during the early stages of target field innervation before the onset of naturally 
occurring neuronal death (Buchman et a l, 1993; Buj-Bello et a l, 1993).
Comparing NT-4/5 to other neurotrophins, I show that NT-4/5 and 
BDNF are survival factors for the same populations of mouse cranial neurons 
and that they are equipotent. In addition, I demonstrate that Xenopus NT-4 
(hereafter referred to as xNT-4) and mammalian NT-4/5 are much less effective 
than mammalian BDNF as survival factors for chick neurons, and that some 
populations of neurons respond to both xNT-4 and NT-4/5, while others respond 
solely to xNT-4.
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3.2 Results.
3.2.1 NT-4/5 is a Survival Factor for Specific Mouse Embryo Neurons
Low-density, dissociated cultures of trigeminal, nodose, and superior 
cervical ganglion (SCG) neurons were established from mouse embryos that 
were between 10 and 18 days gestation (ElO to E18). These neurons were 
grown either in medium alone (control cultures) or in medium supplemented 
with NGF, BDNF or NT-4/5. Except for nodose neurons at a very eaiiy stage of 
their development, virtually all neurons died in control cultures by 48 hours. 
Thus, the effects of neurotrophins on neuronal survival could be clearly 
observed at this time. Furthermore, because the serum-free medium used in 
these cultures prevented the growth of fibroblasts and glial cells, neuronal 
survival was not influenced by the release of growth factors from non-neuronal 
cells. For each experiment the number of neurons that initially attached to the 
plates was determined 6-9 hours after plating, and the percentage of neurons 
surviving after 48 hours was calculated. As depicted in Figure 3.1, similar 
numbers of trigeminal, nodose, and SCG neurons survived in the presence of 
BDNF and NT-4/5, whereas the survival response to NGF was markedly 
different. BDNF and NT-4/5 were both potent survival factors for E l l  
trigeminal neurons, but were unable to support the survival of this neuronal 
population at E15. In contrast, NGF did not support the survival of E ll  
trigeminal neurons but was a potent survival factor for these neurons from E l3 
onward. The majority of nodose neurons were supported by BDNF and NT-4/5 
throughout their development from E ll  to E18. Less than 5% of the SCG 
neurons were supported by either BDNF or NT-4/5 at E18, whereas the majority 
of these neurons were supported by NGF.
To determine whether BDNF and NT-4/5 act on the same subsets of 
trigeminal ganglion neurons, cultures of these neurons were grown in the
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presence of saturating concentrations (2ng/ml) of BDNF or (50ng/ml) NT-4/5 
alone and with both neurotrophins. Cultures of E l l  neurons containing 
individual factors or a combination of BDNF and NT-4/5 sustained the survival 
of a similar' number of neurons for 48 hours (Fig. 3.1 and data not shown). The 
lack of an additive effect indicates that BDNF and NT-4/5 promote the survival 
of the same neuronal populations.
To determine if the early suiwival-promoting effects of BDNF and NT- 
4/5 on NGF-dependent cutaneous sensory neurons are exerted over the same 
period of development, I compared the ability of BDNF and NT-4/5 to prevent 
the death of cultured trigeminal neurons at ages ranging from ElO to E15. 
Figure 3.2 shows that age-related changes in the response of trigeminal neurons 
to NT-4/5 and BDNF are very similar. ElO and E ll  neurons were the most 
responsive. There was a four-fold decrease in the number of responding 
neurons between E l l  and E l2, and there was a further smaller decrease in 
responsiveness at later ages. This indicates that BDNF and NT-4/5 aie active on 
trigeminal neurons over the same period of development.
To investigate the relative potencies of BDNF and NT-4/5,1 conducted a 
series of dose response experiments. Trigeminal and nodose neurons were 
cultured in the presence of different concentrations of BDNF or NT-4/5 and the 
number of surviving cells was determined 48 hours later. BDNF and NT-4/5 
supported the survival of ElO and E ll  trigeminal neurons to the same extent 
over a broad range of factor concentrations (Figs 3.3 and 3.4). Likewise, there 
was no significant difference in the dose responses of nodose neurons to BDNF 
and NT-4/5 in cultuies set up at E12 (Fig. 3.5).
Cultures of sensory ganglia from early developmental stages often 
contain progenitor cells that proliferate and differentiate in vitro (Rohrer et al., 
1985; Wright et al., 1992). It is therefore possible that the increase in the 
number of neurons in E ll  cultures following neurotrophin treatment was due to
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enhanced proliferation or differentiation of progenitor cells and not due to the 
survival of post-mitotic neurons. To exclude this possibility, cohorts of neurons 
were identified by their bipolai* morphology 6  hours after plating, BDNF or NT- 
4/5 was then added and the fate of the individual neurons was monitored for the 
next 42 hours. In these cohort experiments, 85 ± 3.8 % (mean ± SEM, n = 3) of 
neurons grown with BDNF and 89.7 ± 5.2 % (mean ± SEM, n = 3) of neurons 
grown with NT-4/5 survived from 6  to 48 hours in culture. In control cultures, 
none of the neurons identified at 6  hours survived to 48 hours. This indicates 
that BDNF and NT-4/5 have a direct survival-promoting effect on early 
trigeminal neurons. The fact that eaily trigeminal and nodose neurons cultured 
with BDNF or NT-4/5 contained more neurons at 48 hours than at 6  hours after 
plating (Figs. 3.1 and 3.2) suggests that proliferation or differentiation of 
progenitor cells occur in these cultures. It is therefore feasible that, in addition 
to their survival-promoting effects, BDNF or NT-4/5 act as mitogens or 
differentiation accelerating factors for neuronal progenitors in these cultures. 
Finally, although I did not undertake a quantitative study of neuronal 
moiphology, there were no obvious differences in cell body size, or in neurite 
length or branching, between neurons surviving with BDNF and neurons 
surviving in parallel cultures with NT-4/5.
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F igu re  3.1 Survival of m ouse em bryo  neurons in response to neuro troph ins.
The bar graph shows the percentage of neurons surviving after 48 hours in low-density, 
dissociated cultures containing 2 ng/ml of NGF, BDNF or NT-4/5. The mean ± SEM of 
triplicate cultures are shown.
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Figure 3.2 The survival of ElO to E15 mouse trigeminal neurons in cultures containing 
BDNF or NT-4/5.
The graph shows the number of neurons surviving after 48 hrs incubation with 2 ng/ml BDNF 
(filled circles) or 2 ng/ml NT-4/5 (open circles) expressed as a percentage of the number of 
neurons identified 6  to 9 hours after plating. The mean ± SEM of triplicate cultures from three 
separate experiments at each age are shown in both graphs.
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Figure 3.3 Dose response of embryonic mouse trigeminal neurons to BDNF and NT-4/5.
The graph shows the percentage of ElO trigeminal neurons surviving after 48hrs incubation with 
different concentrations of BDNF or NT-4/5. The number of neurons identified 6  to 9 hours and 
48 after plating were used to calculate the percentage. The mean ±  SEM of triplicate cultures 
from a representative experiment is shown.
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Figure 3.4 Dose response of embryonic mouse trigeminal neurons to BDNF and NT-4/5.
Graph depicting the percentage of E l l  trigeminal neurons surviving after 48hrs incubation with 
different concentrations of BDNF or NT-4/5. The mean ± SEM of triplicate cultures from a 
representative experiment is shown.
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Figure 3.5 Dose response of embryonic mouse nodose neurons to BDNF and NT-4/5.
The graph shows the percentage of 1312 nodose neurons surviving after 48hrs incubation with 
different concentrations of BDNF or NT-4/5. The mean ±  SEM of triplicate cultures from a 
representative experiment is depicted.
127
3.3.2 Effect of NT-4/5 on Chick Embryo Neurons, Comparison with xNT-4
The specificity and the potency of NT-4/5 was also tested on cranial 
sensory and autonomic neurons from ElO chick embryos and was compared 
with that of xNT-4. At this developmental age, cranial chick embryo neurons 
can be dissected as homogeneous populations and can be separated from non­
neuronal cells by differential sedimentation (see previous chapter). 
Furthermore, these neurons have an absolute dependence on neurotrophins for 
survival, and without exogenously added factors will all die by 48 hours. 
Surprisingly, NT-4/5 had little effect on any embryonic chick cranial neurons at 
a concentration which is above saturation for responsive embryonic mouse 
neurons (2 ng/ml). I therefore examined the efficacy of NT-4/5 at 50 ng/ml. As 
shown in figure 3.6, addition of NT-4/5 at this concentration had a negligible 
effect on the survival of NGF-dependent DMTG neurons. In cultures of ElO 
BDNF-dependent VLTG, nodose, and TMN neurons, approximately 10% were 
supported by 50ng/ml of NT-4/5 (Figs. B.7-3.9). The percentage of surviving 
neui'ons in these cultures was however, lower than that seen with the equivalent 
concentration of xNT-4 (consistently -  30%). When BDNF and xNT-4 were 
added in combination, no additional survival was observed beyond that seen 
with saturating concentrations of BDNF alone (Figs. 3.7 and 3.8), indicating that 
BDNF and xNT-4 act on the same subsets of trigeminal and nodose neurons. In 
the same experiments, the majority of neurons in cultures containing the most 
effective neurotrophic factor alone or in combination with NT-4/5 (at 50 ng/ml) 
sustained the survival of similai* numbers of neurons (Figs. 3.6 - 3.8).
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Figure 3.6 Survival of ElO chick DMTG neurons in response to neurotrophins.
The bar graph shows the percentage of neurons surviving after 48 hours in low density, 
dissociated, glia-free cultures containing no neurotrophic factors (control), 50 ng/ml of xNT-4 or 
NT-4/5, 2 ng/ml of NGF or combinations of these factors. The mean + SEM of triplicate 
cultures are shown (N = NGF, 4 = xNT-4, 4/5 = NT-4/5).
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Figure 3.7 Survival of ElO chick VLTG neurons in response to neurotrophins.
Bar graph showing the percentage of neurons surviving after 48 hours in low density, 
dissociated, glia-free cultures containing no neurotrophic factors (control) or 50 ng/ml of xNT-4 
or NT-4/5, 2 ng/ml of BDNF, or combinations of these factors. The mean ±  SEM of triplicate 
cultures from a representative experiment are shown. (B = BDNF, 4 = xNT-4,4/5 = NT-4/5)
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Figure 3.8 Survival of ElO chick nodose neurons in response to neurotrophins.
The bar graph shows the percentage of neurons surviving after 48 hours in low density, 
dissociated, glia-free cultures containing no neurotrophic factors (control), or 50 ng/ml of xNT-4 
or NT-4/5, 2 ng/ml of BDNF or combinations of these factors. The mean ±  SEM of triplicate 
cultures from a representative experiment are shown. (B -  BDNF, 4 = xNT-4, 4/5 = NT-4/5)
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Figure 3.9 Survival of ElO chick TMN neurons in response to neurotrophins.
Bar graph showing the percentage of neurons surviving after 48 hours in low density, 
dissociated, glia-free cultures containing no factors (control), or 50 ng/ml of xNT-4, NT-4/5, or 
2 ng/ml of BDNF. The mean ±  SEM of triplicate cultures are shown. (B = BDNF, 4 = xNT-4, 
4/5 = NT-4/5)
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Although ElO chick neurons generally did not respond well to xNT-4 or 
NT-4/5, E6  DMTG neurons, which are BDNF-dependent at this age (Buj-Bello 
et al., 1993), do respond to 50 ng/ml of these factors. I therefore compaied the 
responses of these neurons to the three factors (Fig. 3.10). Although a similar 
number of neurons survived in the presence of saturating concentrations of 
either xNT-4, NT-4/5 or BDNF, xNT-4 and NT-4/5 were far less potent than 
BDNF. For BDNF, the effective concentration at half-maximal survival (EC50) 
was 8 pg/ml, while for xNT-4, the EC50 was 2 2 0  pg/ml, and for NT-4/5, half- 
maximal survival was obtained at 8 ng/ml (calculated by interpolation of the 
data). This data suggests that xNT4 is an order of magnitude, and NT-4/5 three 
orders of magnitude less potent than BDNF as a survival factor for E6  DMTG 
neurons. Similar dose-response experiments were conducted using ElO TMN 
neurons, also revealing striking differences in the efficacy of these 
neurotrophins (see Fig. 3.11). In this case, NT-4/5 was virtually ineffective as a 
survival factor for ElO TMN neurons, and the maximal survival obtained with 
xNT-4 was ~ 60% of that obtained with BDNF.
Thus, unlike other neurotrophins, NT-4/5 can discriminate between 
mouse and chick embryonic neurons. Furthermore, although all the BDNF- 
responsive neurons I tested in the mouse embryo aie supported equally well by 
NT-4/5, certain populations of BDNF-responsive neurons are more effectively 
supported by NT-4/5 than others in the chick embryo. Furthermore, I have 
shown that xNT-4 is more effective in promoting the survival of BDNF 
responsive chick embryo neurons than mammalian NT-4/5.
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Fig.ure 3.10 Dose-responses of embryonic chick DMTG neurons to BDNF, xNT-4 and NT- 
4/5.
The number of E6  DMTG neurons surviving after 48 hrs incubation with different 
concentrations of BDNF (filled circles), xNT-4 (open circles) or NT-4/5 (open squares), are 
expressed as a percentage of the number of neurons identified 6  to 9 hours after plating. The 
mean ± SEM of triplicate cultures from representative experiments are shown.
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Fig.ure 3.11 Dose-responses of embryonic chick TMN neurons to BDNF, xNT-4 and NT- 
4/5. The number of ElO TMN neurons surviving after 48 hrs incubation with different 
concentrations of BDNF (filled circles) or xNT-4 (open circles) are expressed as a percentage of 
the number of neurons identified 6  to 9 hours after plating. The mean ± SEM of triplicate 
cultures from representative experiments are shown. The effective concentration at half- 
maximal survival was; 26 pg/ml for BDNF and 7 ng/ml for xNT-4 (NT-4/5 - not done).
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3.3 Discussion.
I have quantitatively determined the ability of NT-4/5 to promote the 
survival of sensory and autonomic neurons of mouse and chick embryos in low- 
density, glia-free cultures. Furthermore, I have extended this study to compare 
the survival promoting effects of mammalian NT-4/5 with Xenopus NT-4.
NT-4/5 promoted the survival of mouse E ll  trigeminal neurons, which 
are transiently dependent on BDNF at this developmental stage, and of mouse 
E l l  to E l8 nodose neurons, which also depend on BDNF (Fig 3.1). NT-4/5, at 
the concentration tested, had negligible effect on the survival of mouse E15 
trigeminal neurons which are NGF-dependent at this embryonic stage. 
Surprisingly, although NT-4/5 and BDNF were equipotent in promoting the 
survival of mouse neurons, NT-4/5 was 3 orders of magnitude less potent than 
BDNF as a survival factor for homologous populations of chick embryo 
neurons. Furthermore, NT-4/5 had negligible effect on the survival of some 
populations of chick neurons. Thus, NT-4/5 appears to be a species-specific 
nem'otrophin. It displays the same activities as BDNF on mammalian cranial 
neurons and can discriminate between different BDNF-responsive chick 
neurons.
One explanation for the specificity of NT-4/5 among vertebrates is that 
the structure of NT-4/5 was not as conserved between mammals and birds as 
that of other neurotrophins (Ip et al., 1992a). I therefore compared the responses 
of human NT-4/5 with Xenopus NT-4, which bear 65% sequence homology at 
the amino acid level (Ip et al., 1992a). Interestingly, the Xenopus derived NT-4 
is more effective at promoting the survival of BDNF-responsive chick neurons 
than mammalian NT-4/5. There remains the possibility that an avian 
homologue of NT-4/5 exists which is more closely related to xNT-4, however at
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this juncture, none has been identified. Thus, the increased potency of xNT-4 
may arise from a greater affinity for the avian trkB receptor than that of NT-4/5.
Although NT-4/5 is a highly potent neurotrophin for certain populations 
of embryonic mouse neurons, its neuronal specificity is not unique. In this study 
of different populations of neurons at stages throughout their early development, 
NT-4/5 displayed identical neuronal specificity and potency to BDNF. In 
contrast, the neuronal specificity of NGF and NT3 , although partially 
overlapping with that of BDNF and NT-4/5 on early trigeminal neurons, was 
clearly different (Fig 3.1; Hohn et aL, 1990; Rosenthal et al., 1990; Buj-Bello et 
al., 1993). The apparent redundancy in function of NT-4/5 observed here could 
be explained in several ways. First, NT-4/5 may possess unique activities on 
neuronal populations that have not been tested in this study. Second, although 
BDNF and NT-4/5 promote the survival of identical neuronal populations in 
culture, they may each have distinct activities in vivo due to modulation by 
accessory factors. Third, it is possible that the only difference between BDNF 
and NT-4/5 is their distinct tissue distribution. If correct, this possibility implies 
that amino acids which are not conserved between the two proteins are not 
essential for function.
The common neuronal specificity of BDNF and NT-4/5 in mouse embryos 
may be a consequence of the binding of these neurotrophins to the same cell 
surface receptor. Two classes of neurotrophin receptors have been identified: 
p75 and the trk family of tyrosine kinases of which three members, trJcA, trkB 
and trkC, have been identified (Chao, 1992; Meakin and Shooter, 1992). 
Considerable evidence suggests that trk receptors are directly involved in 
neurotrophin signal transduction and ligand discrimination. Neurotrophins 
promote rapid autophosphorylation of trk tyrosine kinases (Kaplan et al., 1991a, 
1991b; Klein et al., 1991a; 1991b; Soppet et ah, 1991) and elicit responses in 
oocytes (Nebreda et al., 1991), cell lines (Cordon-Cardo et al., 1991; Glass et
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ah, 1991; Lamballe et ah, 1991b; Loeb et ah, 1991; Squinto et ah, 1991) and 
embryonic neurons transfected or microinjected with trk cDNAs (Allsopp et ah, 
1993a). In contrast, p75 is probably not a functional neurotrophin receptor 
alone (Bothwell, 1991) and binds NGF, BDNF, NT-3 and Xenopus NT-4 with 
similar affinity (Sutter et ah, 1979; Rodriguez-Tébai* and Barde, 1990; Hallbôôk 
et ah, 1991; Rodriguez-Tebar et ah, 1992).
Using proliferation (Ip et ah, 1992a) and tyrosine phosphorylation 
(Berkemeier et ah, 1991) assays in 3T3 fibroblasts expressing either trkA or 
trkB, NT-4/5 was shown to be a potent activator of trkB and a weak activator of 
tj'JcA . Like NT-4/5, BDNF also promotes rapid phosphorylation of trkB and 
elicits a mitogenic response in trkB-expvess'mg fibroblasts (Glass et ah, 1991; 
Klein et ah, 1991b; Soppet et ah, 1991; Squinto et ah, 1991) but is inactive on 
tJ'JcA and trkC (Lamballe et ah, 1991b). Thus, it seems likely that BDNF and 
NT-4/5 exert their common effects on the survival of embryonic mouse neurons 
by acting via trkB,
NT-4/5 at 50 ng/ml did not show any survival promoting effects on 
either E l8  SCG neurons or E l5 trigeminal neurons, both of which were 
supported by NGF (Fig. 3.1). Therefore, although NT-4/5 at high 
concentrations can activate the trkA high affinity NGF receptor (Hempstead et 
ah, 1991; Kaplan et ah, 1991a, 1991b; Klein et ah, 1991a; Lamballe et ah, 
1991b; Meakin et ah, 1992) in fibroblasts (Berkemeier et ah, 1992; Ip et ah, 
1992a), this activation does not appear to have any physiological relevance for 
the survival of developing mouse neurons.
Previous studies of the biological activity of NT-4/5 reported that it 
promoted the survival of substantial numbers of embryonic chick DRG (Ip et 
ah, 1992a), and sympathetic (Berkemeier et ah, 1991) neurons grown in 
dissociated culture. The discrepancy between these findings and my results may 
have been due to differences in the purity, processing or concentration of NT-
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4/5 used. The previous studies used partially purified conditioned media from 
mammalian cell lines that contained an unknown concentration of NT4/5 and 
could possibly carry aggregated or truncated forms of this protein. In contrast, 
in this study I used highly purified recombinant NT-4/5 and xNT-4 at known 
concentrations that were produced by Eschericia coll
Although BDNF and NT-4/5 display identical specificity and potency as 
survival factors for mouse neurons, they differ in their ability to prevent the 
death of chick embryo neurons. NT-4/5, at a coneentration of 50 ng/ml, 
promoted the survival of E6  DMTG neurons but was an ineffective survival 
factor for ElO TMN neurons. In contrast, BDNF displays similar potency in 
promoting the survival of both of these neuronal populations and is more potent 
than NT-4/5. Thus, NT-4/5 and BDNF differ in both specificity and potency as 
survival factors for chick embryo neurons. Although E6  DMTG neurons 
respond to NGF (Buj-Bello et al., 1993) whereas ElO TMN neurons are 
unresponsive to NGF (Davies et al., 1987), it is unlikely that NT-4/5 exerts its 
effects on E6  DMTG neurons via a regular trkA receptor because it does not 
support the survival of other NGF-dependent neurons. Alternatively, it is 
possible that E6  DMTG and ElO TMN neurons express different forms of the 
tr1<A or trkB receptors or of p75-like accessory molecules. Multiple trkB 
transcripts and at least three distinct trkB  receptors that differ in their 
cytoplasmic domains have already been identified (Klein et al., 1989; Klein et 
al., 1990; Middlemas et al., 1991; Allen et al., 1994). Recently, the 
developmentally regulated expression of truncated trkB  isoforms was 
demonstrated in trigeminal sensory neurons (Ninkina et al,, 1996). These 
isoforms of trkB are up-regulated concomitant with down-regulation of the fully 
functional trkB receptor, at a time when trigeminal neurons lose their 
responsiveness to BDNF (Ninkina et al., 1996). It therefore seems unlikely that 
differences in the specificity of xNT-4 or NT-4/5 are conferred by differential 
activation of the truncated trkB isoforms. The extracellular region of the Trk
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receptors has previously been implicated in discrimination between ligands, and 
several studies have suggested that either the immunoglobulin-like domains of 
trkB or alternatively the leucine-rich motifs of the receptor are involved in this 
discrimination (Urfer et a l, 1995; Windisch et al., 1995a; Windisch et al., 
1995b;Windisch et a l, 1995c; Ninkina et al., 1997). Another recent study has 
shown that a long and a short isoform of chick trkB exist which differ in the 
extracelluar domain (Strôhmaier et al., 1996). Whereas the long and short t?'kB 
isoforms bind BDNF equally well, the short isoform has a markedly reduced 
binding capacity for xNT-4 and NT-4/5 (Strôhmaier et al., 1996). Furthermore, 
differences in the binding capacity of these isoforms were observed which 
suggest that Xenopus NT-4 has greater affinity than mammalian NT-4/5 
(Strôhmaier e/fl/., 1996).
I therefore propose that the observations I have made in the latter part of 
this study can be accounted for in two ways. First, that differences in the 
survival promoting effects of BDNF, xNT-4 and NT-4/5 that I observed on 
cultured BDNF-responsive neurons, are due to the different binding affinities of 
these proteins for trkB, thus; BDNF > xNT-4 > NT-4/5. Second, that the higher 
concentrations of xNT-4 required to support the survival of ElO TMN neurons 
compaied with E6  DMTG neurons (see Figs. 3.10 and 3.11) can be accounted 
for by proposing that the later stage TMN neurons express greater levels of a 
trkB isoform that binds xNT-4 and NT-4/5 with reduced affinity.
Given more time, I would have extended the scope of this study to 
analyse the expression of chick trkB receptor isoforms in different avian cranial 
sensory ganglia at different stages of their development.
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CHAPTER 4
NGF BINDING TO P75 ENHANCES THE SENSITIVITY OF 
SENSORY AND SYMPATHETIC NEURONS TO NGF AT 
DIFFERENT STAGES OF DEVELOPMENT.
4,1 Introduction.
The sensitivity of neurons to neurotrophins is primaiily controlled by the 
expression of their receptors, TrkA, TrkB, TrkC and p75. The Trk family of 
receptor tyrosine kinases are signalling receptors that undergo rapid 
transphosphorylation following neurotrophin binding. Expression studies in cell 
lines have shown that TrkA is a receptor for NGF, TrkB is a receptor for BDNF 
and NT4/5 and TrkC is a receptor for NT3, although NT3 can also bind and 
signal less efficiently via TrkA and TrkB (Bothwell, 1995). The finding that the 
distinctive neuronal deficiencies in mice with null mutations in the trkA, trkB 
and trkC genes aie similai’ to those observed in mice with null mutations in the 
NGF, BDNF and NT3 genes, respectively, suggests that Trks play a key role in 
mediating the specific survival-promoting actions of neurotrophins (Davies, 
1994b; Snider, 1994; Lewin and Bai’de, 1996).
p75 is a transmembrane glycoprotein that binds all neurotrophins with 
the same affinity but with different rate constants. Although p75 is not essential 
for the survival response of neurons to neurotrophins, considerable evidence 
suggests that it plays an important role in modulating the sensitivity of neurons 
to different neurotrophins during development. The finding that embryonic 
sensory and postnatal sympathetic neurons, but not embryonic sympathetic 
neurons, from p757- mice are less sensitive to NGF than wild type neurons 
suggests that p75 selectively enhances the sensitivity of neurons to NGF at 
certain stages of development (Davies et a l, 1993b; Lee et al., 1994). Although 
reductions in the sensitivity of p75-deficient PNS neurons to other neurotrophins
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has not been observed, sympathetic neurons from postnatal p75-deficient mice 
are more sensitive to NT3 than sympathetic neurons from wild type animals 
(Lee et al., 1994). Likewise, the ability of NT3 to activate TrkA in the PC 12 
pheochi'omocytoma cell line is enhanced when NT3 binding to p75 to prevented 
by function-perturbing antibodies or when p75 expression is very low (Benedetti 
et al., 1993; Claiy and Reichardt, 1994), suggesting that p75 reduces the ability 
of NT3 to signal via TrkA. Furthermore, studies with mutated BDNF and 
NT4/5 proteins that bind TrkB normally but fail to bind p75 suggest that p75 
plays a role in TrkB ligand discrimination. Whereas the BDNF mutant activates 
TrkB as effectively as wild type BDNF, the NT4/5 mutant activates TiicB less 
effectively than wild type NT4/5 (Ryden et al., 1995). How p75 selectively 
modulates neuronal responsiveness to neurotrophins is not understood. In 
particular, since p75 and TrlcA cluster independently of NGF in cultured cells 
(Ross et al., 1996), it is unclear whether p75 affects NGF signalling by a direct 
interaction between p75 and TrkA that is independent of NGF binding to p75.
Recently, an additional level of complexity has been added to the 
controversy, involving a novel p75 signalling mechanism mediated by 
sphingomyelin (reviewed by Chao, 1995). Sphingomyelin is a ubiquitous 
sphingolipid residing in the outer leaflet of the cell membrane, which upon 
hydrolysis by a sphingomyelinase enzyme, produces the second messenger 
ceramide (Chaterjee, 1994). The second messenger function of ceramide is 
known to influence both cell growth and gene activation by the transcription 
factor NF-kB (Carter et al., 1996). Ceramide has been shown to induce 
apoptosis in the leukaemic U937 cell line (Obeid et a l, 1993), in the neuron-like 
PC 12 cell line (Hartfield et al., 1997), and in primary cultures of rat embryo 
mesencephalic neurons (Bragg et al., 1996). In contrast, ceramide has also been 
implicated in neuronal survival, and has been shown to rescue cultured 
sympathetic neurons from cell death induced by NGF deprivation (Ito and 
Horigome, 1995). The production of ceramide initiated by NGF thiough the p75
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receptor, has recently been demonstrated in the T9 glioma cell line (Dobrowsky 
et a l, 1994). Ceramide induction through p75 is specifically dependent on NGF 
binding and is mediated by the intracellular domain of the receptor (Dobrowsky 
etal., 1994).
Several studies have implicated the cytoplasmic domain of p75 in 
intracellulai* signalling. For example, when PC 12 cells expressing receptor 
chimeras with an EGF extracellular domain fused with the p75 cytoplasmic 
region are treated with EGF, these cells show a response similar to that seen 
when p75 expressing cells are treated with NGF (Yan et al., 1991). EGF 
treatment of T9 glioma cells expressing these receptor chimeras has been shown 
to mediate an increase in sphingomyelin hydrolysis (Dobrowsky et al., 1994) 
and addition of NGF, BDNF, or NT-3 to p75 expressing NIH 3T3 cells also 
activates this pathway (Dobrowsky et al., 1995). Furtheimore, the transcription 
factor NF-kB is activated in p75 expressing Schwann cells after treatment with 
NGF, an effect which is mimicked by the addition of cell permeable ceramide 
analogs (Carter etal., 1996).
To clarify the role of p75 in enhancing the survival response of sensory 
and sympathetic neurons to NGF at certain stages of development, I have 
compaied the response of these neurons to NGF and an NGF mutant that binds 
TrkA normally, but has negligible binding to p75. I demonstrate here that 
sensory and sympathetic neurons are less responsive to the NGF mutant than 
wild type NGF at the same stages of development at which sensory and 
sympathetic neurons from p75-/- mice are less responsive to wild type NGF than 
neurons from wild type embryos. This confirms, by an alternative approach, the 
stage-specific modulation of NGF sensitivity by p75 in developing sensory and 
sympathetic neurons and demonstrates that this effect requires NGF binding to 
p75. Furthermore, the demonstration that there are similai’ levels of p75 and 
TrkA mRNAs expressed at the stages of maximal NGF sensitivity has
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implications for the formulation of models to explain how p75 modulates NGF 
signalling via TrkA. In addition, I have compaied the survival responses of 
NGF and the NGF mutant in the presence of a cell permeable analogue of the 
lipid second messenger ceramide, demonstiating that the p75 modulated survival 
response is independent of this lipid second messenger pathway.
4.2 Production of the NGF mutant and binding to TrkA and p7S
Mutagenesis, expression and protein chaiacterisation of the NGF mutant 
was performed as described elsewhere (Shih et al., 1994). Oligonucleotide- 
directed mutagenesis of human NGF (Künkel, 1985) was modified according to 
the BioRad Mutagene kit (BioRad). NGF and the mutant protein concentration 
was determined by two independent enzyme-linked immunoassays (ELISA). 
One of these assays utilised a purified rabbit anti-human NGF polyclonal 
antibody and the other utilised a purified murine monoclonal antibody to NGF. 
Each assay was repeated at least three times for NGF and the NGF mutant and 
the results varied by less than 20% in a single transfection. Between separate 
transfections, the concentration of NGF and the mutant ranged between 3 and 8  
mg/ml. Pai'allel metabolic labelling experiments (Shih et al., 1994) indicated 
that >90% of the NGF or NGF mutant was represented in the fully processed 14 
kDa form.
It has been shown previously that mutations within variable region 1 
(residues 25-35) of murine NGF can result in significant loss of p75 binding 
while binding to TrkA is minimally affected (Ibanez et al., 1992). To explore 
the role of p75 in modulating the survival response of developing neurons to 
NGF, I used a bacterially synthesised and expressed mutant form of human NGF 
in which Lys 32, Lys 34 and Glu35 were replaced by Ala (K32A, K34A, E35A).
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The affinity of this mutant for TrkA and p75 was determined by competition 
binding of [125I]ngF to TrkA and p75 immunoadhesion proteins (Fig. 4.1).
The binding of the NGF mutant relative to wild type NGF was 
determined by competition displacement of [^^^I]NGF from TrkA and p75 
receptor immunoadhesion proteins (Shelton et al., 1995). Briefly, detachable 
96-well strips (Corning) were assembled and coated overnight at 4®C with 100 
ng of goat F(Ab')2  fragments of anti-human IgGi Fc domain (Chappel) diluted 
in 0.1 M Tris, pH9. After washing with PBS, 10 ng of trkA-lgG or p75-IgG 
immunoadhesion proteins (gifts of Drs. David Shelton and Avi Ashkenazi, 
Genentech) comprising the Fc portion of human IgGl Human [^^^I]NGF and the 
extracellulai* receptor domains of TrkA or p75, respectively, were incubated in 
each well for 90 minutes at room temperature in binding buffer (LI5 medium, 
20 mM HEPES, pH7.2, 1 mg/ml Fraction V BSA (Sigma) and 0.5 mg/ml 
cytochrome C). The plate was then washed with PBS and increasing 
concentrations of NGF or NGF mutant diluted in binding buffer were added to 
each well together with 25 pM human NGF. Binding was carried out at 
room temperature for 90 minutes. The plates were then washed with PBS plus 
0.05% Tween 20, after which the wells were detached and counted. Human 
[125JJNGF was iodinated by the lactoperoxidase-Enzymobead method (Escandon 
et al., 1993); the specific activity was approximately 60 mCi/mg as determined 
by TCA precipitation. The relative 50% inhibitory concentrations (IC50) for 
human NGF and TrkA (39 ±11 pM, n = 3) or human NGF and p75 (205 ± 85 
pM, n = 3) are within a factor of 2 to 3 of the IC50 and Kd values for mouse 
NGF binding to these receptors reported previously (Sutter et al., 1979; Klein et 
al., 1991a; Kahle etal., 1992; Vroegop etal., 1992).
Production of the NGF mutant and the binding studies referred to in this 
study were cairied out by Dr. John Winslow of Genentech Inc. USA, and are 
reproduced by permission.
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Figure 4.1 Receptor binding of human NGF and the NGF mutant to TrkA and p75. The relative 
affinity of NGF (solid squares) and the mutant (open squares) for TrkA (top panel) and p75 
(bottom panel) receptor immunoadhesion proteins are compared by competitive binding of 
[125I]ngF. The data presented is one representative experiment out of three. Each data point was 
determined in duplicate and the error is between 2-7% of the mean values shown. In this 
particular experiment, the IC5 0  (concentration of NGF or mutant that results in 50% inhibition of 
[125I]ngf binding) for NGF is 28 pM whereas the IC5 0  for the mutant is 45 pM. For p75 
binding, the IC5 0  for NGF is 106 pM while there is no IC5 0  for the mutant even at the highest 
concentration (4,500 pM).
(Courtesy of Dr. John Winslow, Genentech Inc.)
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4.3 Results
To determine if the NGF mutant differs in its effectiveness in promoting 
neuronal survival compared with NGF, I compared the dose-responses of two 
populations of NGF-responsive neurons of developing mice to wild type NGF 
and the NGF mutant. Trigeminal neurons were studied at E14, the age at which 
p75 deficient trigeminal neurons undergo a shift in survival responsiveness, 
requiring higher concentrations of NGF to support their survival (Davies et a l, 
1993). Similarly, sympathetic neurons were studies at two ages, E17 and P4, 
ages at which p75 deficient neurons show differing responses to NGF. Virtually 
all neurons (> 99%) in control (neurotrophin-free ) cultures died by 48 hours of 
incubation.
4.3,1 Influence of the NGF mutant on sensory neuron survival
The dose response of E14 trigeminal neurons to the mutant NGF was 
consistently shifted to higher concentrations compared with the dose response of 
these neurons to NGF (Fig. 4.2). Interpolation of the data from three separate 
dose response experiments on E14 trigeminal neurons showed that there was a 
four-fold difference between the concentration of NGF that elicited half- 
maximal survival (36 pg/ml) and the concentration of the NGF mutant that 
elicited half-maximal survival (146 pg/ml).
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Figure 4.2 Graph of the survival response of E14 mouse trigeminal ganglion neurons to
NGF and the NGF mutant. The means and standard errors of the percentage survival after 48 
hours. The combined dose data from three separate experiments (n = 9) are shown.
147
I
i
4.3.2 Influence of the NGF mutant on sympathetic neuron survival
In conti*ast to trigeminal neurons, E17 SCG neurons responded similaiiy 
to the NGF mutant and NGF (Fig.4.3). The dose response curves for the NGF 
mutant and NGF were very close together. Interpolation of the data from three 
separate dose response experiments on EI7 SCG neurons showed that the 
concentrations of NGF and the NGF mutant that elicited half-maximal survival 
were very similar (78 pg/ml and 94 pg/ml, respectively).
Although embryonic SCG neurons responded equally well to the NGF 
mutant and NGF, by the fourth postnatal day the NGF mutant was less effective 
in promoting the survival of SCG neurons than NGF (Fig. 4.4). Interpolation of 
the data from three separate dose response experiments on P4 SCG neurons 
showed that there was a five-fold difference between the concentration of NGF 
that elicited half-maximal survival (44 pg/ml) and the concentration of the NGF 
mutant that elicited half-maximal survival (234 pg/ml).
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Figure 4.3 Graph of the survival response of E17 mouse SCG neurons to NGF and the
NGF mutant. The means and standard errors of the combined dose data from three separate 
experiments are shown (n = 9).
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Figure 4.4 Graph of the survival response of P4 mouse SCG neurons to NGF and the NGF
mutant. The means and standard errors of the combined dose data from three separate 
experiments aie shown (n = 9 ).
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4.3.3 Influence of the NGF mutant on chicken sensory and sympathetic 
neuron survival.
In addition to comparing the effects of wild type NGF and the NGF 
mutant on the survival response of developing mouse sensory and sympathetic 
neurons, I cairied out similar* studies using embryonic chicken neurons. Like 
E14 embryonic mouse trigeminal ganglion neurons, the NGF-dependent neurons 
of the dorsomedial part of the ElO embryonic chicken trigeminal ganglion 
(DMTG neurons) were less sensitive to the mutant NGF than wild type NGF 
(Fig. 4.5). A three-fold difference in the dose response curve was observed in 
the mid-concentration range between wild type NGF (concentration at half- 
maximal survival = 26 pg/ml) and the NGF mutant (concentration at half- 
maximal survival = 75 pg/ml). Like mouse SCG neurons, the neurons of the 
chicken lumbar* sympathetic chain showed an age-related change in the survival 
response to the NGF mutant (Figs. 4.6 -4.8). At ElO the dose responses of these 
neurons to wild type NGF and the NGF mutant were very similar* (the 
concentrations of NGF and the NGF mutant that promoted half-maximal 
survival were 6.3 pg/ml and 7.4 pg/ml respectively) (Fig. 4.6). Similar* results 
were obtained in chicken sympathetic neuron cultures set up at E 12  
(concentration at half-maximal survival = 16 pg/ml for* NGF, and 20 pg/ml for* 
the NGF mutant) (Fig. 4.7). By E14, the NGF mutant was less effective in 
promoting the survival of these neurons compared with wild type NGF. The 
concentrations of NGF and the NGF mutant that promoted half-maximal 
survival were 17 pg/ml and 130 pg/ml, respectively (Fig. 4.8). These results 
suggest that the age-related modulation of the NGF survival response by p75 is 
conserved between the two classes of ver tebrates.
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Figure 4,5 Graph of the survival response of ElO chicken DMTG neurons to NGF and the
NGF mutant. The means and standard errors of the combined dose data from three separate 
experiments (each set up in tiiplicate) are shown (n = 9).
152
ElO Sympathetic Neurons
1
I
100
8 0 -
60
40 A
20
0
NGF
NGF Mutant
I---- f”vrin, iu( 'i k M I y nTf' • b m i iiiiij n— — g r'fmuj.1 1 10 100 1000 10000
Growth Factor Concentration (pg/ml)
Figure 4.6 Graph of the survival response at 48 hours of ElO chicken lumbar sympathetic 
neurons to NGF and the NGF mutant. The means and standard errors of the combined dose 
data from two separate experiments (each set up in triplicate) are shown (n = 6),
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Figure 4.7 Graph of the survival response at 48 hours of E12 chicken lumbar sympathetic 
neurons to NGF and the NGF mutant. The means and standard errors of the combined dose 
data from two separate experiments (each set up in triplicate) are shown (n = 6 ).
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Figure 4.8 Graph of the survival response at 48 hours of E14 chicken lumbar sympathetic 
neurons to NGF and the NGF mutant. The means and standard errors of the combined dose 
data from three separate experiments (each set up in triplicate) are shown (n = 9 ).
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4.3.4 Influence of the lipid second messenger ceramide on the p75 
modulated survival response.
Since the p75 receptor is known to initiate sphingomyelin hydrolysis to 
produce ceramide upon binding to NGF (Dobrowsky et «/., 1994), I investigated 
whether the cell permeable ceramide analogue A^-acetylsphingosine (C2- 
ceramide) can influence the survival response of ElO DMTG neurons (Fig. 4.9). 
A concentration of lOpM ceramide was used in these experiments, as this has 
previously been shown to be within the effective concentration range for 
mimicking the effects of NGF on cultured T9 glioma cells (Dobrowsky et al., 
1994). Interpolation of the combined data from two separate dose-response 
experiments indicated that C2-ceramide does not significantly enhance the 
survival response of trigeminal neurons in the presence of the NGF mutant (the 
concentration at half-maximal survival for the NGF mutant and the NGF mutant 
+ C2-ceramide = 76 pg/ml and 79 pg/ml respectively). Interestingly, when dose 
response experiments were carried out combining NGF with C2-ceramide, the 
half-maximal survival response was enhanced 1.7 fold (concentration at half- 
maximal survival for NGF and NGF 4- C2-ceramide = 33 pg/ml and 19 pg/ml 
respectively). Similar results were obtained using E l4 mouse trigeminal 
neurons (data not shown), suggesting an additional level of complexity is 
involved in the p75 modulated survival response to NGF.
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Figure 4.9 Graph of the survival response at 48 hours of ElO chicken DMTG neurons to 
NGF and the NGF mutant ±  Cg-ceramide. The means and standard errors of the combined 
dose data from two separate experiments (each set up in triplicate) are shown (n = 6 ).
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4.4 Discussion
I have studied the function of the p75 receptor in developing sensory and 
sympathetic neurons by comparing the survival response of these neurons to 
NGF and an NGF mutant that binds TrkA normally, but shows negligible 
binding to p75.
The binding affinity of human NGF to p75, reported here is slightly 
higher than previously reported values of mouse NGF binding to p75 (Kd = 1 to 
2 X 10-9M), was observed. However, similai’ results have also been reported for 
human NGF binding to p75 (Vrdegop et ah, 1992). Regaidless of the absolute 
affinity within the binding assays, in three separate binding experiments, the 
NGF mutant displayed minimal decrease in TrkA binding relative to the NGF 
control (1.44 +/- 0.22-fold). In contrast, no inhibition of [125I]ngF binding to 
p75 occurred with concentrations of the same mutant as high as 10 nM, 
indicating at least a 100- to 1,000-fold loss of affinity. Similai' relative binding 
affinities for human NGF and the mutant were observed in cell lines expressing 
full-length TrkA and p75 (data not shown). These data suggest that any loss of 
potency or efficacy of neuronal responses in the presence of the NGF mutant can 
be ascribed to loss of interaction with the p75 receptor (J. Winslow, personal 
communication).
In this study, saturating concentrations of the NGF mutant were as 
effective as NGF in promoting neuronal survival, indicating that p75 is not 
essential for NGF signal transduction. This result contrasts with studies using 
tumour cell lines transfected with p75 which suggested that p75 is necessary for 
NGF responsiveness (Hempstead et ah, 1989; Matsushima and Bogenmann, 
1990; Pleasure et ah, 1990; Berg et ah, 1991; Hempstead et ah, 1991). 
However, this data supports a growing body of evidence that signalling via TrlcA 
is sufficient for eliciting responses to NGF. In addition to the demonstration that
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NGF elicits a mitogenic response in fibroblasts expressing TrkA without p75 
(Klein et al, 1991a), previous studies with NGF mutants that bind to TrkA but 
not p75 have shown that saturating levels of these mutants elicit typical NGF 
responses from PC 12 cells and sympathetic neurons (Drinkwater et al., 1991; 
Ibanez et al., 1992).
To assess whether p75 affects neuronal survival at limiting ligand 
concentrations, I compared the dose responses of sensory and sympathetic 
neurons to NGF and the NGF mutant. Although the dose responses of 
embryonic mouse sympathetic neurons to NGF and the NGF mutant were not 
significantly different, the dose responses of postnatal sympathetic and 
embryonic sensory neurons to the NGF mutant were consistently shifted to 
higher concentrations compared with the dose responses of these neurons to 
NGF. Both embryonic sensory and postnatal sympathetic neurons were 4- to 5- 
fold less sensitive to the NGF mutant compared with NGF in the mid 
concentration range. These findings are strikingly consistent with the NGF 
response of sensory and sympathetic neurons obtained from mice with a null 
mutation in the p75 gene (Davies et al., 1993b; Lee et ah, 1994). Whereas the 
p75 mutation does not affect the dose response of embryonic sympathetic 
neurons to NGF, p75-deficient embryonic sensory and postnatal sympathetic 
neurons are less sensitive to NGF than wild type neurons. Remarkably, p75- 
deficient embryonic sensory and postnatal sympathetic neurons were 4- to 5-fold 
less sensitive to NGF than wild type neurons. Thus, my results demonstrate by a 
complementary experimental approach that p75 enhances the survival response 
of embiyonic sensoiy and postnatal sympathetic neurons to NGF.
The data presented here show that the presence of p75 does not in itself 
increase the survival response of neurons to NGF. It is clear that the modulation 
of the NGF survival response by p75 necessitates direct binding of NGF to p75. 
Although p75 and TrkA appear to cluster independently of NGF in cultured cells
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(Ross et al., 1996), an interaction between these receptors is not sufficient to 
enhance NGF responsiveness, because the dose response of neurons co­
expressing p75 and TrkA to the NGF mutant is highly similar to that of p75- 
deficient neurons to wild type NGF.
In addition to showing developmental changes in the responsiveness of 
mouse sympathetic neurons to NGF and the NGF mutant, I have observed a 
similar phenomenon in developing chicken sympathetic neurons. Between ElO 
and E14, chicken sympathetic neurons become less responsive to the NGF 
mutant compared with wild type NGF. Also, like embryonic mouse trigeminal 
neurons, mid-embryonic chicken DMTG neurons were less sensitive to the NGF 
mutant than wild type NGF. These results indicate that p75 plays a similar role 
in modulating the survival response of sensoiy and sympathetic neurons to NGF 
during development in both classes of vertebrates.
Because neurotophin binding to p75 results in the production of ceramide 
(Dobrowsky et al., 1994), I tested whether this lipid second messenger had the 
ability to enhance the survival responses of cultured chick embryo DMTG 
neurons at sub-saturating concentrations of NGF and the NGF mutant. A cell 
permeable analogue of ceramide (C2 ceramide), did not significantly enhance the 
survival of these cells when cultured in the presence of sub-saturating 
concentrations of the NGF mutant. This result indicates that at this stage of 
neuronal development, modulation of neuronal survival by p75 is not dependent 
upon activation of the sphingomyelin pathway. Additionally, since the survival 
response of ElO DMTG neuions was moderately enhanced by €% ceramide in 
the presence of sub-saturating levels of NGF, the sphingomyelin pathway may 
involve further signalling interactions, the investigation of which aie beyond the 
scope this study.
To explain the age-related change in the role of p75 in enhancing the 
NGF survival response in sympathetic neurons the relative levels of p75 and
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TrkA mRNA in embryonic and postnatal mouse sympathetic neurons have been 
measured (Fig. 4.10). In neurons purified from embryonic sympathetic ganglia 
at the stage when p75-deficient neurons and wild type neurons respond similarly 
to NGF (Davies et ah, 1993b), and the dose responses of wild type neurons to 
NGF and the NGF mutant aie similar, the level of p75 mRNA is five-fold lower 
than TrkA mRNA. However, by the fifth postnatal day when p75-deficient 
neurons are less responsive to NGF than wild type neurons (Lee et al, 1994) and 
the NGF mutant is less effective than NGF in promoting the survival of wild 
type neurons, the relative levels of p75 and TrkA mRNA are similar. The 
relative levels of these mRNAs are also similar in purified E14 trigeminal 
neurons, which, like postnatal sympathetic neurons, are less responsive to the 
NGF mutant than wild type NGF. These measurements of the relative levels of 
p75 and TrkA mRNA in purified neurons obtained from trigeminal and 
sympathetic ganglia are similar to the relative levels of the mRNAs measured in 
whole ganglia (Wyatt and Davies, 1993; Wyatt and Davies, 1995), suggesting 
that the neurons of these ganglia largely account for the expression of p75 and 
TrkA.
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Figure 4.10 Bar chart of the relative levels of p7S mRNA in purified E14 trigeminal 
ganglion neurons, E17 SCG neurons and postnatal day 4 SCG neurons expressed as 
percentage of the level of TrkA mRNA in these neurons. In each of three separate 
preparations of neurons there was less than 1% contamination by satellite cells. The mean ±  
SEM for three separate estimations of p75 mRNA and TrkA mRNA in purified neurons are 
plotted.
(Courtesy of Dr. Sean Wyatt, St. Andrews University)
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Although estimates of mRNA levels may not necessarily reflect p75 and 
TrkA mRNA receptor levels, due to the rate of protein translation, prior 
estimates of the p75:TrkA ratio are in the range of 6-20:1 for PC12 cells (Verdi 
et al., 1994; Verdi and Anderson, 1994), and primary sympathetic neurons 
(Sutter et al, 1979). However, these estimates have been largely determined 
from the ratio of low to high affinity NGF binding sites which may not truly 
represent the true ratio of p75:TrkA. For example, high and low affinity 
neurotrophin binding has been determined for the Trk receptors alone (IClein et 
al, 1991a; Tsoulfas et al, 1993, Dr. John Winslow, personal communication) 
and therefore binding affinity alone may not be sufficient for the quantitative 
determination of co-expressed TrkA and p75 receptors.
Quantitative mRNA determination suggests that the p75:TrkA ratio 
approaches one in primary neurons during the period of programmed cell death, 
at a time when p75 appeals to modulate TrkA function. This ratio may be 
effective in enhancing neuronal survival by increasing TrkA activation or 
signalling thimigh TrkA substrate proteins. Increased TrlcA activation may occur 
at higher ratios of p75:TrlcA, as observed in transfected MAH cells (Verdi et al., 
1994), although in this context mitogenesis and not survival is enhanced. Thus, 
although the higher p75;TrkA ratios produced by gene transfer in cell lines can 
result in enhanced TrkA responsiveness, modulation of the NGF neuronal 
survival response by p75 in vivo occurs over a much narrower range, and when 
the ratio is close to 1:1.
How p75 enhances the survival response of NGF-dependent neurons to 
NGF is not cleai". The finding that the binding of NGF to TrkA in PC 12 cells is 
reduced by dismpting NGF binding to p75 by an anti-p75 antibody or by excess 
BDNF, suggests that p75 enhances the binding of NGF to TrlcA (Barker and 
Shooter, 1994). Furthermore, co-expression of TrkA and p75 in fibroblasts 
results in the formation of a class of high-affinity receptors that is not appaiently
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present in cells expressing TrkA alone (Battleman et al, 1993), and expression 
of high levels of p75 in MAH cells enhances NGF-induced TrkA 
phosphorylation compared with cells expressing TrkA alone (Verdi et al., 1994). 
Recently, p75 has been shown to accelerate TrkA-mediated signalling in 
cultured PC 12 cells (Canossa et al., 1996). In addition, p75 forms a complex 
with TrkA on the cell surface (Wolf et al., 1995; Ross et al., 1996) and is 
immunoprecipitated in a complex with TrkA in the presence of [125I]nGF 
(Huber and Chao, 1995). These studies suggest that p75 enhances binding of 
NGF to TrkA which in turn increases the efficiency of TrkA signalling.
Several models have been proposed to explain how p75 might increase 
the efficiency of TrkA signalling. For example, p75 may act to concentrate 
NGF locally in the microenvironment surrounding cell surface TrkA receptors 
(Barker and Shooter, 1994). However, in this model, TrkA receptors are 
envisioned to be surrounded by larger numbers of p75, and it has not been 
demonstrated that there is a large excess of p75 molecules available to surround 
TrkA molecules at the cell surface. In addition to modulating TrkA signalling 
by interacting directly or indirectly with TrkA, it is possible that p75 may 
modulate the survival response of TrkA-expressing neurons by activating certain 
intracellular- signalling pathways directly. For example, NGF has recently been 
shown to promote sphingomyelin hydrolysis (Dobrowsky et al., 1994) and NF- 
kB activation (Carter et a l, 1996) by binding to p75 in certain non-neuronal 
cells that do not express Trks. In addition, p75 signalling activated by NGF 
binding in cells lacking TrkA can promote apoptosis in early retinal cells (Frade 
et a l, 1996) and in cultured oligodendrocytes (Casaccia-Bonnefil et a l, 1996). 
The occurrence of p75-dependent signalling events in neurotrophin-dependent 
neurons and their significance in promoting the survival of sensory neurons has 
not been established. Furthermore, the results of experiments where the lipid 
analog Cz-ceramide was administered to cultured trigeminal sensory neurons
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(Fig. 4.10) argue against a direct involvement of this pathway in the p75 
mediated survival response of sensory neurons.
In conclusion, I have demonstrated that p75 modulates the survival 
response of sensory and sympathetic neurons to NGF at the stages of their 
development when these neurons express similar levels of p75 and TrkA. 
Furthermore, I have shown that modulation of the NGF survival response by p75 
is dependent on NGF binding to p75 rather than on interactions that occur 
between p75 and TrkA independent of NGF binding. The modulation of NGF 
sensitivity by p75 is only observed at low, limiting concentrations of NGF. This 
together with the fact that p75 exerts this effect during the period of naturally 
occurring neuronal death in the trigeminal (Davies and Lumsden, 1984) and 
sympathetic ganglia (Wright et ah, 1983) suggests that p75 expression plays an 
important role in governing the number of neurons that survive to maturity.
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CHAPTER 5
CYTOKINES PROMOTE THE SURVIVAL OF CRANIAL 
SENSORY NEURONS AT DIFFERENT STAGES OF THEIR
DEVELOPMENT.
5.1 Introduction.
Different neurotrophins can co-operate in regulating the survival of a 
paiticular population of neurons by either acting on neurons at the same stage 
during development or by acting sequentially. Examples of concurrent 
neurotrophin action include BDNF and NT3 supporting the survival of the 
proprioceptive neurons of the trigeminal mesencephalic nucleus during the 
period of naturally occurring neuronal death (Davies et a l, 1986a; Hohn et a l, 
1990; Ernfors et a l, 1994a, 1994b; Jones et a l, 1994) and NGF and NT3 acting 
together on sympathetic neurons during an equivalent stage of their development 
(Zhou and Rush, 1995, Wyatt and Davies, 1997). The clearest evidence for the 
sequential action of neurotrophins in regulating the survival of developing 
neurons comes from studies of the embryonic mouse trigeminal ganglion. In 
culture, early trigeminal ganglion neurons show a transient survival response to 
BDNF and NT3 before becoming dependent on NGF for survival (Buchman and 
Davies, 1993; Paul and Davies, 1995). Neuronal apoptosis is mai'kedly elevated 
in the early trigeminal ganglia of mice that are homozygous for a null mutation 
in the trkB gene, which encodes the BDNF receptor tyrosine kinase, whereas 
neuronal apoptosis is markedly elevated later in development in the trigeminal 
ganglia of mice that aie homozygous for a null mutation in the tr1<A gene, which 
encodes the NGF receptor tyrosine kinase (Pinon et a l, 1996). Neuronal 
apoptosis is also markedly elevated in the early trigeminal ganglia of NT3”/" 
mice (Wilkinson et a l,  1996), although the loss of neurons in the early 
trigeminal ganglia may be due in part to the death of progenitor cells (ElShamy 
and Ernfors, 1996).
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In addition to the neurotrophins, several other proteins have been shown 
to promote the survival of neurons during development. Ciliary neurotrophic 
factor (CNTF), leukaemia inhibitory factor (LIF), cardiotrophin-1 (CT-1), 
oncostatin-M (OSM) and interleuldn-6 (IL-6), comprise a family of cytokines 
that although showing less than 15% amino acid sequence identity, share several 
characteristic structural features (Bazan, 1991; Robinson etaL, 1994; McDonald 
et al., 1995) and signal via oligomeric receptor complexes that have one or more 
components in common (Stahl and Yancopoulos, 1994; Wollert et al., 1996). 
These cytokines have multiple actions on cells of the nervous system, including 
promoting survival of some neurons. For example, CNTF promotes the survival 
of sympathetic, parasympathetic, motorneurons and some sensory neurons in 
vitro (Barbin et al., 1984; Arakawa et al., 1990; Oppenheim et al., 1991; 
Burnham et al., 1994), and is involved in promoting the survival of some adult 
motorneurons in vivo (Masu et al., 1993). LIF promotes the survival of 
motorneurons, sympathetic neurons and some sensory neurons in vitro 
(Martinou et a l, 1992; Murphy et a l, 1993; Kotzbauer et al, 1994; Thaler et al, 
1994) and plays a role in promoting the survival of embryonic motorneurons in 
vivo (Li et a l, 1995). CT-1 promotes the survival of cultured ciliary ganglion 
neurons, midbrain dopaminergic neurons and motorneurons (Pennica et a l, 
1995b; Pennica et a l, 1996). IL-6 enhances the in vitro survival of a proportion 
of forebrain cholinergic and midbrain catecholaminergic neurons (Hama et a l, 
1989; Kushima et a l, 1992). OSM promotes the survival of a subset of late 
embryonic DRG neurons in culture (Ware et al, 1995).
Studies of the neurotrophic actions of individual cytokines have been 
restricted to one or just a few stages of development. The purpose of the present 
study was to carry out a comprehensive, compar ative study of the neurotrophic 
effects of cytokines on sensory neurons at closely staged developmental 
intervals to determine when these factors exert their effects, and to determine the 
relationship between cytokine and neurotrophin responsiveness. Cutaneous
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sensory neurons of the trigeminal ganglion, which switch their survival 
requirements from BDNF/NT-3/NT-4/5 to NGF during the early stages of tar get 
field innervation (Davies et al., 1993a; Buchman and Davies, 1993; Paul and 
Davies, 1995; Pinon et al., 1996), and enteroceptive neurons of the nodose 
ganglion, which retain dependence on BDNF throughout embryonic 
development, were chosen for this study (Davies et al., 1993a; Buj-Bello et a l, 
1994). I show that whereas nodose neurons survive in response to CNTF, LIF, 
OSM and CT-1 throughout development, trigeminal neurons do not begin to 
respond to these factors until the late embryonic period. Nodose neurons 
additionally show a survival response to IL-6 in the late embryonic period. 
These findings indicate that cytoldnes are able to influence the survival of 
different populations of sensory neurons at different stages in their development. 
Together with earlier studies, my results indicate that trigeminal neurons pass 
thi'ough several sequential stages during which they have different neurotrophic 
factor survival requirements: an early period of BDNF/NT3 dependence, 
followed by a phase of NGF dependence and a late stage of cytokine 
responsiveness.
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5.2 Results.
5.2.1 Nodose neurons
The survival of the great majority of nodose neurons was promoted by 
BDNF in cultures set up at stages from E ll to E l9, whereas in control cultures 
very few neurons were surviving by 48 hours (Figs. 5.1-5.4). A clear survival 
response to CNTF, LIF, OSM and CT-1 was observed at all ages studied. The 
proportion of neurons responding to these factors increased from between 20% 
and 40% at E l 1 (after subtraction of the small number of neurons surviving in 
control cultures) to between 50% and 80% at E19. In E ll  (Fig. 5.1) and E14 
(Fig 5.2) cultures, there were two to three times more neurons surviving with 
BDNF compared with these cytokines, whereas in E17 (Fig 5.3) and E19 (Fig. 
5.4) cultures, similar numbers of neurons survived with BDNF and these 
cytokines. Although there was no difference in the number of neurons in control 
cultures and cultures supplemented with IL-6 at El 1 and E14, there was a clear 
survival response to IL-6 in E17 cultures, and the number of neurons surviving 
with IL-6 had risen to over 40% in E19 cultures. These results show that nodose 
neurons respond to CNTF, LIF, OSM and CT-1 throughout development and 
exhibit a late survival response to IL-6. Because the serum-free medium used in 
these experiments was not conducive for the survival of non-neuronal cells, the 
survival of neurons was unlikely to be influenced by neurotrophic factors other 
than those added to the cultures.
169
E ll Nodose
1
COI
100
80
60-
40-
2 0 -
BDNF CNTF LIF OSM IL-6 CT-1 Control
Figure 5.1. Bar chart of the percentage survival of E l l  nodose ganglion neurons.
Neurons were cultured for 48 hours with saturating concentrations of BDNF (10 ng/ml ), CNTF, 
LIF, OSM, IL- 6  or CT-1 (50 ng/ml). Control = no added neurotrophic factors. The number of 
neurons surviving at 48 hours is expressed as a percentage of the number of neurons identified 6 - 
9 hours after plating. Tlie mean and standard errors of two experiments are shown (n = 6 ).
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Figure 5.2. Bar chart of the percentage survival of E14 nodose ganglion neurons.
Neurons were cultured for 48 hours with saturating concentrations of BDNF (10 ng/ml ), CNTF, 
LIF, OSM, IL- 6  or CT-1 (50 ng/ml). Control = no added neurotrophic factors. The mean and 
standard errors of two experiments are shown (n = 6 ).
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Figure 5.3 Bar chart of the percentage survival of E17 nodose ganglion neurons.
Neurons were cultured for 48 hours with saturating concentrations of BDNF (10 ng/ml ), CNTF, 
LIF, OSM, IL- 6  or CT-1 (50 ng/ml). Control = no added neurotrophic factors. The mean and 
standard errors of two experiments are shown (n = 6 ).
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Figure 5.4 Bar chart of the percentage survival of E19 nodose ganglion neurons.
Neurons were cultured for 48 hours with saturating concentrations of BDNF (10 ng/ml ), CNTF, 
LIF, OSM, IL- 6  or CT-1 (50 ng/ml). Control = no added neurotiophic factors. The mean and 
standard errors of two experiments are shown (n = 6 ).
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When nodose neurons were cultured with saturating concentrations of 
different neurotrophic factors in combination the overall survival did not 
increase at either E14 or E19 (Fig. 5.5). This indicates that the neurons which 
respond to cytoldnes comprise a subset of those that respond to BDNF early on, 
whereas BDNF, CNTF, LIF, OSM and CT-1 act on the same neurons later in 
development. The lack of any additional survival in E14 cultures containing two 
different cytokines also shows that these cytokines act on the same subset of 
neurons at this age. Interestingly, in E14 cultures there were fewer neurons 
surviving with BDNF plus cytokines compaied with BDNF alone. Statistical 
analysis of the data revealed that whereas the survival response of BDNF 
compared with BDNF and IL-6 in combination did not show a significant 
difference (P = 0.364, Student's /-test), BDNF in combination with other 
cytokines does display a significantly reduced survival response (P = 0.009 for 
BDNF + CNTF, 0.013 for BDNF + LIF, 0.041 for BDNF + CT-1, Student's f- 
test).
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Figure 5.5. Bar charts of the percentage survival of E14 and E19 nodose ganglion neurons.
Neurons were cultured for 48 hours with saturating concentrations of BDNF and cytokines alone 
and in combination. Control = no added neurotrophic factors. In each case, the mean and 
standard errors of two experiments are shown (n = 6 ).
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Dose response analysis (Fig. 5.6) showed that BDNF was the most 
potent neurotrophic factor for nodose neurons at E l9. The concentration of 
BDNF that elicited half maximal survival (EC5 0) was estimated at 181.5 + 23.3 
pg/ml by interpolating the data from 3 sepaiate experiments. CNTF, LIF, OSM 
and CT-1 were slightly less potent; EC5 0 values: 205 + 13.2 pg/ml (9.0 pM), 
462 ± 5 pg/ml (10.2 pM), 357 ± 73 pg/ml (12.7 pM) and 462 ± 99 pg/ml (21.5 
pM), respectively. IL- 6  was the least potent of the cytokines; EC5 0  = 822 + 96 
pg/ml (31.6 pM).
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F igure  5.6 G ra p h  o f the  dose responses o f E19 nodose neurons to  BDNF an d  cytokines.
Concentrations ranging from 3.2 pg/ml to 50 ng/ml were used. The combined mean and 
standard errors of three experiments are shown (n = 9).
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5.2.2 Trigeminal neurons
The influence of cytokines on the survival of trigeminal ganglion 
neurons was compared with that of neurotrophins at stages throughout 
development. Because the survival dependence of trigeminal neurons switches 
from BDNF to NGF during the early stages of taiget field innervation (Buchman 
and Davies, 1993), E ll  cultures were grown with BDNF and E14 and older 
neurons were grown with NGF. In the presence of these neurotrophins, the 
majority of neurons survived for 48 hours (Figs. 5.7 - 5.10). The reason for the 
overall increase in the number of identified neurons in E ll  cultures between 6 
and 48 hours incubation in the presence of BDNF was due to the enhanced 
survival of neurons that differentiate from progenitor cells in these eaiiy cultures 
(Paul and Davies, 1995). Cytokines had no effect on neuronal survival in E ll  
and E14 cultures (Figs 5.7 and 5.8). At these ages virtually all neurons were 
dead in cytoldne-supplemented cultures by 48 hours incubation. In E17 cultures 
(Fig. 5.9) a small proportion of the neurons were supported by CNTF, LIF, OSM 
and CT-1, and this increased to approximately 40% by E19 (Fig. 5.10). There 
was no response to IL-6 throughout development, although 5% of the neurons 
were surviving with this factor in E19 cultures. There was no additional suiwival 
in cultures supplemented with NGF and cytokines (Figure 5.11), indicating that 
a proportion of NGF-responsive neurons acquire responsiveness to cytokines 
during the late embryonic period.
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Figure 5.7 Bar chart of the percentage survival of E l l  trigeminal ganglion neurons.
Neurons were cultured for 48 hours with saturating concentrations of BDNF (10 ng/ml ), CNTF, 
LIF, OSM, IL-6 or CT-1 (50 ng/ml). Control = no added neurotrophic factors. The number of 
neurons surviving at 48 hours is expressed as a percentage of the number of neurons identified 6- 
9 hours after plating. The mean and standard enors of two experiments are shown (n = 6).
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Figure 5.8 Bar chart of the percentage survival of E14 trigeminal ganglion neurons.
Neurons were cultured for 48 hours with saturating concentrations of NGF (10 ng/ml ), CNTF, 
LIF, OSM, IL-6 or CT-1 (50 ng/ml). Control = no added neurotrophic factors. The mean and 
standard errors of two experiments are shown (n = 6).
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Figure 5,9 Bar chart of the percentage survival of E17 trigeminal ganglion neurons
Neurons were cultured for 48 hours with saturating concentiations of NGF (10 ng/ml ), CNTF, 
LIF, OSM, IL-6 or CT-1 (50 ng/ml). Control = no added neurotrophic factors. The mean and 
standard errors of two experiments are shown (n = 6).
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Figure 5.10 Bar chart of the percentage survival of E19 trigeminal ganglion neurons.
Neurons were cultured for 48 hours with saturating concentrations of NGF (10 ng/ml ), CNTF, 
LIF, OSM, IL-6 or CT-1 (50 ng/ml). Control = no added neurotrophic factors. The mean and 
standard errors of two experiments are shown (n = 6).
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F igure  5.11. B a r ch a r t of the  percen tage survival of E19 trigem inal ganglion neurons.
Neurons were cultured for 48 hours with saturating concentrations of NGF and cytokines both 
alone and in combination. Control = no added neurotrophic factors. The number of neurons 
surviving at 48 hours is expressed as a percentage of the number of neurons identified 6-9 hours 
after plating. The mean and standard errors of two experiments are shown (n = 6).
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5.4 Discussion.
Previous work has shown that the neurotrophin survival requirements of 
embryonic trigeminal ganglion neurons switch from BDNF and NT3 to NGF 
eaiiy in development and that they retain dependence on NGF throughout the 
period of natmally occurring neuronal death (Buchman and Davies, 1993; Paul 
and Davies, 1995a; Pinon et a l, 1996; Wilkinson et a l, 1996). Here I 
demonstrate that trigeminal neurons acquire survival responses to CNTF, LIF, 
OSM and CT-1 after the majority of these neurons have become dependent on 
NGF for survival. Because there is no additional survival in cultures containing 
cytokines plus NGF compared with NGF alone, the cytokine-responsive neurons 
do not constitute a separate population of trigeminal neurons but comprise a 
major subset of the NGF-responsive neurons. Since the cytokine survival 
response is evident by E17 and the period of naturally occurring neuronal death 
is not over until birth (Davies and Lumsden, 1984), it is possible that these 
cytokines play a role in regulating the final number of neurons in the trigeminal 
ganglion or are important for sustaining the survival of trigeminal neurons after 
selection of the appropriate number of neurons has taken place as a result of 
competition for target-derived NGF (Davies et al, 1987). Together with 
previous work, my results demonstrate that the responsiveness of trigeminal 
neurons to neurotrophic factors passes through several phases during 
development. After a brief period of neurotrophin independent survival, the 
neurons have a transient dependence on BDNF and NT3 before becoming NGF 
dependent, and subsequently acquire responsiveness to cytoldnes.
In contrast to the late survival response of trigeminal neurons to 
cytokines, I have shown that nodose ganglion neurons respond to CNTF, LIF, 
OSM and CT-1 as early as El l ,  and show a marked survival response to these 
cytokines throughout development. Although a previous in vitro study of rat 
nodose ganglion neurons at a single developmental stage (El6.5) showed that a
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proportion of these neurons survive in response to CNTF and LIF, it was 
reported that these cytokines and BDNF have a partially additive effect on 
survival, suggesting that they act in part on different subsets of neurons (Thaler 
et ah, 1994). In contrast, I found no additive effects of BDNF in combination 
with CNTF, LIF, OSM or CT-1 at either E14 or E19, suggesting that BDNF- 
responsive and cytokine-responsive neurons are completely overlapping. In 
addition, my study has revealed that a subset of nodose neurons acquire a 
survival response to IL-6 at late embryonic stages. Although the IL-6 receptor 
shaies one component in common with the receptors for CNTF, LIF, OSM or 
CT-1 (namely, gpl30), it also comprises a specific receptor component termed 
IL-6Ra. Thus, it is likely that the late response of nodose neurons to IL-6 is a 
consequence of the expression of IL-6Ra at this stage of development.
In vitro studies of mouse dorsal root ganglion (DRG) neurons have 
shown that a small percentage of these neurons respond to LIF with enhanced 
survival in the late embryonic period and that the majority are LIF-responsive 
postnatally (Murphy et a l, 1993). The finding that there is a significant 
reduction in the number of DRG neurons in mice that are homozygous for a 
targeted null mutation in the lifrP gene, which encodes a LIF receptor 
component that is essential for signalling, suggest that the in vitro response of 
DRG neurons to LIF is physiologically relevant (P. Bartlett, personal 
communication). Because LIFRp is also a signalling component of the 
oligomeric receptors for CNTF, OSM and CT-1 (Stahl and Yancopoulos, 1994; 
Wollert et aL, 1996), it is uncleai* which of these cytokines is the physiologically 
relevant LIFRP ligand required for the survival of DRG neurons and the cranial 
sensoiy neurons examined in the present study. Although analysis of mice that 
have targeted mutations in the genes encoding these cytokines may resolve this 
issue, this is already additional circumstantial evidence that LIF may play a role 
in promoting the survival of sensory neurons in vivo. LIF mRNA in skin and 
gut from E l5 onwards (Muiphy et a l, 1993), and the retrograde transport of
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iodinated LIF from the periphery (Hendry et aL, 1992) raises the possibility that 
LIF may function as a taiget-derived neurotrophic factor for late embryonic and 
newborn DRG. Alternatively, because LIF mRNA is also expressed within 
embryonic DRG (Murphy et al„ 1993; Fan and Katz, 1993), it is possible that it 
may also act locally on these neurons.
Several investigators have focused on the ability of various cytoldnes to 
influence the neuropeptide and neurotransmitter expression in sympathetic 
neurons. CNTF, LIF, and CT-1 have been observed to alter the expression of 
neurotransmitters in sympathetic neurons (Fan and Katz, 1993; Pennica et aL, 
1995b). These factors can induce cholinergic function concomitant with a 
reduction of noradrenergic expression, and can also influence the expression of 
several neuropeptides, including substance P, somatostatin, CGRP and VIP (Rao 
et aL, 1990; Pennica et aL, 1995b), Previous in vitro studies have also 
demonstrated that both LIF and CNTF can function to regulate neurotransmitter 
synthesis in rat sensory neurons (Nawa et aL, 1990; Ip et aL, 1991; Murphy et 
aL, 1991; Rao et aL, 1992, Fan and Katz, 1993; Thaler, 1994; Waie et aL, 1995). 
LIF and CNTF were shown to partially inhibit the expression of the 
catecholamine-synthesising enzyme, tyrosine hydroxlyase (TH), in low density 
cultures of E l6.5 rat trigeminal neurons (Fan and Katz, 1993). In contrast, a 
comparison of TH-immunostained nodose and trigeminal ganglia from E13.5, 
E17.5 and E18.5 wild type (WT) and LIFRP"/" mutant mice revealed no obvious 
differences in the numbers of catecholaminergic neurons (Ware et aL, 1995).
In a recent study, Qiu and co-workers have suggested that iodinated LIF 
(i25i_LiF) binds to trigeminal and nodose ganglia of the developing rat (Qiu et 
aL, 1994). Furthermore, they suggest that binding to different types of sensory 
ganglia is detectable in vaiying magnitudes at different developmental stages. 
Although the results produced were semi-quantitative, they suggest that the 
magnitude of bound '^^I-LIF increases between the ages E15/16 and E18/P0. In
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addition, this study demonstrated differences in the amount of bound 
between E18 sensory and sympathetic ganglia, suggesting that the magnitude of 
binding is lower in sympathetic ganglia. This finding is consistent with 
experiments I conducted using E19 SCG neurons, which did not survive in the 
presence of any of the cytokines tested (data not shown). Likewise, E21 
sympathetic neurons could not be supported by either CNTF or LIF, but after 5 
days in culture with NGF could be supported by either of these factors on NGF 
withdrawal (ICotzbauer et al., 1994). P6 sympathetic neurons also survive in the 
presence of LIF and CNTF in dissociated cultures (Kotzbauer et at., 1994). 
Taken together these results indicate that cytokine regulated cell survival may be 
dependent upon the timing of receptor synthesis in cytokine responsive neurons.
In summary, my work has demonstrated clear differences in the 
responses of different populations of cranial sensory neurons to cytokines during 
development. Whereas trigeminal neurons survive in response to CNTF, LIF, 
OSM or CT-1 late in development, most nodose neurons respond to these 
cytokines throughout the greater part of their embryonic development and 
additionally acquire responsiveness to IL-6 at late embryonic stages. These 
results suggest complex interactions between neurotrophins and cytokines in 
regulating the survival of different kinds of sensory neurons during 
development.
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The data presented in this thesis show that during development, different 
populations of sensory neurons can respond differently to survival factors. 
Whereas certain populations of neurons can respond to several factors from the 
eaiiy stages of target innervation, other populations undergo a developmental 
switch in their trophic factor requirements.
I have demonstrated that the enteroceptive neurons of the nodose 
ganglion of the mouse survive in the presence of both neurotrophins, BDNF and 
NT-4/5 and the structurally related cytoldnes CNTF, LIF, OSM, and CT-1 from 
the earliest stages of target encounter throughout development and at later stages 
respond to an additional cytokine, IL-6 (see Fig. 6).
Neurotrophin
Independence
c
BDNF-responsive
NT-4/5-responsive
CNTF-responsive
LIF-responsive
GSM-responsive
CT-1-responsive
rE9 T "E llElO E12 El 3 E14 “T "E15 El 6 E17 E18 E19
Figure 6. Summaiy of the developmental responsiveness of mouse nodose ganglion neurons to 
different neurotrophic factors shown in this study. Developmental time is represented from left 
to right in the diagram.
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The cutaneous sensory neurons of the mouse trigeminal ganglion show 
different neurotrophic factor survival requirements to those of the nodose 
ganglion. After their initial period of neurotrophin independence, these neurons 
initially respond transiently to BDNF and NT4/5 (these neurons are also 
transiently responsive to NT-3 during this period (Buchman and Davies, 1993)). 
Trigeminal neurons then undergo a switch in their survival requirements, 
becoming NGF responsive and finally, begin to respond to the structurally 
related cytokines much later in development (see Fig. 7).
Neurotrophin
independence
E9 “T “ElO
BDNF-responsive
NT-4/5-responsive
E ll nE12
NGF-responsive
El 3 E14
_T-
E15 ” T"E16
CNTF-responsive
LIF-responsive
OSM-responsive
CT-1-responsive
E17 E18 -1E19
Figure 7. Summary of the developmental changes in neurotrophic factor responsiveness 
through which trigeminal ganglion neurons pass. Developmental time is represented from left to 
right in the diagram.
Studies of neurons from p75“/“ mice have shown that during the mid- 
embryonic period, the common low affinity receptor p75 enhances the survival 
responses of trigeminal sensory neurons to NGF (Davies et aL, 1993b).
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Similarly, p75 enhances the sensitivity of neurons from the superior cervical 
sympathetic ganglion to NGF, however in this case these neurons show the 
enhanced response postnatally (Lee et aL, 1994). In this study I have 
investigated the p75 modulated NGF survival response using an alternative 
approach. Using a mutated form of NGF that does not significantly bind p75,1 
have shown that p75 also plays a role in mediating the réponse of embryonic 
trigeminal and postnatal superior cervical sympathetic neurons to NGF. The 
reduced survival response of these neurons is not enhanced by addition of cell 
permeable analogues of the lipid second messenger ceramide, which is generated 
by NGF binding to p75 in other cell types (Dobrowsky et aL, 1994). 
Measurement of the relative levels of p75 and trkA mRNA suggest that 
endogenous p75 enhances the NGF survival response when the levels of p75 and 
trIcA mRNA are similai'.
BDNF responsive neurons from chick embryos are not as effectively 
supported by mammalian NT-4/5 or Xenopus NT-4, as with BDNF due to the 
lack of evolutionary conservation of NT-4/5 compared with other neurotrophins. 
The different activity of NT4/5 among different populations of chick neurons 
may be due to the expression of different isoforms of trkB.
In conclusion, the differing developmental survival responses displayed 
by NGF-dependent and BDNF-dependent neurons may be consequence of the 
functional segregation of the different populations of neurons studied.
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Appendix I
MEDIA AND SOLUTIONS
Liebovits’s L-15
This is a medium used for the purpose of dissection only. It is air buffered, and 
is made up from a powdered stock solution supplied by Gibco (Gibco Cat. No. 
41300-021). IL of medium is made up from the powdered stock using double 
distilled de-ionized water (ddH20), and to this add:
lOOmg Streptomycin sulphate 
60mg Penicillin G
The pH is adjusted to 7.3 using HCl or NaOH and the medium is then filter 
sterilised using a 0.22-|im filter.
Ham's F-12
This is an air buffered general puipose medium supplemented with L-glutamine 
which is used for rinsing cells and dishes. The medium is supplied by Gibco as 
a powdered concentrate (Gibco Cat. No. 21700-026). IL of medium is made up 
from powdered stock using ddH20 to this add:
lOOmg Streptomycin sulphate 
60mg Penicillin G
Heat Inactivated Horse Semm (Gibco 26050-039) to 10%
The pH is adjusted to 7.3 using HCl or NaOH the medium is then filter sterilised 
using a 0.22-p,m filter.
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Ham's F“14
This is a specially formulated bicarbonate buffered growth medium used for 
culturing embryonic sensory neurons . The formulation of this medium is based 
on that of Ham's F-12 but contains several modifications. The constituents of 
the medium are as follows.
Amino Acids
L-Alanine 
L-Arginine HCl 
L-Asparagine H2 O 
L-Aspartic Acid 
L-Cysteine HCI.H2 O 
L-Glutamic Acid 
L-Glutamine 
Glycine
L-ffistidineHCl.H20
L-Isoleucine
L-Leucine
L-Lysine HCl
L-Methionine
L-Phenylalanine
L-Proline
L-Serine
L-Threonine
L-Tryptophan
L-Tyrosine
L-Valine
mg/I
17.70
422.00 
30.01 
26.50 
70.32
29.30
292.00
14.90
41.96 
7.94 
26.10
72.90 
8.88
9.96
68.90
20.90
23.90 
4.04 
15.58
23.30
Vitamins
Ascorbic Acid 
d-Biotin
D-Ca Pantothenate 
Choline Chloride 
Folic Acid 
i-Inositol 
Lipoic Acid 
Nicotinamide 
Pyridoxine HCl 
Riboflavin 
Thiamine HCl 
Vitamin B 1 2
mg/1
15.00 
0.00073 
0.48 
13.96 
1.30
18.00 
0.21 
0.037 
0.062 
0.038 
0.34 
1.36
Inorganic Salts
CaCl2.2H2.0
CUSO4 .5 H2 .O
FeS0 4 .7 H2 . 0
KCl
MgS0 4 .6H2.0
M gS 04.7H 2.0
NaCl
NaHCOs
mg/1
283.22
0.000249
0.834
372.80
174
37.00
7599.00
1176.00
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Na2HP04 142.04
ZnS04.7H2.0 0.863
Other Componenets
D-Glucose 1981.80
Hypoxanthine 4.00
Linoleic Acid 0.084
Phenol Red 1.20
Putrescine 2HC1 0.161
Sodium Pyruvate 220.00
Thymidine 0.73
Source: Bai'de et a l (1980)
The medium is supplied by Imperial Laboratories (Cat No. 3-791-35) as a 
powdered concentrate and is made up to IL (from a lOL stock preparation) 
using ddH20, and is stored at -40°C in 50ml aliquots.
To 500ml of F-14 add:
50mg Streptomycin sulphate 
30mg Penicillin G
Alternatively, these antibiotics can be added to the stock preparation.
To make up 500ml F-14 add to the 50ml stock:
450ml ddH20 
Ig NaHCOs
Heat Inactivated Horse Serum to 10%
The pH is adjusted to ~7.0 using CO2  (dry ice) and the medium is filter 
sterilised using a 0.22-p.m filter.
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SATO
SATO medium is a specially formulated defined medium used for culturing 
embiyonic neurons.
To malce up a 222ml stock solution add the following:
Pathocyte-4-BSA
(ICN Biomedicals Cat. No. 810101)
Putrescine (160mg/100ml H2 O)
(Ig) (Sigma P-7505)
Progesterone (lmg/1.6ral EtOH)
(Img) Sigma P-6149
L-Thyroxine (4mg/10ml EtOH)
(4mg) Sigma T- 0397
Sodium selenite (lmg/2.6ml PBS)
(Img) Sigma S-9133
Tri-iodo-thyronine (16.8mg/50ml EtOH) 
(lOOmg) Sigma T-6397
100ml
100ml
1ml
10ml
1ml
10ml
The above ingredients are aliquoted in 11.1ml aliquots, stored at -40"C. Sato 
aliquots (11.1 ml) are added to 500ml Ham's F-14 medium containing Ig 
NaHCOg and 5ml of 200mM glutamine (Gibco Cat. No. 25030-024). The 
medium is then equilibrated to a pH of -7.0 using dry ice. Source Sato, (1985).
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General Solutions 
Borate buffer (0.15M)
4.6g boric acid (Sigma) are dissolved in 500ml ddH20 (pH 8.4 with NaOH). 
This solution is used to dissolve the poly ornithine.
HBSS
Hank's balanced salt solution (Gibco, Cat No. 1410-070) is supplied Ca and Mg 
free. This solution is used to dilute aliquots of laminin and trypsin, and is used 
to trypsinize and suspend dissociated cells prior to placing them on a dropping 
funnel.
KOH
5M KOH 140g KOH pellets (Sigma) in 500ml ddH20. This solution is used for 
making tungsten wire needles.
Laminin
(Sigma L2020) This is a basement membrane protein required for cell 
attatchment. Stored at -70°C. Remove 1ml from freezer and defrost in fridge for 
Ihr. Aliquot 20ml in 1.5ml eppendorfs . This solution is reconstituted with 1ml 
of medium and used to coat 35 mm culture dishes prior to neuronal culture.
Polyornithine (P-ORN)
(Sigma P-8638) Stored at 4“C. 250mg are added to 500ml borate buffer. Filter 
sterilise into 100ml bottles, with 0.22-|im filter. This solution is used for coating 
35 mm tissue culture dishes, prior to adding laminin.
Trypsin
Supplied by Worthington Inc. 50mg are added to 5ml of Ca/Mg free HBSS 
(Gibco). Filter sterilise using a 0.22- pm filter. This solution is used for the 
enzymatic dissociation of ganglionic tissues and is inactivated using Ham's F-12 
+ 10% HIHS.
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Appendix II
SEQUENCE ALIGNMENTS OF THE NEUROTROPHIC FACTORS 
AND THEIR RECEPTORS
I Protein sequence comparisons between the different members of the 
neurotrophin family used in this study,
10 20 30 40 50 60
I I I I I I' I I I I IHuman NGF MSMLFYTLITAFLIGIQAEPHSESNVPAGHTIP QVHVWIOjQHSLDTALRRARSAPAAAIAAR
Human BDNF MTILFLTMVISYFGCMECAAPMKEANIRGQGGLAYPGVRTHGTLESVNGPKAGSRGLTSLADTFEHV
Human NT-4/5 M-LPL--------- PSCSLPIL------- LLFLL--PSVPIESQPPPS-----------TLPPF
Xenopus NT4 MILRLYAM7ISY-CCAICAAPFQSRT TDLDYGPDKTSEASDRQSVPN---------- NFSHV
70 80 90 100 110 120 130
Human NGF VAG QTRNITVDPRLFKKRRLRSPRVLFSTQPPREAAD TQDLDFEVGGAAPFNRTHRSKRS
Human BDNF lEELLDEDQKVRPNEENNKDADLYTSRVMLSSQVPLEPPLLFLLEEYKNYLDAANMSMRVRRHSDP
Human NT-4/5 L--------------- APEWDLLSPRWLSRGAPAGPPLLFLLEAGAFRESAGAPANRSRRGV-S
Xenopus NT4 LQNGFFPDLSSTYSSMAGKDWNLYSPRVTLSSEEPSGPPLLFLSEETWHPEPANKTSRLKRASGS
140 150 160 170 180 190I I I I I I
| a o o | | o * « | | |  *  a  a  |  a  a  a  a  a a |  |  |  |  a  a  a | a  a | a
Human NGF SSHPIFHRGEFSVCDSVSVW— GDKTTATDIKGKEVMVLGEVNINN-SVFKQYFFETKCRDPNPV
Human BDNF  ARRGELSVCDSISEWVTAADKKTAVDMSGGTVTVLEKVPVSKG-QLKQYFYETKCNP-
Human NT-4/5 ETAPASRRGELAVCDAVSGWVT— DRRTAVDLRGREVEVLGEVPAAGGSPLRQYFFETRCKADNAE 
Xenopus NT4 DSVSLSRRGELSVCDSVNVWVT— DKRTAVDDRGKIVTVMSEIQTLTG-PLKQYFFETKCNP---
200 210 220 230 240 250I I I I I I
a  a  a  I a  | | a  a  a  j | | | a | e a e  a | |  |  a  a  a a a a a j a a a  a  | a  |
Human NGF DSG------ CRGIDSKHWNSYCTTTHTFVKALTMDGKQ-AAWRFIRIDTACVCVLSRKAVRRA
Human BDNF  MGYTKEGCRGIDKRHWNSQCRTTQSYVRALTMDSKKRIGWRFIRIDTSCVCTLTIKRGR
Human NT-4/5 EGGPGAGGGGCRGVDRRHWVSEa<AKQSYVRALTADAQGRVGWRWIRIDTACVCTLLSRTGR-A 
Xenopus NT4  SGSTTRGCRGVDKKQWISECKAKQSYVRALTIDANKLVGWRWIRIDTACVCTLLSRTGR-T
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II Protein sequence comparisons between the different members of the 
neurotrophin receptor tyrosine kinase family of proteins.
10 20 30 40 50 60
• I »  « • •  | j * a « » | | *  I «Human TrkA MLRGGRRGQIiGWHSWAAGPGSLL AWLILA-SAGAAPCPDAC-CPHGSSGIJlCTRDGA-IiDSDHHIiHuman TrkB MS--------- SWIRWHQPAMAKL.WGFCWI1WGFWRAAPACPTSCKCSASR— IWCSDPSPGIVAPPRLHuman TrkC MDVSLCPAKCSF— WR IPLLGSVWD— DYVGSVLACPANCVC— SKTEINCRRPDDG-NIjFPLL
70 80 90 100 110 120 130
Human TrJcA Human TrkB Human TrkC
Human TrkA Human TrkB Human TrkC
Human TrkA Human TrkB Human TrkC
Human TrkA Human TrkB Human TrkC
I «  | . | o « j o ] | |  «  I . | | . . .  «  I I • •P  GAEN-------------- IiTErjYIENQQHLQHriELRDBRGLGELRNBTIVKSGLRFVAPDAFHFEPNSVDPEN-------------- ITEIFIANQKRI,ElINEDDVEAyVGI.BKIIiTIVnSGI.KFVAHKAFI»KEGQDSGNSNGNANINITDISRNITSIHIENWRSLHTUNAVDMELYTGLQKLTIKNSGBRSIQPRAPAK
140 150 170
I
180 
. I
190.1 200160
I I »  I «  I I '  "  I " I I I » » » . .  . | . , . ] » | |  I »  I ITPRLSRLNIjSFNAIiESLSWKTVQGLSLQELVI.SGNPIjHCSCAIjRWIjQRWEEEGL.GGVPEQKLQCHGQGNSNLQHINFTRNKI.TSLSRKHFRHIjDIjSEIiILVGWPFTCSCDIMWIKTL.QE-AKSSPDTQDLYCrJSIESNPHLRYIuriSSNRLTTLSWQLFQTLSIjRELQriEQNFFNCSCDIRWMQLWQEQGEAItlJSfSQMLYCINAD
210 2 2 0 230 240 250
1*1
260 270
 PLAHMPNASCGVPTBICVQVPNASVDVGDDVtiLRCQVEGRGLEQAGWILTELEQSATV MKSGSKNIPIiANrjQIPNCGLPSANtiAAPNLTVEEGKSITLSCSVAGDPVPNMYWDVGNL— VSKH MNETGSQLPtiFRMNISQCDLPEISVSHVNLTVREGDNAVXTCNGSGSPLPDVDWIVTGLQSINTHQTNLNWT
280 290 300
1*1
310 320 330 340
. I
I I « I I I I « I I IGIiPSLGIiTLANVTSDIiNRKNLTCWAENDVGRAEVSVQVNVSPPASVQ-LHTAVEMHHWSIPFSVDGQPSHTQGSLRITNISSDDSGKQISCVAENI.VGEDQDSVNLTVHPAPTITFLESPTSDHHWC1PFTVICGNPNVHAINLTLVNVTSEDNGFTLTCIAENWGMSNASVALTVYSTPPRWSLEEPELRriEHCIEFWRGNP
350 360 370 380 390 400
“ ' I I *  I I * * *  i l l * ' *  * * * | * » » | *  * I *  » IHuman TrkA APSLRWLFNGSVLNETSFIFTEFBEPAflJSTETVRHGCBRLNQPTHVNNGiSIYTLLjAANPFGQASASIMAA Human TrkB KPALQWFYNGAIIiNESICYICTKI— HVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAH Human TrkC PPTLHWIiHNGQPLRESKIIHVEYYQEG EISEGCLLFNKPTHYNNGNYTLIAKNPIiGTANQTINGH
410 420 430 460
I
470440 450
• I  .  I i l  '  I '  ...................................Human TrkA FMDNP-FEFNPEDPIPD---------TNSTSGDPVEKKDETP------------------FGVSVAVGLAVFHuman TrkB FMGWPGIDDGANPNYPDVIYEDYGTAANDIGDTTNRSNEIPSTDVTDKTGREHLSVYAVWIASWGF Human TrkC FLKEP-FPESTDNF ILFDEVSPT---------------- PPITVTHKPEED---TFGVSIAVGIAAF
480 490 500 510 520 530 540
' I I I  I I I  I I * I I ' "  I I *  * 1 1  i l l  '  I "  I '  I '  I I I  I I  IHuman TrlcA ACLFLSTLLLVLNKCGRRNKFGINRPA-VIAPEDGLAMSIJHFMTBGGSSLSPTEGKGSGL----- QGHHuman TrlcB -CLLVMLFLLKL ARHSKPGMKGPASVISNDDDSASPLHHISMGSNTPSSSEGGPDAVI IGMTKl PHuman TrkC ACVBriWLFVMINKYGRRSKPGMKGPVAVISGEEDSASPLHHINHGITTPSSIjDAGPDTVVIGMTRIP
Human TrkA Human TrkB Human TrkC
Human TrkA Human TrkB Human TrkC
550 560 570 580 590 600 610
I »  «  » » » « « * 1 '  * 1 1 1  t i l l *  * * lI lENPQYFS--------- DACVHHIKRRDIVriKWEDGEGAFGKVFLAECHNLEiPEQDKMIjVAVKAriKEAVIENPQYFGITNSQLKPDTFVQHIKRHKIVLKREIiGEGAFGKVFIiAEC'XNLCPEQDKILVAVKTLKDA VIENPQYFRQGHNCHKPDTWV---------------------FSNI------------DNHGIL NLKD-
620
I
630
I ,
640 650
I
660 670 680
SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV SDNARKDFHREAELLTNIjQHEHlVKFYGVCVEGDPLIMVFEYMKHGDIiNKFBRAHGPDAVBMAEGN—   --------------------NRDHXjV --------------------------------------PSTHYl YEEPEV
690 700
I
710
I
720 740730
I * I '  I I '  '  I 1 1 * 1  I I 'Human TrkA APGPLGLGQLLAVASQVAAGMVYIoAGLHFVHRDLATRNCI.VGQGt.WKIGDFGMSRDIYSTDYYR.VGG Human TrkB PPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG Human TrkC QSGEVS------------------ YPRSHGF-REIMLNPISLPGHSKPLNHGIYVEDVNVY----------
750 760 770 780 790 800
I - I
810
Human TrkA RTMLPIRWMPPESILYRKFTTESDVWSFGWLVJEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACP Human TrkB HTMLPIRV®ÏPPESIMYRKFTTESDVWSLGWLWEIFTYGKQPWYQLSNNEVÏECITQGRVLQRPRTCP Human TrkC ----------------------------------------- FSKGRHGF
820
I
830 840 850
o«B»»oo| « j » * I I » I •»Human TrlcA PEVYAÎMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG Human TrkB QEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLDILG Human TrkC
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I l l  Protein sequence compaiisons between the neurotrophic cytokines used in 
this study.
10 20 30 40 50 60
Human CNTF 
Human LIF 
Human GSM 
Human IL-6 
Human CT-1
Human CNTF 
Human LIF 
Human GSM 
Human IL-6 
Human CT-1
MA— FTEHSPLTLHRRDL----------- CSRSIWL------ ARKIRSDLTALTESYVKHQGLNKN
 GSPLPITPV-------- NATCAIRHPCHNNLMNQIRSQLAQ-LNGSANALFILYYTAQG-EPF
MGVLLTQRTLLSLVLALLFPSMASMAAIGSCSKEYRVLLGQLQKQTDLMQDTSRLLDPYIRIQGLDVP 
MNSFSTSAPGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQP-LTSSERIDKQIRYILDGISAL 
MSRREGSLEDPQT-------- DSSVSL-LPHLEAKIRQTHSIAHL-LTKYAEQLLQEYVQLQG-DPF
70
I
80
I
90 100 110 120 130
INLDSADC3ÆPVA— STDQWSELTEA-- ERLQENLQ-AYRTFHVLLARLLEDQQVH FTPTEGDFH
— PN-NLDKL--- CGPNVTDFPPFHANGTEKAKLVELYRIWYLGTSLGNITRDQKI-LNPSALSLH
KLREHCRERPGAFPSEETLRGLGRRGFLQTLNATLGCVLHRLADLEQRLPKAQDLERSGLNIEDLEKL
RKETCNKSNM CESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLE-FEVYLEYLQ
GLPSFSPPRL PVAGLSAPAPSHAGLPVHERLRLDAAALAALPPLLDAVCRRQAE-LNPRAPRLL
140 150 160 170 180 190 200
Human CNTF QAIHTLLLQVAAFAYQIEELMILLEYKIPANEADGM PINVGDGGLFENKLWGLKVLQE------
Human LIF SKLNATADILRGL LSNVLCRLCSKYHVGHVD— VTYGPDTSGKDVFQKKKLGCQLLG--K----
Human GSM QMARPNILGLRNNIYCMAQLLDNSDTAEPTKAGRGASQPPTPTPASDAFQRKLEGCRFLHGYHRFMHS
Human IL-6 NRFESSEEQARAVQMSTKVLIQFL— QKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQD--MTTHL
Human CT-1 RRLEDAARQARALGAAVEALLAALGAANRGPRAEPPAATASAASATGVFPAKVLGLRVCG--L----
210 220 230 240
Human CNTF  LSQWTVRSIHDLRFISSHQTGIPARGSHYIANNKKM
Human LIF  YKQ IIAVLA-------------------- QAF
Human GSM VGRVFSKWGESPNRSRRHSPHQALRKGVRRTRPSRKGKRLMTRGQLPR
Human IL-6 ILRSFKEFLQSSLRALR-------------------- QM
Human CT-1  YREWLSRTEGDLG-------------------- QLLPGG— SA
262
